Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA single nuclei brain specificity"	"RNA single nuclei brain distribution"	"RNA single nuclei brain specificity score"	"RNA single nuclei brain specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA tissue cell type enrichment"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"Secretome function"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Brain expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	Interactions	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Cancer prognostics - Bladder Urothelial Carcinoma (TCGA)"	"Cancer prognostics - Breast Invasive Carcinoma (TCGA)"	"Cancer prognostics - Breast Invasive Carcinoma (validation)"	"Cancer prognostics - Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (TCGA)"	"Cancer prognostics - Colon Adenocarcinoma (TCGA)"	"Cancer prognostics - Colon Adenocarcinoma (validation)"	"Cancer prognostics - Glioblastoma Multiforme (TCGA)"	"Cancer prognostics - Glioblastoma Multiforme (validation)"	"Cancer prognostics - Head and Neck Squamous Cell Carcinoma (TCGA)"	"Cancer prognostics - Kidney Chromophobe (TCGA)"	"Cancer prognostics - Kidney Renal Clear Cell Carcinoma (TCGA)"	"Cancer prognostics - Kidney Renal Clear Cell Carcinoma (validation)"	"Cancer prognostics - Kidney Renal Papillary Cell Carcinoma (TCGA)"	"Cancer prognostics - Liver Hepatocellular Carcinoma (TCGA)"	"Cancer prognostics - Liver Hepatocellular Carcinoma (validation)"	"Cancer prognostics - Lung Adenocarcinoma (TCGA)"	"Cancer prognostics - Lung Adenocarcinoma (validation)"	"Cancer prognostics - Lung Squamous Cell Carcinoma (TCGA)"	"Cancer prognostics - Lung Squamous Cell Carcinoma (validation)"	"Cancer prognostics - Ovary Serous Cystadenocarcinoma (TCGA)"	"Cancer prognostics - Ovary Serous Cystadenocarcinoma (validation)"	"Cancer prognostics - Pancreatic Adenocarcinoma (TCGA)"	"Cancer prognostics - Pancreatic Adenocarcinoma (validation)"	"Cancer prognostics - Prostate Adenocarcinoma (TCGA)"	"Cancer prognostics - Rectum Adenocarcinoma (TCGA)"	"Cancer prognostics - Rectum Adenocarcinoma (validation)"	"Cancer prognostics - Skin Cuteneous Melanoma (TCGA)"	"Cancer prognostics - Stomach Adenocarcinoma (TCGA)"	"Cancer prognostics - Testicular Germ Cell Tumor (TCGA)"	"Cancer prognostics - Thyroid Carcinoma (TCGA)"	"Cancer prognostics - Uterine Corpus Endometrial Carcinoma (TCGA)"
ACE	"ACE1, CD143, DCP1"	ENSG00000159640	"Angiotensin I converting enzyme"	P12821	17	63477061-63498380	"Candidate cardiovascular disease genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"Calmodulin-binding, Carboxypeptidase, Hydrolase, Metalloprotease, Protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 257.7;testis: 99.0"	"Group enriched"	"Detected in many"	20	"Early spermatids: 373.5;Late spermatids: 1317.0;Proximal enterocytes: 1039.2"	"Cell type enhanced"	"Detected in many"		"endothelial cell: 5.9;medium spiny neuron: 7.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"memory B-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cancer enhanced"	"Detected in many"		"Neuroblastoma: 17.2"	"Adipose subcutaneous - Adipose progenitor cells, Kidney - Proximal tubular cells, Kidney - Proximal tubular cells, Pituitary gland - Corticotropes, Skin - Fibroblast_1, Testis - Late spermatids, Thyroid gland - Fibroblasts"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002426, CAB002921, HPA029298, HPA069790"	Enhanced		Approved	Vesicles	"Secreted to blood"	Enzyme	NA	NA	104000000	130000000	"Cluster 14: Non-specific - Unknown function"	"Cluster 25: Small intestine - Absorption"	"Cluster 33: Neurons - Mixed function"	"Cluster 11: Neuronal - Sensory perception"	"Cluster 22: Proximal enterocytes - Digestion"	4	Vesicles		"CAB002426: AB_442052, CAB002921: , HPA029298: AB_10960255, HPA069790: AB_2686197"	"unprognostic (2.23e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.07e-2)"	"unprognostic (4.01e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.68e-1)"	"unprognostic (4.46e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.90e-1)"	"validated prognostic favorable (2.65e-5)"	"validated prognostic favorable (2.01e-4)"	"unprognostic (4.85e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.62e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.67e-1)"	"unprognostic (9.69e-3)"	"unprognostic (1.32e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.16e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.71e-1)"	"unprognostic (6.94e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.92e-2)"
ACP3	"ACP-3, ACPP, PAP, TM-PAP"	ENSG00000014257	"Acid phosphatase 3"	P15309	3	132317369-132368302	"Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Lipid metabolism"	Hydrolase	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	76	"prostate: 3512.4"	"Cell type enriched"	"Detected in many"	443	"Prostatic glandular cells: 16688.0"	"Cell type enriched"	"Detected in some"	4	"central nervous system macrophage: 55.6"	"Cancer enriched"	"Detected in many"	268	"Prostate Adenocarcinoma (TCGA): 2890.7"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 139.9"	"Lineage enhanced"	"Detected in many"		"granulocytes: 139.9"	"Cancer enriched"	"Detected in many"	36	"prostate cancer: 250.9"	"Adipose subcutaneous - Macrophages, Adipose visceral - Macrophages, Adrenal gland - Adrenal cortex cells, Breast - Breast glandular cells, Lung - Alveolar cells type 2, Prostate - Prostate glandular cells, Spleen - Neutrophils"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB000071, HPA004335, HPA063916"	Enhanced				"Secreted to blood"	Enzyme	NA	NA	460000	470000	"Cluster 7: Non-specific - Innate immune response"	"Cluster 64: Neuronal - Transcription"	"Cluster 55: Non-specific - Transcription"	"Cluster 60: Prostate cancer - Unknown function"	"Cluster 40: Prostatic glandular cells - Transcription"	2			"CAB000071: , HPA004335: AB_1079684, HPA063916: AB_2685152"	"unprognostic (7.88e-2)"	"unprognostic (1.70e-1)"		"unprognostic (2.87e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.05e-2)"	"unprognostic (4.42e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.36e-1)"		"unprognostic (1.54e-1)"				"unprognostic (7.46e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.14e-1)"	"unprognostic (4.84e-2)"	"unprognostic (3.99e-2)"	"unprognostic (4.19e-1)"	"unprognostic (8.01e-2)"	"unprognostic (9.41e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.26e-3)"	"unprognostic (7.95e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.68e-1)"
ALB		ENSG00000163631	Albumin	P02768	4	73397114-73421482	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	136	"liver: 205952.1"	"Cell type enriched"	"Detected in many"	4	"Hepatocytes: 59612.0"	"Low cell type specificity"	"Detected in many"			"Cancer enriched"	"Detected in many"	407	"Liver Hepatocellular Carcinoma (TCGA): 38403.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in many"	24	"liver cancer: 1846.4"	"Kidney - Proximal tubular cells, Liver - Hepatocytes"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB006262, HPA031024, HPA031025"	Enhanced		Approved	"Endoplasmic reticulum,Golgi apparatus"	"Secreted to blood"	Transport	NA	NA	40000000000000			"Cluster 31: Liver - Plasma proteins"	"Cluster 33: Neurons - Mixed function"	"Cluster 18: Liver cancer - Metabolism"	"Cluster 43: Hepatocytes - Metabolism"	24	"Endoplasmic reticulum, Golgi apparatus"		"CAB006262: AB_425297, HPA031024: AB_2673703, HPA031025: AB_2673704"	"unprognostic (6.95e-3)"	"unprognostic (2.77e-1)"	"unprognostic (7.30e-2)"	"unprognostic (6.46e-2)"							"validated prognostic favorable (3.80e-4)"	"validated prognostic favorable (3.74e-4)"	"unprognostic (2.18e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.17e-3)"	"unprognostic (1.17e-2)"	"unprognostic (7.56e-2)"	"unprognostic (2.47e-1)"	"unprognostic (3.17e-1)"			"unprognostic (4.51e-2)"	"potential prognostic unfavorable (8.71e-4)"	"unprognostic (3.58e-2)"	"unprognostic (2.35e-1)"		"unprognostic (3.31e-1)"	"unprognostic (1.95e-3)"	"unprognostic (5.35e-2)"	"unprognostic (1.69e-3)"	"unprognostic (2.59e-1)"
AMY2A	AMY2	ENSG00000243480	"Amylase alpha 2A"	P04746	1	103617427-103625780	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted secreted proteins"	"Carbohydrate metabolism"	"Glycosidase, Hydrolase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4638	"pancreas: 148982.6"	"Cell type enriched"	"Detected in some"	135	"Exocrine glandular cells: 251.1"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	1678	"Pancreatic Adenocarcinoma (TCGA): 1235.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Pancreas - Exocrine glandular cells"									"HPA045394, HPA045399, CAB045960, HPA046980"	Enhanced		Approved	"Golgi apparatus,Cytosol"	"Secreted to digestive system"	Enzyme	NA	NA				"Cluster 15: Pancreas - Proteolysis"	"Cluster 51: Neurons - Mixed function"	"Cluster 24: Non-specific - Unknown function"	"Cluster 60: Pancreatic exocrine cells - Proteolysis"	6	"Golgi apparatus, Cytosol"		"CAB045960: AB_2226891, HPA045394: AB_2679311, HPA045399: AB_2679313, HPA046980: AB_2679889"			"unprognostic (3.64e-1)"																			"unprognostic (1.95e-1)"	"unprognostic (1.01e-1)"								
ANGPT2	Ang2	ENSG00000091879	"Angiopoietin 2"	O15123	8	6499632-6563409	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins, RAS pathway related proteins"	"Angiogenesis, Differentiation"	"Developmental protein"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"Lymphatic endothelial cells: 498.2"	"Cell type enhanced"	"Detected in all"		"endothelial cell: 236.5"	"Cancer enhanced"	"Detected in all"		"Kidney Renal Clear Cell Carcinoma (TCGA): 44.7"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.6"	"Low lineage specificity"	"Detected in single"			"Cancer enhanced"	"Detected in many"		"ovarian cancer: 10.4"	"Breast - Endothelial cells, Colon - Endothelial cells, Heart muscle - Endothelial cells, Liver - Vascular Endothelial cells, Prostate - Endothelial cells, Skeletal muscle - Endothelial cells, Skin - Endothelial cells, Testis - Endothelial cells"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB011437, CAB017626"	Approved				"Secreted to blood"	"Developmental protein"	NA	NA	3780000	130000	"Cluster 34: B-cells - Unknown function"	"Cluster 34: Non-specific - Mixed function"	"Cluster 49: Hindbrain - Mixed function"	"Cluster 15: Kidney cancer - Membrane components"	"Cluster 54: Lymphatic endothelial cells - Lymph vessel development"	5			"CAB011437: , CAB017626: AB_1118956"	"unprognostic (8.64e-2)"	"unprognostic (6.31e-2)"	"unprognostic (3.30e-2)"	"potential prognostic unfavorable (2.43e-4)"	"unprognostic (2.31e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.94e-3)"	"unprognostic (9.20e-3)"	"unprognostic (1.42e-2)"	"potential prognostic unfavorable (1.27e-4)"	"validated prognostic unfavorable (7.06e-5)"	"validated prognostic unfavorable (4.83e-5)"	"unprognostic (2.51e-2)"	"unprognostic (2.45e-3)"	"unprognostic (3.96e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.85e-2)"	"unprognostic (2.02e-3)"	"unprognostic (4.40e-3)"	"unprognostic (3.32e-2)"	"unprognostic (1.16e-1)"	"unprognostic (8.78e-2)"	"unprognostic (8.55e-2)"	"unprognostic (2.11e-3)"	"potential prognostic unfavorable (4.53e-4)"	"unprognostic (2.59e-1)"	"unprognostic (8.48e-3)"	"unprognostic (4.03e-2)"
ANGPTL3	ANGPT5	ENSG00000132855	"Angiopoietin like 3"	Q9Y5C1	1	62597520-62606313	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Angiogenesis, Cell adhesion, Lipid metabolism"	Heparin-binding	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"liver: 655.3"	"Group enriched"	"Detected in some"	22	"Hepatocytes: 694.2;Proximal tubular cells: 210.2"	"Cell type enhanced"	"Detected in single"		"astrocyte: 1.4"	"Cancer enriched"	"Detected in some"	24	"Liver Hepatocellular Carcinoma (TCGA): 124.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	39	"liver cancer: 9.2"	"Kidney - Proximal tubular cells, Liver - Hepatocytes, Liver - Hepatocytes, Stomach - Parietal cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA038097	Approved				"Secreted to blood"	"Cell adhesion"	NA	NA	225000000	88000000		"Cluster 1: Liver & Kidney - Metabolism"	"Cluster 31: Non-specific - Transcription"	"Cluster 18: Liver cancer - Metabolism"	"Cluster 43: Hepatocytes - Metabolism"				"HPA038097: AB_10675628"											"validated prognostic favorable (7.27e-6)"	"validated prognostic favorable (4.89e-5)"	"unprognostic (2.32e-2)"	"unprognostic (6.44e-2)"	"potential prognostic favorable (6.81e-5)"								"unprognostic (8.64e-2)"	"unprognostic (7.02e-2)"							
ANXA1	"ANX1, LPC1"	ENSG00000135046	"Annexin A1"	P04083	9	73151865-73170393	"Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Adaptive immunity, Immunity, Inflammatory response, Innate immunity"	"Phospholipase A2 inhibitor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 7281.3"	"Cell type enhanced"	"Detected in many"		"granulocytes: 3470.5;Squamous epithelial cells: 3652.5;Suprabasal keratinocytes: 8372.3;Syncytiotrophoblasts: 8404.5"	"Group enriched"	"Detected in many"	13	"endothelial cell: 140.6;ependymal cell: 259.6;fibroblast: 148.8;leukocyte: 226.5;vascular associated smooth muscle cell: 74.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 2824.3"	"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"				"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011271, HPA011272, CAB013023, CAB035987, CAB058693, CAB080415"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to blood"	Immunity	NA	Yes	17600000	1200000000	"Cluster 42: Non-specific - Vesicular transport"	"Cluster 29: Squamous epithelium - Innate immune response"	"Cluster 39: Astrocytes - Mixed function"	"Cluster 5: Rhabdoid - Unknown function"	"Cluster 59: Suprabasal keratinocytes - Cornification"	32	"Plasma membrane, Cytosol"	Nucleoplasm	"CAB013023: AB_2533983, CAB035987: , CAB058693: AB_2665585, CAB080415: , HPA011271: AB_1844883, HPA011272: AB_1844884"	"unprognostic (2.41e-3)"	"unprognostic (9.20e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.39e-2)"	"unprognostic (2.17e-2)"	"unprognostic (5.11e-3)"	"unprognostic (8.49e-2)"	"unprognostic (4.02e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.11e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.63e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.86e-3)"	"unprognostic (3.66e-3)"	"unprognostic (3.30e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.76e-3)"	"unprognostic (1.51e-1)"	"unprognostic (3.59e-2)"	"unprognostic (4.87e-2)"	"potential prognostic favorable (8.16e-4)"	"unprognostic (2.84e-2)"
ANXA2	"ANX2, ANX2L4, CAL1H, LIP2, LPC2D"	ENSG00000182718	"Annexin A2"	P07355	15	60347134-60402883	"Cancer-related genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Host-virus interaction"	RNA-binding	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 2124.0"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 5295.0;Ductal cells: 3448.7;Pancreatic endocrine cells: 3363.7"	"Cell type enhanced"	"Detected in many"		"ependymal cell: 101.5;fibroblast: 169.0;vascular associated smooth muscle cell: 96.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 4446.3;classical monocyte: 2767.4;intermediate monocyte: 2404.9;myeloid DC: 4023.2;non-classical monocyte: 2699.3;T-reg: 1686.0"	"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Pancreas - Ductal cells"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 213.0"	"CAB004311, HPA046964, HPA061798"	Enhanced		Approved	"Plasma membrane,Cytosol"	"Secreted to blood"	Other	NA	NA	26700000000	23000000	"Cluster 10: Non-specific - Membrane trafficking"	"Cluster 75: Epithelium - Extracellular exosomes"	"Cluster 12: Non-specific - Vasculature"	"Cluster 72: Neuronal - Signal transduction"	"Cluster 45: Non-specific - Mixed function"	49	"Plasma membrane"	Cytosol	"CAB004311: AB_626677, HPA046964: AB_2732537, HPA061798: AB_2732671"	"unprognostic (3.58e-3)"	"unprognostic (1.72e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.13e-2)"	"unprognostic (1.89e-3)"	"potential prognostic unfavorable (1.89e-4)"	"unprognostic (1.41e-3)"	"unprognostic (1.44e-2)"	"potential prognostic unfavorable (4.91e-4)"	"unprognostic (3.19e-2)"	"unprognostic (5.16e-2)"	"validated prognostic unfavorable (7.78e-4)"	"validated prognostic unfavorable (5.03e-4)"	"potential prognostic unfavorable (1.13e-4)"	"unprognostic (1.89e-2)"	"unprognostic (2.44e-2)"	"unprognostic (2.35e-3)"	"unprognostic (1.67e-2)"	"unprognostic (4.36e-2)"	"potential prognostic unfavorable (1.38e-5)"	"unprognostic (9.67e-3)"	"unprognostic (5.95e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.63e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.14e-1)"	"unprognostic (9.57e-2)"	"unprognostic (2.86e-2)"	"unprognostic (8.85e-3)"
APOC3	"Apo-C3, Apo-CIII, ApoC-3, ApoC-III, APOCIII"	ENSG00000110245	"Apolipoprotein C3"	P02656	11	116829706-116833072	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism, Lipid transport, Transport"		"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	25	"liver: 26980.2"	"Cell type enriched"	"Detected in some"	9	"Hepatocytes: 87587.5"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in many"	453	"Liver Hepatocellular Carcinoma (TCGA): 11879.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	4	"liver cancer: 40.4"	"Kidney - Proximal tubular cells, Liver - Hepatocytes"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA065365, HPA073918"	Supported		Approved	"Nucleoplasm,Nucleoli,Cell Junctions"	"Secreted to blood"	Apolipoprotein	NA	NA	106000000000	27000000000		"Cluster 31: Liver - Plasma proteins"		"Cluster 18: Liver cancer - Metabolism"	"Cluster 43: Hepatocytes - Metabolism"	8	Nucleoplasm	"Nucleoli, Cell Junctions"	"HPA065365: AB_2732733, HPA073918: "			"unprognostic (7.06e-1)"								"unprognostic (7.88e-2)"	"unprognostic (2.55e-3)"	"unprognostic (3.22e-1)"	"validated prognostic favorable (3.08e-4)"	"validated prognostic favorable (2.30e-4)"							"unprognostic (1.55e-1)"	"unprognostic (1.11e-1)"		"unprognostic (4.06e-1)"			"unprognostic (2.96e-3)"	"unprognostic (4.05e-2)"		
APP	"AD1, alpha-sAPP"	ENSG00000142192	"Amyloid beta precursor protein"	P05067	21	25880535-26171128	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Apoptosis, Cell adhesion, Endocytosis, Notch signaling pathway"	"Heparin-binding, Protease inhibitor, Serine protease inhibitor"	"Alzheimer disease, Amyloidosis, Disease variant, FDA approved drug targets, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 810.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"plasmacytoid DC: 36.4"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 36.4"	"Low cancer specificity"	"Detected in all"			"Thyroid gland - Thyroid glandular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000157, HPA001462"	Enhanced		Supported	"Golgi apparatus,Vesicles"	"Secreted to blood"	"Cell adhesion"	NA	NA		96000000	"Cluster 2: Dendritic cells - Unknown function"	"Cluster 34: Non-specific - Mixed function"	"Cluster 27: Non-specific - Mixed function"	"Cluster 15: Kidney cancer - Membrane components"	"Cluster 54: Lymphatic endothelial cells - Lymph vessel development"	492	"Golgi apparatus"	Vesicles	"CAB000157: AB_323833, HPA001462: AB_1078185"	"unprognostic (5.14e-2)"	"unprognostic (3.42e-1)"	"unprognostic (2.22e-1)"	"unprognostic (3.69e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.28e-1)"	"unprognostic (4.67e-3)"	"unprognostic (1.03e-1)"	"validated prognostic favorable (8.44e-9)"	"validated prognostic favorable (1.85e-5)"	"unprognostic (1.82e-1)"	"unprognostic (1.43e-1)"	"unprognostic (9.93e-2)"	"unprognostic (8.97e-3)"	"unprognostic (3.91e-2)"	"unprognostic (6.82e-3)"	"unprognostic (9.35e-3)"	"unprognostic (5.29e-2)"	"unprognostic (6.25e-2)"	"unprognostic (1.31e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.96e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.43e-1)"	"unprognostic (3.59e-1)"	"unprognostic (4.49e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.46e-2)"
BCHE	"CHE1, CHE2, E1"	ENSG00000114200	Butyrylcholinesterase	P06276	3	165772904-165837462	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Serine esterase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	13	"liver: 508.2"	"Group enriched"	"Detected in many"	7	"Hepatocytes: 505.6;Mesothelial cells: 169.6;Oligodendrocyte precursor cells: 197.2"	"Cell type enhanced"	"Detected in many"		"committed oligodendrocyte precursor: 92.9;oligodendrocyte precursor cell: 269.3"	"Group enriched"	"Detected in many"	5	"Glioblastoma Multiforme (TCGA): 72.4;Kidney Renal Papillary Cell Carcinoma (TCGA): 18.8;Liver Hepatocellular Carcinoma (TCGA): 41.4;Skin Cuteneous Melanoma (TCGA): 40.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Adipose visceral - Mesothelial cells, Kidney - Proximal tubular cells, Liver - Hepatocytes, Minor Salivary Gland - Fibroblasts, Pituitary gland - Corticotropes, Prostate - Smooth muscle cells, Testis - Early spermatids"	"Low region specificity"	"Detected in all"							HPA001560	Approved				"Secreted to blood"	Enzyme	NA	NA	3820000000	5500000000		"Cluster 83: Liver - Metabolism"	"Cluster 13: Oligodendrocytes - Mixed function"	"Cluster 51: Myeloma - Immunoglobulins"	"Cluster 43: Hepatocytes - Metabolism"	8			"HPA001560: AB_1078271"	"unprognostic (1.09e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.03e-2)"			"unprognostic (5.73e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.61e-1)"	"potential prognostic unfavorable (3.23e-5)"		"unprognostic (7.08e-2)"	"unprognostic (1.70e-3)"	"unprognostic (2.70e-1)"	"unprognostic (1.72e-1)"	"unprognostic (9.56e-3)"	"unprognostic (1.28e-1)"	"unprognostic (7.94e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.58e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.09e-1)"		"unprognostic (7.71e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.60e-3)"	"unprognostic (1.01e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.71e-2)"
BGLAP	OCN	ENSG00000242252	"Bone gamma-carboxyglutamate protein"	P02818	1	156242184-156243317	"FDA approved drug targets, Predicted secreted proteins"	Biomineralization	Hormone	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 7.1;intestine: 8.3"	"Cell type enhanced"	"Detected in some"		"Distal tubular cells: 3.1;Serous glandular cells: 2.3;Sertoli cells: 2.7"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	17	"NK-cell: 1.8;plasmacytoid DC: 1.6"	"Group enriched"	"Detected in many"	17	"dendritic cells: 1.6;NK-cells: 1.8"	"Cancer enhanced"	"Detected in some"		"Leukemia: 5.8;Myeloma: 14.4"	"Colon - Enteric glia cells"	"Region enriched"	"Detected in single"	7	"olfactory bulb: 5.3"	"Low region specificity"	"Detected in all"								"Secreted to blood"	Hormone	NA	NA	15500000	2100000	"Cluster 8: Plasmacytoid DCs - Unknown function"	"Cluster 60: Choroid plexus - Transmembrane transport"	"Cluster 30: White matter - Myelination"	"Cluster 51: Myeloma - Immunoglobulins"	"Cluster 77: Plasma cells - Protein processing"					"unprognostic (1.42e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.14e-1)"	"unprognostic (7.82e-3)"		"unprognostic (1.06e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.22e-3)"	"unprognostic (9.32e-3)"	"unprognostic (1.81e-1)"			"unprognostic (1.27e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.07e-2)"					"potential prognostic favorable (1.82e-4)"	"unprognostic (4.13e-3)"	"unprognostic (3.54e-1)"		"unprognostic (1.68e-1)"		"unprognostic (2.36e-1)"	"unprognostic (1.48e-1)"	"unprognostic (8.21e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.42e-1)"	"unprognostic (7.64e-2)"
C1S		ENSG00000182326	"Complement C1s"	P09871	12	6988259-7071032	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Disease variant, Ehlers-Danlos syndrome, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"liver: 2762.6"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 717.8;Hepatocytes: 2248.0;Leydig cells: 1204.3;Mesothelial cells: 578.3;Ovarian stromal cells: 401.7;Peritubular cells: 631.2"	"Cell type enriched"	"Detected in all"	5	"fibroblast: 348.0"	"Cancer enhanced"	"Detected in all"		"Liver Hepatocellular Carcinoma (TCGA): 745.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Adipose subcutaneous - Adipose progenitor cells, Adipose visceral - Adipose progenitor cells, Breast - Fibroblasts, Liver - Hepatocytes, Lung - Fibroblast_2, Skin - Fibroblast_2, Spleen - Fibroblast_2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB016722, HPA018852"	Supported		Approved	Nucleoplasm,Cytosol	"Secreted to blood"	"Complement pathway"	NA	NA	93000000000	20000000000		"Cluster 31: Liver - Plasma proteins"	"Cluster 39: Astrocytes - Mixed function"	"Cluster 44: Connective tissue cells - ECM organization"	"Cluster 53: Fibroblasts - ECM organization"	3	Nucleoplasm	Cytosol	"CAB016722: , HPA018852: AB_1847112"	"unprognostic (7.81e-3)"	"unprognostic (6.27e-3)"	"unprognostic (1.58e-1)"	"unprognostic (6.27e-2)"	"unprognostic (5.88e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.55e-3)"	"unprognostic (1.04e-1)"	"unprognostic (9.25e-2)"	"potential prognostic unfavorable (1.67e-5)"	"unprognostic (1.49e-3)"	"potential prognostic unfavorable (7.14e-5)"	"validated prognostic favorable (5.46e-4)"	"validated prognostic favorable (2.13e-5)"	"unprognostic (1.20e-1)"	"unprognostic (7.56e-2)"	"unprognostic (9.06e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.31e-2)"	"unprognostic (7.88e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.23e-1)"	"unprognostic (4.93e-2)"	"unprognostic (6.79e-2)"	"unprognostic (7.09e-3)"	"unprognostic (2.72e-1)"	"unprognostic (5.77e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.27e-2)"	"unprognostic (1.65e-3)"
C3	"ARMD9, C3a, C3b, CPAMD1"	ENSG00000125730	"Complement C3"	P01024	19	6677704-6730562	"Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Complement alternate pathway, Complement pathway, Fatty acid metabolism, Immunity, Inflammatory response, Innate immunity, Lipid metabolism"		"Age-related macular degeneration, Disease variant, FDA approved drug targets, Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	9	"liver: 5250.9"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 657.6;Exocrine glandular cells: 845.2;Hepatocytes: 3158.4;Mesothelial cells: 2220.5"	"Cell type enriched"	"Detected in many"	49	"central nervous system macrophage: 753.0"	"Cancer enriched"	"Detected in all"	4	"Liver Hepatocellular Carcinoma (TCGA): 2548.0"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"non-classical monocyte: 14.5"	"Lineage enriched"	"Detected in many"	5	"monocytes: 14.5"	"Cancer enhanced"	"Detected in many"		"liver cancer: 255.0"	"Adrenal gland - Adrenal cortex cells, Liver - Hepatocytes, Lung - Fibroblast_2, Pituitary gland - Macrophages, Thyroid gland - Macrophages"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA003563, CAB004209, HPA020432"	Enhanced				"Secreted to blood"	"Complement pathway"	NA	NA	1260000000000	220000000000	"Cluster 40: Monocytes - Innate immune response"	"Cluster 83: Liver - Metabolism"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 62: Hepatocytes - Metabolism"	40			"CAB004209: AB_627277, HPA003563: AB_1847117, HPA020432: AB_1847118"	"potential prognostic favorable (1.46e-4)"	"unprognostic (3.99e-3)"	"unprognostic (2.04e-2)"	"unprognostic (6.44e-2)"	"unprognostic (6.78e-2)"	"unprognostic (8.30e-2)"	"unprognostic (2.71e-2)"	"unprognostic (3.60e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.25e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.98e-1)"	"unprognostic (2.64e-3)"	"potential prognostic favorable (2.99e-6)"	"unprognostic (1.82e-1)"	"unprognostic (3.09e-3)"	"unprognostic (7.40e-3)"	"unprognostic (6.78e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.19e-1)"	"unprognostic (8.47e-3)"	"unprognostic (3.71e-2)"	"unprognostic (7.20e-2)"	"unprognostic (1.04e-1)"	"unprognostic (8.27e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.35e-2)"	"unprognostic (5.99e-2)"
C4A	"C4, C4A2, C4A3, C4A4, C4A6, C4B, C4S, CO4, CPAMD2, RG"	ENSG00000244731	"Complement C4A (Rodgers blood group)"	P0C0L4	6	31982057-32002681	"Blood group antigen proteins, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Inflammatory response, Innate immunity"	"Blood group antigen"	"Disease variant, FDA approved drug targets, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 112.2;liver: 328.2"	"Group enriched"	"Detected in some"	4	"Hepatocytes: 6.8;Mesothelial cells: 8.5"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"Breast Invasive Carcinoma (TCGA): 55.1;Kidney Renal Clear Cell Carcinoma (TCGA): 49.6;Kidney Renal Papillary Cell Carcinoma (TCGA): 32.8;Liver Hepatocellular Carcinoma (TCGA): 90.9;Thyroid Carcinoma (TCGA): 27.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"liver cancer: 8.8;Myeloma: 6.7"	"Breast - Breast glandular cells, Kidney - Proximal tubular cells, Liver - Hepatocytes"									"CAB009811, CAB032603, HPA046356, HPA048287, HPA050103"	Supported				"Secreted to blood"	"Complement pathway"	NA	NA	342000000	200000000000		"Cluster 83: Liver - Metabolism"	"Cluster 39: Astrocytes - Mixed function"	"Cluster 70: DU4475 - Unknown function"	"Cluster 62: Hepatocytes - Metabolism"	13			"CAB009811: AB_2066891, CAB032603: AB_2290613, HPA046356: AB_2679635, HPA048287: AB_2680341, HPA050103: AB_2681016"	"unprognostic (3.29e-2)"	"unprognostic (5.40e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.97e-2)"	"unprognostic (2.58e-1)"	"unprognostic (9.96e-2)"		"unprognostic (8.69e-2)"	"unprognostic (7.36e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.61e-3)"	"unprognostic (1.64e-3)"	"unprognostic (2.16e-2)"	"unprognostic (2.03e-1)"	"unprognostic (8.15e-3)"	"unprognostic (4.88e-2)"	"unprognostic (2.63e-2)"	"unprognostic (3.99e-2)"	"unprognostic (7.66e-2)"	"unprognostic (5.83e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.94e-1)"		"unprognostic (9.91e-2)"	"unprognostic (7.39e-2)"	"unprognostic (6.37e-2)"	"unprognostic (6.46e-2)"
C4B	"C4B1, C4B3, C4F, CH, CO4, CPAMD3"	ENSG00000224389	"Complement C4B (Chido blood group)"	P0C0L5	6	32014795-32035418	"Blood group antigen proteins, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Inflammatory response, Innate immunity"	"Blood group antigen"	"FDA approved drug targets, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 214.6;liver: 375.4"	"Group enriched"	"Detected in some"	5	"Hepatocytes: 7.1;Mesothelial cells: 13.6"	"Cell type enhanced"	"Detected in some"		"astrocyte: 1.4;vascular associated smooth muscle cell: 1.0"	"Cancer enhanced"	"Detected in all"		"Liver Hepatocellular Carcinoma (TCGA): 238.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"liver cancer: 6.7;Myeloma: 3.9"	"Liver - Hepatocytes"									"HPA046356, HPA048287, HPA050103"	Approved				"Secreted to blood"	"Complement pathway"	NA	NA	447000000000	200000000000		"Cluster 83: Liver - Metabolism"	"Cluster 39: Astrocytes - Mixed function"	"Cluster 70: DU4475 - Unknown function"	"Cluster 62: Hepatocytes - Metabolism"	2			"HPA046356: AB_2679635, HPA048287: AB_2680341, HPA050103: AB_2681016"	"unprognostic (7.64e-2)"	"unprognostic (2.28e-1)"		"unprognostic (4.09e-2)"	"unprognostic (3.50e-2)"	"unprognostic (2.70e-3)"	"unprognostic (2.73e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.57e-2)"	"unprognostic (4.36e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.34e-1)"	"unprognostic (7.96e-2)"	"unprognostic (1.61e-3)"	"unprognostic (8.48e-2)"	"unprognostic (1.16e-3)"	"unprognostic (1.30e-1)"	"potential prognostic unfavorable (7.93e-4)"	"unprognostic (2.86e-1)"	"unprognostic (2.41e-3)"	"unprognostic (2.31e-2)"	"unprognostic (3.75e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.00e-1)"	"unprognostic (6.92e-3)"	"unprognostic (4.65e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.29e-1)"
C5	"C5a, C5b, CPAMD4"	ENSG00000106804	"Complement C5"	P01031	9	120932987-121075195	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Inflammatory response, Innate immunity"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	30	"liver: 434.4"	"Cell type enriched"	"Detected in many"	14	"Hepatocytes: 435.9"	"Low cell type specificity"	"Detected in all"			"Cancer enriched"	"Detected in many"	9	"Liver Hepatocellular Carcinoma (TCGA): 102.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in many"	5	"liver cancer: 21.1"	"Liver - Hepatocytes, Thyroid gland - Fibroblasts"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA029339	Supported				"Secreted to blood"	"Complement pathway"	NA	NA	113000000000	41000000000		"Cluster 83: Liver - Metabolism"	"Cluster 46: Brainstem - Mixed function"	"Cluster 18: Liver cancer - Metabolism"	"Cluster 62: Hepatocytes - Metabolism"	22			"HPA029339: AB_10601125"		"unprognostic (3.43e-1)"	"unprognostic (1.10e-1)"	"potential prognostic favorable (8.56e-4)"	"unprognostic (9.85e-3)"	"potential prognostic unfavorable (1.70e-4)"	"unprognostic (1.01e-1)"	"unprognostic (2.40e-1)"	"unprognostic (9.54e-3)"		"unprognostic (1.75e-1)"	"unprognostic (7.55e-2)"	"unprognostic (1.60e-3)"	"unprognostic (5.49e-3)"	"unprognostic (1.16e-3)"	"unprognostic (2.48e-1)"	"unprognostic (6.56e-2)"	"unprognostic (2.76e-2)"	"unprognostic (3.72e-1)"		"unprognostic (1.08e-1)"	"unprognostic (5.01e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.19e-1)"	"unprognostic (5.09e-2)"	"unprognostic (8.39e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.09e-1)"	
CA6		ENSG00000131686	"Carbonic anhydrase 6"	P23280	1	8945867-8975092	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted secreted proteins"		Lyase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	296	"salivary gland: 9125.4"	"Cell type enriched"	"Detected in some"	51	"Serous glandular cells: 8255.0"	"Cell type enriched"	"Detected in single"	4	"leukocyte: 3.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"naive CD4 T-cell: 5.7;naive CD8 T-cell: 16.6"	"Lineage enriched"	"Detected in many"	12	"T-cells: 16.6"	"Cancer enhanced"	"Detected in some"		"Gastric cancer: 4.3"	"Breast - Breast glandular cells (progenitors)"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA028550, HPA028692"	Enhanced				"Secreted to digestive system"	Enzyme	NA	NA		11000000	"Cluster 43: Non-specific - Transcription & Translation"	"Cluster 38: Salivary gland - Salivary secretion"	"Cluster 6: Non-specific - Immune response"	"Cluster 70: DU4475 - Unknown function"	"Cluster 75: Serous glandular cells - Salivary secretion"	35			"HPA028550: AB_10600105, HPA028692: AB_10601883"		"unprognostic (8.10e-3)"	"unprognostic (3.02e-1)"			"unprognostic (1.87e-2)"										"unprognostic (9.04e-2)"										"unprognostic (4.33e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.47e-1)"			"unprognostic (1.20e-1)"
CALCA	"CALC1, CGRP, CGRP-alpha"	ENSG00000110680	"Calcitonin related polypeptide alpha"	"P01258, P06881"	11	14966622-14972354	"Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins, Transporters"		Hormone	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"parathyroid gland: 172.4;thyroid gland: 149.5"	"Cell type enriched"	"Detected in some"	15	"Ionocytes: 371.5"	"Cell type enriched"	"Detected in single"	13	"thalamic excitatory: 5.3"	"Cancer enriched"	"Detected in many"	4	"Lung Adenocarcinoma (TCGA): 436.5"	"Region enhanced"	"Detected in many"		"pons: 79.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in many"	13	"thyroid cancer: 2800.5"	"Colon - Colon enteroendocrine cells, Thyroid gland - Parafollicular cells"	"Region enriched"	"Detected in all"	5	"pons and medulla: 58.0"					"HPA059886, HPA064453"	Enhanced	Supported			"Secreted to blood"	Hormone	NA	NA	49600	150000		"Cluster 24: Parathyroid gland - Vesicular transport"	"Cluster 43: Hindbrain - Mixed function"	"Cluster 16: Thyroid cancer - Neuronal signaling"	"Cluster 35: Respiratory epithelial cells - Unknown function"	7			"HPA059886: , HPA064453: "	"unprognostic (8.93e-2)"				"unprognostic (1.74e-1)"					"unprognostic (1.97e-1)"	"unprognostic (1.03e-1)"			"unprognostic (1.24e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.14e-2)"	"unprognostic (4.91e-3)"	"unprognostic (3.87e-1)"	"unprognostic (6.91e-2)"		"unprognostic (1.10e-1)"	"unprognostic (1.91e-1)"		"unprognostic (1.79e-1)"	"unprognostic (9.27e-2)"	"unprognostic (2.60e-1)"		"unprognostic (6.63e-2)"		"unprognostic (2.99e-3)"	"unprognostic (1.55e-3)"
CALCB	"CALC2, CGRP-II, FLJ30166"	ENSG00000175868	"Calcitonin related polypeptide beta"	P10092	11	14904997-15082342	"FDA approved drug targets, Plasma proteins, Predicted secreted proteins"		Hormone	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 9.3;thyroid gland: 20.0"	"Cell type enhanced"	"Detected in some"		"Melanocytes: 3.4;Oocytes: 2.2;Spermatocytes: 1.6;Spermatogonia: 4.3;T-cells: 1.2"	"Cell type enhanced"	"Detected in many"		"thalamic excitatory: 31.5;upper rhombic lip: 50.4"	"Cancer enhanced"	"Detected in many"		"Colon Adenocarcinoma (TCGA): 13.3;Uterine Corpus Endometrial Carcinoma (TCGA): 31.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"Bone cancer: 19.8;colorectal cancer: 60.6;thyroid cancer: 62.5"	"Colon - Colon enteroendocrine cells, Thyroid gland - Parafollicular cells"	"Region enriched"	"Detected in some"	7	"pons and medulla: 9.6"	"Group enriched"	"Detected in all"	5	"amygdala: 42.9;basal ganglia: 101.5;hypothalamus: 69.1;midbrain: 47.2;pons: 56.7"	HPA059886		Supported			"Secreted to blood"	Hormone	NA	NA	4500			"Cluster 51: Thyroid gland - Unknown function"	"Cluster 41: Monoamines - Neurotransmitter signalling"	"Cluster 16: Thyroid cancer - Neuronal signaling"	"Cluster 7: T-cells - T-cell receptor"	5			"HPA059886: "	"unprognostic (3.87e-2)"				"unprognostic (5.16e-2)"	"unprognostic (2.40e-1)"				"unprognostic (3.60e-1)"						"unprognostic (2.34e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.55e-1)"			"unprognostic (1.69e-1)"					"unprognostic (2.57e-2)"			"unprognostic (1.87e-1)"	"unprognostic (2.12e-1)"	"unprognostic (4.38e-2)"
CARTPT	CART	ENSG00000164326	"CART prepropeptide"	Q16568	5	71719275-71721048	"FDA approved drug targets, Human disease related genes, Predicted secreted proteins"		"Neuropeptide, Neurotransmitter"	"FDA approved drug targets, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 520.9"	"Group enriched"	"Detected in some"	5	"Early spermatids: 35.6;Horizontal cells: 141.6;Spermatocytes: 44.4"	"Group enriched"	"Detected in many"	7	"hippocampal CA4: 269.3;thalamic excitatory: 361.5"	"Cancer enriched"	"Detected in many"	11	"Breast Invasive Carcinoma (TCGA): 355.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	10	"Neuroblastoma: 24.8"	"Adrenal gland - Adrenal medulla cells, Prostate - Prostate glandular cells, Testis - Early spermatids"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"hippocampal formation: 307.9"	"CAB025515, HPA046278, CAB079776"	Enhanced	Supported			"Secreted to blood"	Neuropeptide	NA	NA				"Cluster 33: Brain - Neuronal signaling"	"Cluster 41: Monoamines - Neurotransmitter signalling"	"Cluster 17: Neuroblastoma - Neuronal signaling"	"Cluster 70: Spermatocytes & Spermatids - Spermatid development"	6			"CAB025515: , CAB079776: , HPA046278: AB_10961570"		"unprognostic (1.34e-1)"	"unprognostic (2.62e-1)"					"unprognostic (4.46e-2)"												"unprognostic (3.86e-1)"		"unprognostic (2.07e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.76e-2)"	"unprognostic (2.91e-1)"	"unprognostic (4.36e-2)"		"potential prognostic unfavorable (3.21e-4)"		"unprognostic (9.82e-2)"	
CD44	"CD44R, CSPG8, HCELL, IN, MC56, MDU2, MDU3, MIC4, Pgp1"	ENSG00000026508	"CD44 molecule (Indian blood group)"	P16070	11	35138882-35232402	"Blood group antigen proteins, Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Cell adhesion"	"Blood group antigen, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 484.4"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 983.9;Exocrine glandular cells: 928.7;granulocytes: 1083.6;Langerhans cells: 2343.8;monocytes: 1059.3"	"Cell type enhanced"	"Detected in many"		"astrocyte: 403.2;leukocyte: 474.2;vascular associated smooth muscle cell: 152.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cancer enhanced"	"Detected in all"		"Adrenocortical cancer: 1400.7"	"Adipose subcutaneous - Adipose progenitor cells, Prostate - Urothelial cells, Skin - Keratinocyte (other)"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000112, CAB000316, HPA005785"	Enhanced		Supported	"Golgi apparatus,Plasma membrane"	"Secreted to blood"	Receptor	NA	NA	260000000	660000000	"Cluster 38: Monocytes & Neutrophils - Degranulation"	"Cluster 48: Stomach - Proteolysis"	"Cluster 39: Astrocytes - Mixed function"	"Cluster 72: Neuronal - Signal transduction"	"Cluster 29: Monocytes - Innate immune response"	26	"Plasma membrane"	"Golgi apparatus"	"CAB000112: , CAB000316: AB_2076596, HPA005785: AB_1078467"	"unprognostic (1.93e-3)"	"unprognostic (1.85e-1)"	"unprognostic (3.84e-1)"	"unprognostic (7.75e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.90e-2)"	"unprognostic (3.00e-2)"	"unprognostic (3.19e-1)"	"potential prognostic unfavorable (1.71e-4)"	"unprognostic (1.76e-2)"	"unprognostic (1.32e-3)"	"unprognostic (3.08e-3)"	"unprognostic (1.73e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.77e-3)"	"unprognostic (1.44e-2)"	"unprognostic (8.40e-2)"	"unprognostic (1.58e-2)"	"unprognostic (5.89e-3)"	"unprognostic (8.97e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.97e-2)"	"unprognostic (8.74e-2)"
COL1A1	OI4	ENSG00000108821	"Collagen type I alpha 1 chain"	P02452	17	50184101-50201632	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes, Disease variant, Dwarfism, Ehlers-Danlos syndrome, FDA approved drug targets, Osteogenesis imperfecta, Osteoporosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 1284.0;gallbladder: 1170.7;ovary: 1172.9"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 1832.0;Fibroblasts: 1713.3;Leydig cells: 547.1;Ovarian stromal cells: 435.9;Pancreatic endocrine cells: 1558.7;Smooth muscle cells: 617.8"	"Group enriched"	"Detected in some"	6	"fibroblast: 118.6;vascular associated smooth muscle cell: 32.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in all"		"Brain cancer: 1387.0"	"Adipose subcutaneous - Adipose progenitor cells, Adipose visceral - Adipose progenitor cells, Breast - Fibroblasts, Heart muscle - Fibroblasts, Kidney - Fibroblasts, Lung - Fibroblast_2, Pituitary gland - Corticotropes, Skeletal muscle - Fibroblasts, Skin - Fibroblast_1, Spleen - Fibroblast_1, Stomach - Fibroblasts, Thyroid gland - Fibroblasts"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 170.5"	"HPA011795, HPA012111"	Approved		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to extracellular matrix"	"No annotated function"	NA	NA		89000000		"Cluster 62: Connective tissue - ECM organization"	"Cluster 12: Non-specific - Vasculature"	"Cluster 64: Connective tissue cells - ECM organization"	"Cluster 50: Connective tissue cells - ECM organization"	44	"Endoplasmic reticulum"	Vesicles	"HPA011795: AB_1847088, HPA012111: "	"unprognostic (1.71e-2)"	"unprognostic (3.02e-1)"	"unprognostic (9.50e-2)"	"unprognostic (5.85e-3)"	"unprognostic (2.11e-2)"	"unprognostic (2.74e-1)"	"unprognostic (6.08e-2)"	"unprognostic (9.19e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.98e-3)"	"unprognostic (1.00e-1)"	"potential prognostic unfavorable (8.35e-7)"	"unprognostic (4.68e-2)"	"unprognostic (1.75e-1)"	"potential prognostic unfavorable (9.95e-4)"	"unprognostic (3.45e-2)"	"unprognostic (6.12e-2)"	"unprognostic (3.04e-1)"	"unprognostic (4.06e-3)"	"unprognostic (3.29e-2)"	"unprognostic (4.66e-2)"	"unprognostic (9.19e-2)"	"unprognostic (9.67e-2)"	"unprognostic (4.08e-2)"	"unprognostic (7.63e-3)"	"unprognostic (3.39e-2)"	"unprognostic (9.07e-3)"	"unprognostic (6.56e-2)"	"unprognostic (5.02e-2)"	"unprognostic (2.00e-1)"
COL2A1	"AOM, SEDC, STL1"	ENSG00000139219	"Collagen type II alpha 1 chain"	P02458	12	47972967-48004554	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted secreted proteins"			"Cancer-related genes, Cataract, Deafness, Disease variant, Dwarfism, FDA approved drug targets, Stickler syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"epididymis: 18.6;pituitary gland: 8.9;retina: 5.4;stomach 1: 12.2"	"Cell type enhanced"	"Detected in some"		"Breast myoepithelial cells: 6.6;Early spermatids: 11.0;Enteroendocrine cells: 27.4;Granulosa cells: 9.7;Horizontal cells: 24.5;Late spermatids: 11.5;Muller glia cells: 21.3"	"Cell type enhanced"	"Detected in some"		"fibroblast: 2.8;hippocampal dentate gyrus: 5.7"	"Group enriched"	"Detected in many"	4	"Breast Invasive Carcinoma (TCGA): 22.3;Prostate Adenocarcinoma (TCGA): 19.7;Skin Cuteneous Melanoma (TCGA): 14.8;Testicular Germ Cell Tumor (TCGA): 22.7;Uterine Corpus Endometrial Carcinoma (TCGA): 8.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in many"	7	"liver cancer: 78.5"	"Pituitary gland - Gonadotropes, Testis - Late spermatids"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB002214, HPA055753"	Approved		Approved	Nucleoplasm	"Secreted to extracellular matrix"	"No annotated function"	No	NA		3200000		"Cluster 50: Epididymis - Male reproductive secretion"		"Cluster 34: Testis cancer - Unknown function"	"Cluster 20: Enteroendocrine cells - Hormone signaling"	3	Nucleoplasm		"CAB002214: AB_563666, HPA055753: AB_2682908"	"unprognostic (6.77e-3)"	"unprognostic (2.16e-1)"	"unprognostic (5.49e-2)"	"unprognostic (7.27e-2)"			"unprognostic (2.63e-2)"	"unprognostic (1.11e-1)"						"unprognostic (5.52e-2)"	"unprognostic (7.13e-2)"	"unprognostic (1.04e-1)"		"unprognostic (6.95e-2)"	"unprognostic (7.34e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.07e-1)"			"unprognostic (1.93e-1)"		"unprognostic (2.54e-2)"	"unprognostic (1.91e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.81e-1)"		"unprognostic (1.31e-1)"
COL3A1	EDS4A	ENSG00000168542	"Collagen type III alpha 1 chain"	P02461	2	188974373-189012746	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Aortic aneurysm, Disease variant, Ehlers-Danlos syndrome, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 2284.1;gallbladder: 2022.4;placenta: 1914.8;smooth muscle: 2059.5"	"Group enriched"	"Detected in many"	4	"Endometrial stromal cells: 2579.5;Fibroblasts: 1454.9;Smooth muscle cells: 696.2"	"Cell type enhanced"	"Detected in some"		"fibroblast: 216.1;vascular associated smooth muscle cell: 78.5"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"cerebral cortex: 21.6;choroid plexus: 22.8;thalamus: 22.8;white matter: 8.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Rhabdoid: 1300.8;Sarcoma: 607.6;testis cancer: 879.7"	"Adipose subcutaneous - Adipose progenitor cells, Adipose visceral - Adipose progenitor cells, Kidney - Fibroblasts, Liver - Hepatic stellate cells, Minor Salivary Gland - Fibroblasts, Skeletal muscle - Fibroblasts, Skin - Fibroblast_1, Spleen - Fibroblast_1"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 74.6"	"HPA007583, CAB016766, CAB059993"	Approved		Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	"No annotated function"	NA	NA		28000000		"Cluster 62: Connective tissue - ECM organization"	"Cluster 12: Non-specific - Vasculature"	"Cluster 64: Connective tissue cells - ECM organization"	"Cluster 50: Connective tissue cells - ECM organization"	1	"Endoplasmic reticulum"		"CAB016766: , CAB059993: AB_2314211, HPA007583: AB_1078548"	"unprognostic (5.65e-3)"	"unprognostic (2.00e-1)"	"unprognostic (9.08e-2)"	"unprognostic (1.18e-2)"	"unprognostic (9.14e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.77e-1)"	"unprognostic (3.32e-3)"	"unprognostic (1.37e-1)"	"unprognostic (3.85e-3)"	"unprognostic (2.37e-1)"	"unprognostic (4.75e-3)"	"potential prognostic unfavorable (1.93e-8)"	"unprognostic (5.86e-2)"	"unprognostic (2.07e-1)"	"unprognostic (5.82e-2)"	"unprognostic (8.53e-3)"	"unprognostic (4.80e-2)"	"unprognostic (2.62e-1)"	"unprognostic (3.43e-3)"	"potential prognostic unfavorable (8.45e-4)"	"unprognostic (3.54e-2)"	"unprognostic (4.40e-1)"	"unprognostic (2.24e-1)"	"unprognostic (8.48e-2)"	"unprognostic (4.48e-3)"	"unprognostic (3.44e-3)"	"unprognostic (1.33e-3)"	"unprognostic (4.31e-2)"	"unprognostic (7.46e-2)"	"unprognostic (4.51e-2)"
CPB2	"CPU, PCPB, TAFI"	ENSG00000080618	"Carboxypeptidase B2"	Q96IY4	13	46053186-46105033	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Fibrinolysis, Hemostasis"	"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	84	"liver: 1439.0"	"Cell type enriched"	"Detected in some"	5	"Hepatocytes: 1226.7"	"Cell type enhanced"	"Detected in many"		"oligodendrocyte: 87.4"	"Cancer enriched"	"Detected in some"	57	"Liver Hepatocellular Carcinoma (TCGA): 350.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	6	"liver cancer: 11.2"	"Liver - Hepatocytes, Lung - Alveolar cells type 2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA004146	Approved				"Secreted to blood"	"Blood coagulation"	NA	NA		6100000000		"Cluster 31: Liver - Plasma proteins"	"Cluster 28: Oligodendrocytes - Mixed function"	"Cluster 18: Liver cancer - Metabolism"	"Cluster 43: Hepatocytes - Metabolism"				"HPA004146: AB_1078397"						"unprognostic (1.22e-1)"								"potential prognostic favorable (2.55e-4)"	"unprognostic (2.42e-3)"	"unprognostic (1.94e-2)"	"unprognostic (7.95e-2)"		"unprognostic (3.87e-1)"				"unprognostic (5.07e-3)"			"unprognostic (6.85e-2)"					
CSF2RA	"alphaGMR, CD116, CSF2R"	ENSG00000198223	"Colony stimulating factor 2 receptor subunit alpha"	P15509	X	1268800-1310381	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Predicted secreted proteins"		Receptor	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 61.6"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 243.7;Extravillous trophoblasts: 130.8;Langerhans cells: 703.6;Macrophages: 108.0;Schwann cells: 140.4;Syncytiotrophoblasts: 345.1"	"Cell type enriched"	"Detected in single"	8	"central nervous system macrophage: 4.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 319.8"	"Group enriched"	"Detected in all"	29	"dendritic cells: 170.1;granulocytes: 319.8;monocytes: 160.9"	"Cancer enriched"	"Detected in many"	7	"Adrenocortical cancer: 111.7"	"Adipose subcutaneous - Adipocytes (Subcutaneous), Adrenal gland - Macrophages, Minor Salivary Gland - Macrophages, Pancreas - Macrophages, Skeletal muscle - Macrophages, Spleen - Neutrophils, Thyroid gland - T-cells"	"Low region specificity"	"Detected in single"							CAB016148	Uncertain				"Secreted to blood"	Receptor	NA	NA		6300000	"Cluster 38: Monocytes & Neutrophils - Degranulation"	"Cluster 58: Placenta - Pregnancy"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 34: Testis cancer - Unknown function"	"Cluster 28: Dendritic cells - Antigen presentation"	2			"CAB016148: AB_626868"	"unprognostic (2.91e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.85e-2)"	"potential prognostic favorable (1.75e-4)"	"unprognostic (4.20e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.82e-1)"		"potential prognostic favorable (8.00e-4)"	"unprognostic (8.58e-2)"	"unprognostic (4.83e-3)"	"unprognostic (3.35e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.77e-2)"		"unprognostic (7.06e-2)"	"unprognostic (9.07e-3)"	"unprognostic (3.80e-2)"	"unprognostic (5.23e-2)"	"unprognostic (7.11e-3)"	"unprognostic (2.25e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.31e-3)"	"unprognostic (6.19e-2)"	"unprognostic (1.07e-3)"	"potential prognostic favorable (3.57e-4)"	"unprognostic (9.22e-2)"	"unprognostic (5.63e-3)"	"unprognostic (1.03e-3)"	"unprognostic (9.14e-2)"	"unprognostic (3.42e-1)"
DPP4	"ADCP2, CD26, DPPIV"	ENSG00000197635	"Dipeptidyl peptidase 4"	P27487	2	161992245-162074394	"CD markers, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Cell adhesion, Host-virus interaction"	"Aminopeptidase, Hydrolase, Protease, Receptor, Serine protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 134.2;parathyroid gland: 151.0;placenta: 129.7;prostate: 103.7"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 135.0;Prostatic glandular cells: 195.7;Proximal enterocytes: 277.2;Serous glandular cells: 142.3;Syncytiotrophoblasts: 167.3"	"Cell type enhanced"	"Detected in many"		"deep-layer corticothalamic and 6b: 38.5;leukocyte: 104.6"	"Cancer enhanced"	"Detected in all"		"Prostate Adenocarcinoma (TCGA): 108.1"	"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 52.4"	"Lineage enriched"	"Detected in many"	10	"T-cells: 52.4"	"Cancer enhanced"	"Detected in many"		"Kidney cancer: 54.4"	"Adipose visceral - Mesothelial cells, Kidney - Proximal tubular cells, Liver - Hepatocytes, Minor Salivary Gland - Minor salivary glandular cells, Prostate - Prostate glandular cells, Skin - Fibroblast_2, Testis - Early spermatids"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB045970, HPA068778, HPA071236"	Enhanced				"Secreted to blood"	Receptor	NA	NA	643000000	160000000	"Cluster 1: T-cells - Unknown function"	"Cluster 55: Kidney & Intestine - Metabolism"	"Cluster 53: Neurons - Mixed function"	"Cluster 15: Kidney cancer - Membrane components"	"Cluster 22: Proximal enterocytes - Digestion"	142			"CAB045970: AB_11140529, HPA068778: , HPA071236: "	"unprognostic (1.45e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.26e-1)"	"unprognostic (8.68e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.95e-1)"	"validated prognostic favorable (2.36e-9)"	"validated prognostic favorable (2.32e-5)"	"unprognostic (2.15e-3)"	"unprognostic (1.78e-1)"	"unprognostic (3.32e-2)"	"unprognostic (8.15e-3)"	"unprognostic (1.45e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.22e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.80e-3)"	"potential prognostic unfavorable (9.06e-4)"	"unprognostic (2.10e-1)"	"unprognostic (1.01e-1)"	"unprognostic (9.98e-2)"	"unprognostic (3.70e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.07e-3)"	"unprognostic (1.58e-1)"
EGFR	"ERBB, ERBB1, ERRP"	ENSG00000146648	"Epidermal growth factor receptor"	P00533	7	55019017-55211628	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins, Transporters"	"Host-virus interaction"	"Developmental protein, Host cell receptor for virus entry, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 63.5"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 278.2;Salivary duct cells: 235.0;Syncytiotrophoblasts: 428.1"	"Cell type enhanced"	"Detected in many"		"astrocyte: 363.8;bergmann glia: 419.5"	"Cancer enriched"	"Detected in all"	4	"Glioblastoma Multiforme (TCGA): 324.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Heart muscle - Fibroblasts, Prostate - Prostate basal glandular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000035, HPA001200, HPA018530, CAB068186, CAB073534, CAB080313, CAB080314, CAB080473, CAB080474, CAB080475, CAB080506, CAB080507, CAB080508, CAB080509, CAB080510, CAB080511, CAB080513"	Enhanced		Supported	"Nucleoli,Golgi apparatus,Plasma membrane,Cell Junctions,Primary cilium,Basal body,Cytosol,Mid piece,Principal piece,End piece"	"Secreted to blood"	Receptor	NA	NA	4740000	60000000		"Cluster 58: Placenta - Pregnancy"	"Cluster 19: Astrocytes - Mixed function"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 53: Fibroblasts - ECM organization"	904	"Golgi apparatus, Plasma membrane"	"Nucleoli, Cell Junctions, Primary cilium, Basal body, Cytosol, Mid piece, Principal piece, End piece"	"CAB000035: , CAB068186: AB_2665679, CAB073534: , CAB080313: , CAB080314: , CAB080473: , CAB080474: , CAB080475: , CAB080506: , CAB080507: , CAB080508: , CAB080509: , CAB080510: , CAB080511: , CAB080513: , HPA001200: AB_1078723, HPA018530: AB_1848044"	"unprognostic (7.14e-2)"	"unprognostic (2.28e-2)"	"unprognostic (9.66e-2)"	"unprognostic (2.14e-3)"	"unprognostic (9.48e-2)"	"unprognostic (9.42e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.07e-2)"	"unprognostic (3.73e-2)"	"unprognostic (2.68e-3)"	"potential prognostic favorable (8.23e-5)"	"unprognostic (1.24e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.01e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.38e-1)"	"unprognostic (6.90e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.35e-3)"	"unprognostic (2.91e-1)"	"unprognostic (5.73e-3)"	"potential prognostic unfavorable (4.42e-5)"	"unprognostic (1.11e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.92e-2)"	"unprognostic (4.08e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.14e-2)"	"unprognostic (9.81e-2)"
ELANE	"ELA2, HLE, HNE, NE, PMN-E"	ENSG00000197561	"Elastase, neutrophil expressed"	P08246	19	851014-856247	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	92	"bone marrow: 3840.6"	"Cell type enhanced"	"Detected in some"		"Fibroblasts: 12.5;Kupffer cells: 9.1;Langerhans cells: 5.5;Leydig cells: 6.8;Oocytes: 19.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"Pancreatic Adenocarcinoma (TCGA): 5.4;Stomach Adenocarcinoma (TCGA): 7.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"classical monocyte: 4.0;neutrophil: 12.2"	"Group enriched"	"Detected in many"	9	"granulocytes: 12.2;monocytes: 4.0"	"Cancer enriched"	"Detected in some"	227	"Leukemia: 236.6"	"Lung - Neutrophil_1, Pituitary gland - Neutrophils, Skin - Fibroblast_2, Spleen - Hematopoietic stem cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB015409, HPA066836, HPA073774"	Enhanced		Supported	"Golgi apparatus,Vesicles"	"Secreted to blood"	Enzyme	NA	NA	157000000	460000	"Cluster 38: Monocytes & Neutrophils - Degranulation"	"Cluster 6: Bone marrow - Innate immune response"		"Cluster 14: Myeloid leukemia - Innate immune response"	"Cluster 74: Neutrophils - Degranulation"	3	Vesicles	"Golgi apparatus"	"CAB015409: AB_831596, HPA066836: AB_2685733, HPA073774: "			"unprognostic (1.95e-1)"																			"unprognostic (2.50e-1)"						"unprognostic (1.86e-2)"			
F10		ENSG00000126218	"Coagulation factor X"	P00742	13	113122799-113149529	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Hydrolase, Protease, Serine protease"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 156.1"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 109.1;Hepatocytes: 170.7;Leydig cells: 217.7;Peritubular cells: 232.6;Smooth muscle cells: 57.6"	"Cell type enhanced"	"Detected in many"		"fibroblast: 49.8;pericyte: 28.0"	"Cancer enriched"	"Detected in many"	9	"Liver Hepatocellular Carcinoma (TCGA): 183.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Adrenocortical cancer: 6.9;liver cancer: 16.8"	"Breast - Fibroblasts, Colon - Fibroblasts, Liver - Hepatocytes, Minor Salivary Gland - Fibroblasts, Pancreas - Alpha cells, Pituitary gland - Fibroblasts, Prostate - Fibroblasts, Skeletal muscle - Fibroblasts, Skin - Fibroblast_1, Skin - Fibroblast_2, Spleen - Fibroblast_2, Thyroid gland - Fibroblasts"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted to blood"	"Blood coagulation"	NA	NA		7900000000		"Cluster 83: Liver - Metabolism"	"Cluster 49: Hindbrain - Mixed function"	"Cluster 18: Liver cancer - Metabolism"	"Cluster 53: Fibroblasts - ECM organization"	11				"unprognostic (1.38e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.71e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.54e-1)"			"unprognostic (4.04e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.78e-3)"	"unprognostic (6.28e-2)"	"unprognostic (5.64e-3)"	"unprognostic (2.49e-3)"	"unprognostic (5.69e-2)"	"potential prognostic unfavorable (4.00e-4)"	"unprognostic (1.88e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.99e-2)"	"potential prognostic favorable (4.34e-5)"	"unprognostic (4.45e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.78e-2)"	"unprognostic (5.29e-2)"	"unprognostic (6.38e-2)"	"unprognostic (3.50e-2)"	"unprognostic (3.61e-2)"	"unprognostic (2.18e-2)"	"unprognostic (3.01e-2)"
F11	FXI	ENSG00000088926	"Coagulation factor XI"	P03951	4	186266189-186289681	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Heparin-binding, Hydrolase, Protease, Serine protease"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"liver: 235.6"	"Cell type enriched"	"Detected in some"	7	"Hepatocytes: 69.2"	"Cell type enriched"	"Detected in some"	9	"midbrain-derived inhibitory: 33.8"	"Cancer enriched"	"Detected in some"	12	"Liver Hepatocellular Carcinoma (TCGA): 46.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"liver cancer: 1.8"	"Kidney - Ascending Loop of Henle cells, Liver - Hepatocytes, Lung - Alveolar cells type 2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA039808			Approved	Vesicles	"Secreted to blood"	"Blood coagulation"	NA	NA		2800000000		"Cluster 83: Liver - Metabolism"	"Cluster 38: Sub-cortical - Mixed function"	"Cluster 18: Liver cancer - Metabolism"	"Cluster 62: Hepatocytes - Metabolism"		Vesicles		"HPA039808: AB_2676693"										"unprognostic (1.91e-2)"	"potential prognostic favorable (4.99e-4)"	"unprognostic (2.90e-3)"		"validated prognostic favorable (1.19e-4)"	"validated prognostic favorable (5.80e-6)"	"unprognostic (3.74e-2)"	"unprognostic (6.64e-2)"					"unprognostic (6.81e-2)"	"unprognostic (4.06e-2)"								
F12		ENSG00000131187	"Coagulation factor XII"	P00748	5	177402133-177416583	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Fibrinolysis, Hemostasis"	"Hydrolase, Protease, Serine protease"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	311	"liver: 589.9"	"Cell type enriched"	"Detected in many"	5	"Hepatocytes: 375.4"	"Cell type enhanced"	"Detected in many"		"hippocampal CA4: 19.9"	"Cancer enriched"	"Detected in many"	96	"Liver Hepatocellular Carcinoma (TCGA): 275.5"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"eosinophil: 1.7"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.7"	"Low cancer specificity"	"Detected in many"			"Kidney - Proximal tubular cells, Liver - Hepatocytes, Stomach - Mitotic cells (Stomach)"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA003825	Approved				"Secreted to blood"	"Blood coagulation"	NA	NA	1040000	7400000000	"Cluster 19: Eosinophils - Unknown function"	"Cluster 31: Liver - Plasma proteins"		"Cluster 71: Lymphoma - Inflammatory response"	"Cluster 62: Hepatocytes - Metabolism"	43			"HPA003825: AB_1078790"		"unprognostic (5.73e-2)"	"unprognostic (4.24e-1)"	"unprognostic (1.13e-3)"	"unprognostic (8.13e-2)"	"unprognostic (8.98e-3)"	"unprognostic (8.33e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.39e-1)"		"unprognostic (1.81e-2)"	"unprognostic (8.65e-2)"	"unprognostic (2.12e-1)"	"validated prognostic favorable (8.62e-5)"	"validated prognostic favorable (1.55e-4)"			"unprognostic (3.36e-2)"			"unprognostic (2.85e-1)"	"unprognostic (2.65e-1)"	"unprognostic (4.61e-1)"		"unprognostic (3.83e-1)"	"unprognostic (1.37e-1)"		"unprognostic (7.12e-2)"			
F13A1	F13A	ENSG00000124491	"Coagulation factor XIII A chain"	P00488	6	6144084-6321013	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Acyltransferase, Transferase"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 224.8;placenta: 473.0"	"Group enriched"	"Detected in many"	4	"Hofbauer cells: 791.5;Langerhans cells: 206.4;Macrophages: 321.2"	"Cell type enhanced"	"Detected in many"		"central nervous system macrophage: 99.1;fibroblast: 174.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 141.3;myeloid DC: 179.8"	"Group enriched"	"Detected in many"	184	"dendritic cells: 179.8;granulocytes: 50.0;monocytes: 141.3"	"Cancer enhanced"	"Detected in some"		"cervical cancer: 13.1;Leukemia: 20.7"	"Adipose subcutaneous - Macrophages, Adipose visceral - Macrophages, Adrenal gland - Macrophages, Breast - Macrophages, Colon - Macrophages, Heart muscle - Macrophages, Minor Salivary Gland - Macrophages, Pituitary gland - Macrophages, Prostate - Macrophages, Skeletal muscle - Macrophages, Spleen - Platelets, Stomach - Macrophages, Testis - Macrophages, Thyroid gland - Macrophages"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"HPA001804, CAB002155"	Enhanced				"Secreted to blood"	"Blood coagulation"	NA	NA		2200000000	"Cluster 38: Monocytes & Neutrophils - Degranulation"	"Cluster 58: Placenta - Pregnancy"	"Cluster 8: Immune cells - Immune response"	"Cluster 14: Myeloid leukemia - Innate immune response"	"Cluster 58: Macrophages - Innate immune response"	15			"CAB002155: AB_564077, HPA001804: AB_1078792"	"unprognostic (1.58e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.05e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.69e-1)"	"unprognostic (6.99e-3)"	"unprognostic (6.41e-3)"	"unprognostic (3.38e-3)"	"unprognostic (4.55e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.27e-2)"	"unprognostic (3.94e-2)"	"unprognostic (3.04e-2)"	"unprognostic (1.05e-2)"	"unprognostic (8.60e-3)"	"potential prognostic unfavorable (3.86e-4)"	"unprognostic (1.59e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.81e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.90e-2)"	"unprognostic (5.49e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.30e-1)"
F13B	FXIIIB	ENSG00000143278	"Coagulation factor XIII B chain"	P05160	1	197038741-197067260	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"		"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	210	"liver: 194.1"	"Cell type enriched"	"Detected in some"	16	"Hepatocytes: 59.1"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	580	"Liver Hepatocellular Carcinoma (TCGA): 57.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Liver - Hepatocytes"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA003827, HPA052139"	Supported				"Secreted to blood"	"Blood coagulation"	NA	NA		4900000000		"Cluster 31: Liver - Plasma proteins"		"Cluster 18: Liver cancer - Metabolism"	"Cluster 43: Hepatocytes - Metabolism"	1			"HPA003827: AB_1078794, HPA052139: AB_2681744"														"potential prognostic favorable (6.42e-5)"	"unprognostic (4.78e-2)"																
F2		ENSG00000180210	"Coagulation factor II, thrombin"	P00734	11	46719196-46739506	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Acute phase, Blood coagulation, Hemostasis"	"Hydrolase, Protease, Serine protease"	"Cancer-related genes, Disease variant, FDA approved drug targets, Thrombophilia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	1310	"liver: 1180.6"	"Cell type enriched"	"Detected in some"	7	"Hepatocytes: 841.1"	"Low cell type specificity"	"Detected in single"			"Cancer enriched"	"Detected in some"	76	"Liver Hepatocellular Carcinoma (TCGA): 827.3"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	10	"liver cancer: 64.3"	"Liver - Hepatocytes"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB016780, HPA051476, HPA054698"	Enhanced				"Secreted to blood"	"Blood coagulation"	NA	NA	108000000000	54000000000		"Cluster 31: Liver - Plasma proteins"	"Cluster 15: Non-specific - Transcription"	"Cluster 18: Liver cancer - Metabolism"	"Cluster 62: Hepatocytes - Metabolism"	8			"CAB016780: , HPA051476: AB_2681498, HPA054698: AB_2682578"											"validated prognostic unfavorable (1.23e-6)"	"validated prognostic unfavorable (4.97e-4)"		"unprognostic (1.43e-1)"	"unprognostic (1.69e-3)"	"potential prognostic unfavorable (1.80e-4)"												"unprognostic (9.50e-3)"	"unprognostic (4.13e-1)"		
F3	"CD142, TF"	ENSG00000117525	"Coagulation factor III, tissue factor"	P13726	1	94529173-94541759	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Blood coagulation, Hemostasis"		"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 673.7;Basal respiratory cells: 344.3;Club cells: 387.7;Exocrine glandular cells: 355.4;Ionocytes: 309.6;Peritubular cells: 505.4"	"Cell type enhanced"	"Detected in many"		"astrocyte: 248.5;fibroblast: 443.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"head and neck cancer: 655.6"	"Kidney - Podocytes, Liver - Cholangiocyte, Lung - Alveolar cells type 2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009438, HPA049292, HPA069132"	Uncertain		Approved	Vesicles	"Secreted to blood"	"Blood coagulation"	NA	NA	603000			"Cluster 64: Neuronal - Transcription"	"Cluster 40: Astrocytes - Astrocyte-neuron interactions"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 45: Non-specific - Mixed function"	12	Vesicles		"CAB009438: AB_668005, HPA049292: AB_2680701, HPA069132: AB_2686092"	"unprognostic (1.24e-1)"	"unprognostic (5.40e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.73e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.11e-2)"	"potential prognostic unfavorable (7.75e-5)"	"unprognostic (4.84e-3)"	"unprognostic (1.44e-3)"	"potential prognostic unfavorable (2.57e-4)"	"unprognostic (3.19e-2)"	"unprognostic (1.61e-2)"	"unprognostic (5.22e-2)"	"unprognostic (4.06e-2)"	"unprognostic (7.62e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.99e-1)"	"unprognostic (1.71e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.43e-1)"	"potential prognostic unfavorable (1.26e-5)"	"unprognostic (2.62e-2)"	"unprognostic (2.11e-1)"	"unprognostic (6.14e-2)"	"unprognostic (3.20e-2)"	"unprognostic (3.77e-1)"	"unprognostic (5.69e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.55e-1)"	"unprognostic (8.97e-2)"
F5		ENSG00000198734	"Coagulation factor V"	P12259	1	169511951-169586588	"Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"		"Disease variant, FDA approved drug targets, Thrombophilia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"choroid plexus: 79.3;liver: 171.0;placenta: 45.4"	"Group enriched"	"Detected in many"	7	"Cholangiocytes: 95.4;Cytotrophoblasts: 83.4;Hepatocytes: 220.7;Syncytiotrophoblasts: 60.4"	"Cell type enriched"	"Detected in many"	7	"choroid plexus epithelial cell: 358.5"	"Cancer enriched"	"Detected in many"	6	"Liver Hepatocellular Carcinoma (TCGA): 78.0"	"Region enriched"	"Detected in all"	22	"choroid plexus: 306.3"	"Group enriched"	"Detected in some"	4	"classical monocyte: 4.1;eosinophil: 8.1;neutrophil: 7.0;T-reg: 6.2"	"Group enriched"	"Detected in many"	13	"granulocytes: 8.1;monocytes: 4.1;T-cells: 6.2"	"Cancer enhanced"	"Detected in many"		"liver cancer: 17.9"	"Adrenal gland - Neutrophils, Kidney - Podocytes, Liver - Hepatocytes, Lung - Neutrophil_2, Minor Salivary Gland - Minor salivary glandular cells, Prostate - Urothelial cells, Skin - Eccrine sweat gland cells, Spleen - Neutrophils"	"Group enriched"	"Detected in many"	5	"basal ganglia: 2.7;hippocampal formation: 6.6;pons and medulla: 4.4;thalamus: 5.5"	"Group enriched"	"Detected in all"	7	"amygdala: 53.1;basal ganglia: 46.2;cerebral cortex: 89.3;hippocampal formation: 80.9;olfactory bulb: 37.0"	HPA002036			Approved	"Golgi apparatus"	"Secreted to blood"	"Blood coagulation"	NA	NA	7670000000	9400000000	"Cluster 7: Non-specific - Innate immune response"	"Cluster 11: Liver - Plasma proteins"	"Cluster 36: Choroid plexus - Mixed function"	"Cluster 2: Mucus-secreting cells - Unknown function"	"Cluster 62: Hepatocytes - Metabolism"	4	"Golgi apparatus"		"HPA002036: AB_1078787"	"unprognostic (1.18e-1)"		"unprognostic (1.31e-1)"		"unprognostic (2.79e-1)"	"unprognostic (5.12e-2)"		"unprognostic (1.69e-1)"		"unprognostic (1.84e-1)"	"unprognostic (2.60e-2)"	"unprognostic (1.72e-1)"	"potential prognostic unfavorable (7.66e-5)"	"potential prognostic favorable (9.55e-4)"	"unprognostic (3.33e-1)"	"unprognostic (2.70e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.38e-1)"			"unprognostic (2.70e-2)"	"unprognostic (3.66e-2)"	"unprognostic (7.12e-2)"	"unprognostic (3.54e-2)"	"unprognostic (9.36e-2)"	"unprognostic (3.92e-1)"	"unprognostic (1.42e-3)"	"unprognostic (5.88e-2)"	"unprognostic (3.13e-1)"	"unprognostic (6.90e-2)"
F7		ENSG00000057593	"Coagulation factor VII"	P08709	13	113105788-113120685	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Hydrolase, Protease, Serine protease"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	102	"liver: 156.3"	"Cell type enriched"	"Detected in some"	7	"Hepatocytes: 119.3"	"Cell type enhanced"	"Detected in some"		"mammillary body: 1.2"	"Cancer enriched"	"Detected in some"	15	"Liver Hepatocellular Carcinoma (TCGA): 63.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"breast cancer: 3.0;liver cancer: 8.7"	"Liver - Hepatocytes"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to blood"	"Blood coagulation"	NA	NA	351000000	720000000		"Cluster 31: Liver - Plasma proteins"	"Cluster 1: Neurons - Mixed function"	"Cluster 18: Liver cancer - Metabolism"	"Cluster 62: Hepatocytes - Metabolism"	3					"unprognostic (5.69e-2)"	"unprognostic (7.46e-2)"			"unprognostic (1.38e-1)"				"potential prognostic favorable (3.40e-5)"				"unprognostic (2.90e-3)"	"unprognostic (1.50e-1)"										"unprognostic (3.37e-1)"	"unprognostic (1.16e-1)"			"unprognostic (1.60e-1)"		
F8	"DXS1253E, F8C, FVIII, HEMA"	ENSG00000185010	"Coagulation factor VIII"	P00451	X	154835788-155026940	"Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Acute phase, Blood coagulation, Hemostasis"		"Disease variant, FDA approved drug targets, Hemophilia, Thrombophilia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 51.5"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 107.1;Endothelial cells: 203.3;Lymphatic endothelial cells: 132.0"	"Low cell type specificity"	"Detected in all"			"Cancer enhanced"	"Detected in all"		"Kidney Renal Clear Cell Carcinoma (TCGA): 33.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Colon - Endothelial cells, Kidney - Endothelial cells"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			CAB018777	Enhanced				"Secreted to blood"	"Blood coagulation"	NA	NA		27000000	"Cluster 33: Non-specific - ATP binding"	"Cluster 30: Heart muscle - Heart development"	"Cluster 23: Choroid plexus - Mixed function"	"Cluster 36: Non-specific - mRNA processing"	"Cluster 41: Adipocytes & Endothelial cells - Mixed function"	2			"CAB018777: AB_640320"	"unprognostic (1.45e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.81e-2)"	"unprognostic (5.87e-3)"	"unprognostic (1.52e-2)"	"unprognostic (8.58e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.91e-1)"	"potential prognostic favorable (7.94e-10)"	"unprognostic (2.34e-3)"	"unprognostic (7.71e-2)"	"unprognostic (1.82e-2)"	"unprognostic (3.51e-3)"	"unprognostic (2.86e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.08e-2)"	"unprognostic (9.94e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.91e-1)"	"unprognostic (6.20e-3)"	"unprognostic (4.84e-2)"	"unprognostic (1.68e-2)"	"unprognostic (8.40e-2)"
F9	FIX	ENSG00000101981	"Coagulation factor IX"	P00740	X	139530739-139563459	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Hydrolase, Protease, Serine protease"	"Disease variant, FDA approved drug targets, Hemophilia, Thrombophilia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	2448	"liver: 683.7"	"Group enriched"	"Detected in some"	12	"Hepatocytes: 519.8;Kupffer cells: 161.1"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	823	"Liver Hepatocellular Carcinoma (TCGA): 82.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Liver - Hepatocytes"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to blood"	"Blood coagulation"	NA	NA		5400000000		"Cluster 31: Liver - Plasma proteins"		"Cluster 10: Ciliated cells - Ion channel activity"	"Cluster 62: Hepatocytes - Metabolism"																		"unprognostic (1.65e-3)"	"potential prognostic favorable (3.31e-5)"																
FCGR3A	"CD16, CD16a, FCG3, FcgammaRIIIa, FCGR3, FcGRIIIA"	ENSG00000203747	"Fc gamma receptor IIIa"	P08637	1	161541759-161550968	"CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	Immunity	"IgG-binding protein, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 202.0;lymphoid tissue: 294.7"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 240.5;Kupffer cells: 656.2;Macrophages: 303.8;monocytes: 1050.2;NK-cells: 597.4"	"Group enriched"	"Detected in some"	73	"central nervous system macrophage: 8.0;leukocyte: 6.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"intermediate monocyte: 1806.3;non-classical monocyte: 4107.1"	"Lineage enriched"	"Detected in all"	6	"monocytes: 4107.1"	"Not detected"	"Not detected"			"Adipose subcutaneous - Macrophages, Adipose visceral - Macrophages, Adrenal gland - Macrophages, Breast - Macrophages, Colon - Macrophages, Heart muscle - Macrophages, Kidney - Macrophages, Liver - Kupffer cells, Lung - Macrophages, Pancreas - Macrophages, Pituitary gland - Macrophages, Prostate - Macrophages, Skeletal muscle - Macrophages, Skin - Macrophages, Spleen - Macrophages, Stomach - Macrophages, Thyroid gland - Macrophages"									"CAB032435, HPA055431"	Supported				"Secreted to blood"	Receptor	NA	NA			"Cluster 37: Monocytes & Neutrophils - Innate immune response"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 14: Myeloid leukemia - Innate immune response"	"Cluster 29: Monocytes - Innate immune response"	4			"CAB032435: AB_626925, HPA055431: AB_2682815"	"unprognostic (1.54e-1)"	"unprognostic (6.90e-2)"	"unprognostic (2.67e-1)"	"unprognostic (6.27e-2)"	"unprognostic (8.73e-2)"	"unprognostic (6.79e-2)"	"unprognostic (2.89e-2)"	"unprognostic (6.36e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.24e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.46e-1)"	"unprognostic (4.24e-3)"	"unprognostic (3.67e-2)"	"unprognostic (3.44e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.39e-1)"	"unprognostic (9.13e-3)"	"unprognostic (3.31e-2)"	"unprognostic (2.98e-1)"	"unprognostic (3.55e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.53e-1)"	"unprognostic (9.66e-2)"	"unprognostic (6.55e-2)"	"unprognostic (2.44e-2)"	"unprognostic (4.57e-2)"
FCGR3B	"CD16, CD16b, FCG3, FcgammaRIIIb, FCGR3, FcRIIIb"	ENSG00000162747	"Fc gamma receptor IIIb"	O75015	1	161623196-161631963	"CD markers, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"		"IgG-binding protein, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 32.5;lymphoid tissue: 79.0"	"Cell type enriched"	"Detected in some"	7	"Serous glandular cells: 28.8"	"Group enriched"	"Detected in some"	23	"central nervous system macrophage: 2.1;leukocyte: 2.6"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"cerebral cortex: 11.0;pons: 4.2"	"Immune cell enriched"	"Detected in many"	356	"neutrophil: 6077.6"	"Lineage enriched"	"Detected in many"	356	"granulocytes: 6077.6"	"Not detected"	"Not detected"			"Adipose visceral - Neutrophils, Colon - Neutrophils, Heart muscle - Neutrophils, Minor Salivary Gland - Neutrophils, Pituitary gland - Neutrophils, Skeletal muscle - Neutrophils, Spleen - Neutrophils, Stomach - Neutrophils, Thyroid gland - Neutrophils"														"Secreted to blood"	Receptor	NA	NA			"Cluster 4: Neutrophils - Degranulation"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 12: Non-specific - Vasculature"	"Cluster 14: Myeloid leukemia - Innate immune response"	"Cluster 74: Neutrophils - Degranulation"	16				"unprognostic (9.39e-3)"	"unprognostic (1.59e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.08e-1)"	"unprognostic (8.14e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.27e-1)"	"unprognostic (2.06e-3)"	"unprognostic (7.70e-2)"		"unprognostic (5.61e-2)"	"unprognostic (9.38e-3)"	"unprognostic (8.82e-2)"	"unprognostic (3.26e-2)"	"potential prognostic favorable (1.48e-4)"	"unprognostic (1.44e-1)"	"unprognostic (2.08e-1)"	"unprognostic (8.95e-2)"	"unprognostic (7.10e-2)"		"unprognostic (1.20e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.78e-2)"		"unprognostic (1.21e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.94e-1)"	"unprognostic (5.97e-2)"			"unprognostic (7.81e-2)"
FGA		ENSG00000171560	"Fibrinogen alpha chain"	P02671	4	154583126-154590742	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"	"Adaptive immunity, Blood coagulation, Hemostasis, Immunity, Innate immunity"		"Amyloidosis, Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	386	"liver: 17848.7"	"Cell type enriched"	"Detected in many"	30	"Hepatocytes: 13631.3"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in many"	21	"Liver Hepatocellular Carcinoma (TCGA): 5313.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	6	"liver cancer: 180.5"	"Liver - Hepatocytes, Stomach - Parietal cells, Testis - Early spermatids, Testis - Late spermatids"									"CAB016776, HPA051370, HPA064755"	Supported		Enhanced	"Endoplasmic reticulum"	"Secreted to blood"	"Blood coagulation"	NA	NA	407000000	160000000000		"Cluster 31: Liver - Plasma proteins"		"Cluster 18: Liver cancer - Metabolism"	"Cluster 62: Hepatocytes - Metabolism"	14	"Endoplasmic reticulum"		"CAB016776: , HPA051370: AB_2681458, HPA064755: AB_2685345"		"unprognostic (1.36e-1)"		"unprognostic (4.10e-2)"							"unprognostic (5.40e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.41e-3)"	"unprognostic (1.26e-3)"	"unprognostic (2.52e-2)"	"unprognostic (2.72e-1)"	"potential prognostic unfavorable (3.10e-5)"	"unprognostic (2.81e-1)"			"unprognostic (1.59e-1)"	"potential prognostic unfavorable (7.62e-6)"		"unprognostic (7.32e-2)"		"unprognostic (3.70e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.16e-1)"		"unprognostic (4.56e-1)"
FGB		ENSG00000171564	"Fibrinogen beta chain"	P02675	4	154563011-154572807	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Adaptive immunity, Blood coagulation, Hemostasis, Immunity, Innate immunity"		"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	372	"liver: 17393.5"	"Cell type enriched"	"Detected in some"	8	"Hepatocytes: 15989.7"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in many"	21	"Liver Hepatocellular Carcinoma (TCGA): 4509.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in many"	8	"liver cancer: 219.4"	"Liver - Hepatocytes"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA001900, HPA001901, CAB008624"	Enhanced		Enhanced	"Endoplasmic reticulum"	"Secreted to blood"	"Blood coagulation"	NA	NA		130000000000		"Cluster 31: Liver - Plasma proteins"		"Cluster 18: Liver cancer - Metabolism"	"Cluster 62: Hepatocytes - Metabolism"	23	"Endoplasmic reticulum"		"CAB008624: AB_1615610, HPA001900: AB_1078865, HPA001901: AB_1078864"	"unprognostic (1.05e-3)"	"unprognostic (8.75e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.84e-2)"		"unprognostic (3.73e-3)"					"unprognostic (1.02e-1)"	"unprognostic (4.31e-2)"	"unprognostic (4.17e-2)"	"unprognostic (7.12e-3)"	"potential prognostic favorable (7.15e-4)"	"unprognostic (7.37e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.83e-1)"				"unprognostic (8.27e-2)"	"potential prognostic unfavorable (3.44e-9)"		"unprognostic (1.46e-1)"		"unprognostic (3.78e-1)"	"unprognostic (2.40e-2)"	"unprognostic (9.50e-2)"		"unprognostic (1.01e-1)"
FGF1	"AFGF, ECGF, ECGF-beta, ECGFA, ECGFB, FGF-alpha, FGFA, GLIO703, HBGF1"	ENSG00000113578	"Fibroblast growth factor 1"	P05230	5	142592178-142698070	"Cancer-related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"	"Angiogenesis, Differentiation"	"Developmental protein, Growth factor, Heparin-binding, Mitogen"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 290.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 71.2;Breast myoepithelial cells: 29.1;Cardiomyocytes: 70.6;Muller glia cells: 66.4;Oligodendrocytes: 111.5"	"Cell type enhanced"	"Detected in all"		"fibroblast: 259.4;pericyte: 375.4;vascular associated smooth muscle cell: 234.3"	"Cancer enriched"	"Detected in many"	11	"Glioblastoma Multiforme (TCGA): 76.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Adipose visceral - Mesothelial cells, Kidney - Podocytes, Liver - Hepatic stellate cells, Skin - Outer root sheath cells, Thyroid gland - Fibroblasts"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003265, CAB017519"	Enhanced		Supported	Nucleoplasm	"Secreted in other tissues"	"Growth factor"	NA	NA				"Cluster 9: Oligodendrocytes - Myelination"	"Cluster 13: Oligodendrocytes - Mixed function"	"Cluster 70: DU4475 - Unknown function"	"Cluster 10: Muller glia cells - Visual perception"	28	Nucleoplasm		"CAB017519: AB_629473, HPA003265: AB_1848522"	"unprognostic (8.14e-2)"	"unprognostic (3.53e-2)"	"unprognostic (3.82e-1)"	"unprognostic (1.52e-2)"		"unprognostic (2.01e-1)"	"unprognostic (6.06e-2)"	"potential prognostic unfavorable (4.46e-4)"	"unprognostic (1.67e-1)"	"unprognostic (1.87e-1)"	"validated prognostic favorable (2.26e-6)"	"validated prognostic favorable (5.12e-4)"	"unprognostic (8.56e-2)"			"unprognostic (1.46e-2)"	"unprognostic (3.31e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.15e-3)"	"unprognostic (2.63e-2)"	"potential prognostic unfavorable (1.17e-4)"	"unprognostic (1.15e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.01e-1)"		"unprognostic (4.07e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.17e-3)"		"potential prognostic favorable (6.46e-5)"	"unprognostic (4.32e-2)"
FGF2	FGFB	ENSG00000138685	"Fibroblast growth factor 2"	P09038	4	122826682-122898236	"Cancer-related genes, Candidate cardiovascular disease genes, FDA approved drug targets, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins, Transporters"	"Angiogenesis, Differentiation"	"Developmental protein, Growth factor, Heparin-binding, Mitogen"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 33.5;Astrocytes: 105.3;Endometrial stromal cells: 38.6;Oligodendrocyte precursor cells: 39.6;Schwann cells: 56.0;Secretory cells: 37.4"	"Cell type enhanced"	"Detected in all"		"astrocyte: 189.6;bergmann glia: 186.9;choroid plexus epithelial cell: 151.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in all"			"Adrenal gland - Endothelial cells, Heart muscle - Endothelial cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000125, HPA065502"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"	"Secreted in other tissues"	"Growth factor"	NA	NA				"Cluster 64: Neuronal - Transcription"	"Cluster 46: Brainstem - Mixed function"	"Cluster 64: Connective tissue cells - ECM organization"	"Cluster 41: Adipocytes & Endothelial cells - Mixed function"	21	"Nucleoplasm, Nuclear bodies"		"CAB000125: , HPA065502: "	"unprognostic (8.59e-3)"	"unprognostic (4.34e-3)"	"unprognostic (4.75e-2)"	"unprognostic (2.44e-1)"	"unprognostic (7.71e-2)"	"unprognostic (2.77e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.96e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.33e-1)"	"unprognostic (9.18e-2)"	"unprognostic (7.38e-2)"		"unprognostic (4.88e-2)"	"unprognostic (3.85e-3)"	"unprognostic (1.66e-1)"			"potential prognostic unfavorable (5.26e-4)"	"unprognostic (1.14e-1)"	"unprognostic (2.06e-1)"		"unprognostic (1.49e-2)"	"unprognostic (2.74e-1)"	"unprognostic (4.48e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.29e-1)"
FGFR2	"BEK, CD332, CEK3, CFD1, ECT1, JWS, K-SAM, KGFR, TK14, TK25"	ENSG00000066468	"Fibroblast growth factor receptor 2"	P21802	10	121478332-121598458	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	Apoptosis	"Heparin-binding, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Craniosynostosis, Disease variant, Ectodermal dysplasia, FDA approved drug targets, Intellectual disability, Lacrimo-auriculo-dento-digital syndrome, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 594.1"	"Group enriched"	"Detected in many"	5	"Astrocytes: 216.4;Cholangiocytes: 190.8;Oligodendrocytes: 523.6"	"Group enriched"	"Detected in many"	4	"bergmann glia: 1277.6;choroid plexus epithelial cell: 1305.0;oligodendrocyte: 929.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"basophil: 3.0;eosinophil: 2.0"	"Lineage enriched"	"Detected in single"	28	"granulocytes: 3.0"	"Cancer enhanced"	"Detected in many"		"Gastric cancer: 171.5"	"Lung - Alveolar cells type 2, Minor Salivary Gland - Minor salivary gland ductal cells, Pituitary gland - Undifferentiated cells (Pituitary gland), Skin - Keratinocyte (other), Testis - Spermatogonia, Thyroid gland - Thyroid glandular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010886, HPA035305"	Uncertain		Approved	"Nucleoplasm,Vesicles,Cell Junctions"	"Secreted - unknown location"	Receptor	NA	NA		860000	"Cluster 46: Basophils - Proteolysis"	"Cluster 9: Oligodendrocytes - Myelination"	"Cluster 30: White matter - Myelination"	"Cluster 40: Non-specific - Unknown function"	"Cluster 51: Oligodendrocytes - Unknown function"	34	"Cell Junctions"	"Nucleoplasm, Vesicles"	"CAB010886: AB_259379, HPA035305: AB_10672862"	"unprognostic (1.73e-2)"	"unprognostic (2.01e-1)"	"unprognostic (6.80e-2)"	"unprognostic (1.18e-2)"	"unprognostic (6.89e-2)"	"unprognostic (5.27e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.04e-3)"	"unprognostic (2.90e-1)"	"unprognostic (1.11e-3)"	"potential prognostic favorable (3.24e-6)"	"unprognostic (6.37e-2)"	"unprognostic (8.26e-2)"	"unprognostic (6.57e-3)"	"unprognostic (7.91e-3)"	"unprognostic (3.60e-2)"	"unprognostic (1.82e-3)"	"potential prognostic favorable (2.43e-5)"	"unprognostic (3.77e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.53e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.99e-1)"
FGFR3	"ACH, CD333, CEK2, JTK4"	ENSG00000068078	"Fibroblast growth factor receptor 3"	P22607	4	1793293-1808872	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	Apoptosis	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Craniosynostosis, Deafness, Disease variant, Dwarfism, Ectodermal dysplasia, FDA approved drug targets, Lacrimo-auriculo-dento-digital syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 155.8;esophagus: 135.7;skin 1: 264.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 389.2;Basal keratinocytes: 98.3;Cholangiocytes: 70.6;Suprabasal keratinocytes: 96.2"	"Group enriched"	"Detected in many"	6	"astrocyte: 516.1;bergmann glia: 251.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Myeloma: 150.3"	"Minor Salivary Gland - Minor salivary gland basal cells, Pituitary gland - Corticotropes, Testis - Spermatogonia"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004231, HPA067204"	Enhanced		Supported	"Endoplasmic reticulum"	"Secreted - unknown location"	Receptor	NA	NA		1500000		"Cluster 80: Non-specific - Endocytosis"	"Cluster 19: Astrocytes - Mixed function"	"Cluster 51: Myeloma - Immunoglobulins"	"Cluster 47: Astrocytes - Unknown function"	217	"Endoplasmic reticulum"		"CAB004231: AB_627596, HPA067204: AB_2685804"	"unprognostic (7.73e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.81e-2)"	"unprognostic (8.61e-2)"	"potential prognostic favorable (6.13e-6)"	"unprognostic (1.48e-1)"	"unprognostic (2.38e-3)"	"unprognostic (2.46e-2)"		"potential prognostic favorable (2.62e-4)"	"unprognostic (1.54e-3)"	"unprognostic (1.17e-1)"	"unprognostic (9.96e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.30e-1)"	"unprognostic (8.95e-3)"	"unprognostic (5.08e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.59e-1)"	"unprognostic (5.81e-2)"	"unprognostic (1.92e-1)"	"unprognostic (9.33e-3)"	"unprognostic (3.15e-2)"	"unprognostic (8.71e-2)"	"unprognostic (5.51e-2)"	"unprognostic (3.73e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.47e-2)"	"unprognostic (5.02e-2)"
FGG		ENSG00000171557	"Fibrinogen gamma chain"	P02679	4	154604134-154612967	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"		"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	330	"liver: 16058.1"	"Cell type enriched"	"Detected in some"	10	"Hepatocytes: 9849.5"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in many"	9	"Liver Hepatocellular Carcinoma (TCGA): 4055.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in many"	6	"liver cancer: 229.6"	"Liver - Hepatocytes"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA011159, HPA027529, CAB033120, HPA074638"	Supported		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to blood"	"Blood coagulation"	NA	NA	267000000000	81000000000		"Cluster 31: Liver - Plasma proteins"		"Cluster 71: Lymphoma - Inflammatory response"	"Cluster 62: Hepatocytes - Metabolism"	6	"Endoplasmic reticulum"	Vesicles	"CAB033120: AB_2103818, HPA011159: , HPA027529: AB_10601322, HPA074638: "	"unprognostic (2.72e-2)"	"unprognostic (3.50e-2)"	"unprognostic (2.97e-1)"	"unprognostic (6.99e-2)"							"unprognostic (6.67e-2)"	"unprognostic (4.64e-3)"	"unprognostic (9.60e-2)"	"unprognostic (5.43e-3)"	"unprognostic (2.77e-2)"	"unprognostic (3.65e-2)"	"unprognostic (3.67e-1)"	"potential prognostic unfavorable (1.24e-4)"	"unprognostic (2.58e-1)"			"unprognostic (8.80e-3)"	"potential prognostic unfavorable (3.59e-5)"					"unprognostic (3.39e-3)"	"unprognostic (3.28e-1)"		
FLT1	"FLT, VEGFR1"	ENSG00000102755	"Fms related receptor tyrosine kinase 1"	P17948	13	28300346-28495145	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	"Angiogenesis, Chemotaxis, Differentiation"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"placenta: 405.3"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 383.1;Endothelial cells: 364.4;Extravillous trophoblasts: 980.8;Microglial cells: 414.2;Syncytiotrophoblasts: 1127.1"	"Cell type enriched"	"Detected in many"	12	"endothelial cell: 3142.1"	"Cancer enhanced"	"Detected in all"		"Kidney Renal Clear Cell Carcinoma (TCGA): 123.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"skin cancer: 15.1;testis cancer: 39.8"	"Adipose visceral - Endothelial cells, Breast - Endothelial cells, Colon - Endothelial cells, Heart muscle - Endothelial cells, Liver - Vascular Endothelial cells, Minor Salivary Gland - Endothelial cells, Pituitary gland - Endothelial cells, Prostate - Endothelial cells, Skin - Endothelial cells, Stomach - Endothelial cells, Testis - Early spermatids"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011740, HPA014290, CAB068189, CAB068190"	Enhanced		Supported	"Plasma membrane,Actin filaments,Cytosol"	"Secreted to blood"	Receptor	NA	NA	876000	120000		"Cluster 58: Placenta - Pregnancy"	"Cluster 47: Endothelial cells - Vasculature"	"Cluster 49: HMC-1 - Innate immune response"	"Cluster 4: Extravillous trophoblasts - Unknown function"	21	"Plasma membrane"	"Actin filaments, Cytosol"	"CAB068189: AB_2665636, CAB068190: AB_2665637, HPA011740: AB_1858737, HPA014290: AB_1858738"	"unprognostic (1.82e-1)"	"unprognostic (2.40e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.42e-3)"	"unprognostic (4.86e-3)"	"unprognostic (3.34e-2)"	"unprognostic (2.12e-1)"	"unprognostic (5.01e-3)"	"unprognostic (6.22e-2)"	"unprognostic (1.45e-1)"	"validated prognostic favorable (2.61e-8)"	"validated prognostic favorable (3.90e-4)"	"unprognostic (1.78e-3)"	"unprognostic (7.66e-2)"	"unprognostic (1.43e-1)"	"unprognostic (4.42e-3)"	"unprognostic (9.15e-3)"	"unprognostic (2.65e-3)"	"unprognostic (2.15e-1)"	"unprognostic (3.53e-1)"	"potential prognostic unfavorable (8.13e-4)"	"unprognostic (3.90e-1)"	"unprognostic (2.96e-3)"	"unprognostic (2.92e-1)"	"unprognostic (1.41e-2)"	"unprognostic (9.98e-2)"	"unprognostic (4.56e-2)"	"unprognostic (1.28e-2)"	"unprognostic (6.21e-2)"	"unprognostic (7.24e-2)"	"unprognostic (6.25e-3)"
FLT4	"PCL, VEGFR-3, VEGFR3"	ENSG00000037280	"Fms related receptor tyrosine kinase 4"	P35916	5	180601506-180649624	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins, Transporters"	Angiogenesis	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	4	"Lymphatic endothelial cells: 193.6"	"Cell type enriched"	"Detected in some"	8	"endothelial cell: 32.6"	"Cancer enhanced"	"Detected in all"		"Kidney Renal Clear Cell Carcinoma (TCGA): 20.8"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"MAIT T-cell: 3.8"	"Lineage enriched"	"Detected in single"	14	"T-cells: 3.8"	"Low cancer specificity"	"Detected in many"			"Kidney - Endothelial cells, Liver - Vascular Endothelial cells, Minor Salivary Gland - Endothelial cells, Pancreas - Endothelial cells, Prostate - Endothelial cells, Skeletal muscle - Endothelial cells"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA067906, HPA074389"	Approved		Approved	"Microtubules,Cytokinetic bridge,Primary cilium,Calyx,Connecting piece,Mid piece,Principal piece"	"Secreted to blood"	Receptor	Yes	NA	20000000	170000000	"Cluster 1: T-cells - Unknown function"	"Cluster 47: Spleen - Immune response"	"Cluster 47: Endothelial cells - Vasculature"	"Cluster 54: Non-specific - Transcription"	"Cluster 54: Lymphatic endothelial cells - Lymph vessel development"	24	"Microtubules, Primary cilium"	"Cytokinetic bridge, Calyx, Connecting piece, Mid piece, Principal piece"	"HPA067906: AB_2732775, HPA074389: "	"unprognostic (4.13e-2)"	"unprognostic (1.18e-1)"	"unprognostic (7.15e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.14e-2)"	"unprognostic (7.99e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.09e-2)"	"validated prognostic favorable (5.61e-6)"	"validated prognostic favorable (8.45e-5)"	"unprognostic (8.98e-2)"	"unprognostic (4.80e-2)"	"potential prognostic favorable (2.55e-4)"	"unprognostic (1.80e-1)"	"unprognostic (1.98e-2)"	"potential prognostic unfavorable (9.96e-4)"	"unprognostic (6.93e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.34e-1)"	"unprognostic (9.09e-3)"	"unprognostic (4.82e-2)"	"unprognostic (9.24e-2)"	"unprognostic (7.37e-2)"	"unprognostic (6.89e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.09e-1)"	"unprognostic (4.47e-2)"
FN1	"CIG, FINC, GFND2, LETS, MSF"	ENSG00000115414	"Fibronectin 1"	P02751	2	215360440-215436073	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Acute phase, Angiogenesis, Cell adhesion, Cell shape"	Heparin-binding	"Cancer-related genes, Disease variant, Dwarfism, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 1674.5;placenta: 2828.8"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 3161.0;Fibroblasts: 697.7;Hepatocytes: 800.2;Pancreatic endocrine cells: 517.9;Smooth muscle cells: 482.6"	"Cell type enhanced"	"Detected in all"		"endothelial cell: 716.1;pericyte: 1227.5"	"Cancer enhanced"	"Detected in all"		"Thyroid Carcinoma (TCGA): 3346.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in all"		"testis cancer: 4284.8;thyroid cancer: 4456.7"	"Adipose subcutaneous - Adipose progenitor cells, Breast - Fibroblasts, Colon - Smooth muscle cells, Prostate - Smooth muscle cells, Skeletal muscle - Fibroblasts, Skin - Fibroblast_2, Spleen - Smooth muscle cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000126, HPA027066"	Enhanced				"Secreted to blood"	"Acute phase"	NA	NA	227000000000	80000000000		"Cluster 11: Liver - Plasma proteins"	"Cluster 12: Non-specific - Vasculature"	"Cluster 64: Connective tissue cells - ECM organization"	"Cluster 32: Smooth muscle cells - Muscle contraction"	59			"CAB000126: , HPA027066: AB_10602500"	"unprognostic (2.38e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.37e-1)"	"potential prognostic unfavorable (8.26e-4)"	"unprognostic (2.89e-2)"	"unprognostic (2.20e-1)"	"unprognostic (9.78e-3)"	"unprognostic (1.79e-1)"	"unprognostic (1.47e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.21e-2)"	"potential prognostic unfavorable (4.98e-7)"	"unprognostic (9.55e-2)"	"unprognostic (1.63e-1)"	"unprognostic (5.30e-2)"	"unprognostic (1.32e-3)"	"unprognostic (7.42e-3)"	"unprognostic (9.45e-3)"	"potential prognostic unfavorable (3.40e-4)"	"unprognostic (7.71e-3)"	"unprognostic (1.43e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.05e-1)"	"unprognostic (3.47e-1)"	"unprognostic (9.78e-3)"	"unprognostic (1.01e-1)"	"potential prognostic unfavorable (3.60e-4)"	"unprognostic (8.07e-2)"	"unprognostic (1.85e-1)"	"unprognostic (3.75e-2)"
FOLH1	"FOLH, GCP2, GCPII, NAALAD1, NAALAdase, PSM, PSMA"	ENSG00000086205	"Folate hydrolase 1"	Q04609	11	49145092-49208638	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"Carboxypeptidase, Dipeptidase, Hydrolase, Metalloprotease, Multifunctional enzyme, Protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 259.0;prostate: 73.4"	"Group enriched"	"Detected in many"	13	"Oligodendrocytes: 342.1;Prostatic glandular cells: 547.4"	"Cell type enriched"	"Detected in many"	5	"oligodendrocyte: 694.1"	"Cancer enriched"	"Detected in all"	17	"Prostate Adenocarcinoma (TCGA): 277.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	25	"prostate cancer: 262.4;Rhabdoid: 177.2"	"Kidney - Proximal tubular cells, Kidney - Proximal tubular cells, Liver - Hepatocytes, Lung - Fibroblast_1, Minor Salivary Gland - Minor salivary glandular cells, Pancreas - Fibroblasts, Prostate - Prostate glandular cells, Stomach - Fibroblasts, Thyroid gland - Fibroblasts"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001451, HPA010593"	Enhanced				"Intracellular and membrane"	Enzyme	NA	NA				"Cluster 25: Small intestine - Absorption"	"Cluster 11: White matter - Signal transduction"	"Cluster 3: Rhabdoid - Membrane components"	"Cluster 40: Prostatic glandular cells - Transcription"				"CAB001451: AB_563979, HPA010593: AB_1079685"	"unprognostic (5.40e-3)"	"unprognostic (4.91e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.46e-2)"	"unprognostic (3.97e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.78e-1)"	"unprognostic (9.93e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.20e-1)"	"potential prognostic favorable (3.69e-6)"	"unprognostic (1.86e-2)"	"potential prognostic unfavorable (3.87e-5)"	"unprognostic (1.76e-3)"	"unprognostic (9.30e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.69e-2)"	"potential prognostic favorable (2.33e-4)"	"unprognostic (5.53e-3)"	"unprognostic (1.14e-2)"	"unprognostic (4.44e-3)"	"unprognostic (7.67e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.55e-2)"	"unprognostic (2.51e-1)"	"unprognostic (5.39e-2)"	"unprognostic (5.60e-2)"	"unprognostic (1.34e-1)"	"unprognostic (9.35e-2)"	"unprognostic (1.47e-1)"
FOLR1	"FOLR, FRalpha"	ENSG00000110195	"Folate receptor alpha"	P15328	11	72189558-72196323	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	Transport	Receptor	"FDA approved drug targets, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	14	"choroid plexus: 2944.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 387.7;Alveolar cells type 2: 264.2;Breast glandular cells: 223.4;Ciliated cells: 209.6;Collecting duct cells: 254.8;Cytotrophoblasts: 468.5;Proximal tubular cells: 245.3;Secretory cells: 415.8;Syncytiotrophoblasts: 323.9"	"Group enriched"	"Detected in many"	4	"choroid plexus epithelial cell: 156.2;ependymal cell: 44.1"	"Cancer enhanced"	"Detected in many"		"Ovary Serous Cystadenocarcinoma (TCGA): 633.3"	"Region enriched"	"Detected in all"	38	"choroid plexus: 993.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"ovarian cancer: 85.2"	"Kidney - Proximal tubular cells, Lung - Alveolar cells type 1, Minor Salivary Gland - Minor salivary glandular cells, Pituitary gland - Undifferentiated cells (Pituitary gland), Skin - Eccrine sweat gland cells, Thyroid gland - Thyroid glandular cells"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Secreted to blood"	Receptor	NA	NA	448000	58000		"Cluster 60: Choroid plexus - Transmembrane transport"	"Cluster 36: Choroid plexus - Mixed function"	"Cluster 15: Kidney cancer - Membrane components"	"Cluster 17: Breast glandular cells - Lactation"	4				"unprognostic (1.62e-2)"	"unprognostic (3.07e-1)"	"unprognostic (7.33e-2)"	"unprognostic (3.44e-1)"	"unprognostic (8.91e-2)"	"unprognostic (1.32e-1)"	"unprognostic (5.36e-3)"	"unprognostic (1.16e-3)"	"unprognostic (1.05e-2)"	"unprognostic (2.85e-1)"	"potential prognostic favorable (3.68e-4)"	"unprognostic (2.11e-1)"	"unprognostic (6.32e-2)"	"potential prognostic unfavorable (3.17e-4)"	"unprognostic (4.26e-2)"	"unprognostic (4.55e-3)"	"unprognostic (6.90e-2)"	"unprognostic (5.50e-2)"	"unprognostic (8.25e-2)"	"unprognostic (5.34e-2)"	"unprognostic (7.13e-2)"	"unprognostic (4.34e-2)"	"unprognostic (2.35e-1)"	"unprognostic (9.84e-3)"	"unprognostic (2.70e-1)"	"unprognostic (3.06e-2)"		"unprognostic (1.71e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.76e-1)"	"unprognostic (4.19e-2)"
GAST	GAS	ENSG00000184502	Gastrin	P01350	17	41712331-41715969	"Cancer-related genes, FDA approved drug targets, Predicted secreted proteins"		Hormone	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	167	"stomach 1: 9294.1"	"Group enriched"	"Detected in some"	4	"Glandular and luminal cells: 105.4;Plasma cells: 56.3"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"Pancreatic Adenocarcinoma (TCGA): 99.5;Stomach Adenocarcinoma (TCGA): 40.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"cervical cancer: 2.8;colorectal cancer: 2.5;Esophageal cancer: 4.6;Gastric cancer: 9.0;head and neck cancer: 5.9"		"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			CAB000038	Enhanced				"Secreted to digestive system"	Hormone	NA	NA		81000		"Cluster 48: Stomach - Proteolysis"	"Cluster 56: Hypothalamus - Neuropeptide signaling"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 23: Plasma cells - Humoral immune response"	24			"CAB000038: "				"unprognostic (8.80e-2)"					"unprognostic (8.49e-3)"					"unprognostic (5.63e-3)"	"unprognostic (2.04e-1)"			"unprognostic (1.81e-1)"	"unprognostic (3.50e-3)"			"unprognostic (2.28e-1)"						"unprognostic (3.31e-1)"			
GHR	GHBP	ENSG00000112964	"Growth hormone receptor"	P10912	5	42423439-42721878	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Predicted secreted proteins"	Endocytosis	Receptor	"Disease variant, Dwarfism, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 81.8;liver: 206.8"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 51.2;Hepatocytes: 119.8;Inhibitory neurons: 111.4;Oligodendrocyte precursor cells: 169.8;Syncytiotrophoblasts: 46.6"	"Low cell type specificity"	"Detected in all"			"Cancer enhanced"	"Detected in many"		"Prostate Adenocarcinoma (TCGA): 17.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"skin cancer: 6.9"	"Adipose subcutaneous - Adipocytes (Subcutaneous), Adipose visceral - Adipocytes (Visceral), Breast - Adipocytes (Breast), Liver - Hepatocytes, Lung - Fibroblast_1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045339, HPA057705"	Enhanced		Supported	"Plasma membrane,Cytosol,Cytoplasmic bodies"	"Secreted to blood"	Receptor	NA	NA	2200000	14000000		"Cluster 83: Liver - Metabolism"	"Cluster 56: Hypothalamus - Neuropeptide signaling"	"Cluster 3: Rhabdoid - Membrane components"	"Cluster 8: Neurons - Neuronal signaling"	31	"Plasma membrane, Cytosol, Cytoplasmic bodies"		"HPA045339: AB_2679294, HPA057705: AB_2683507"	"unprognostic (6.47e-2)"	"unprognostic (1.26e-2)"	"unprognostic (8.47e-2)"	"unprognostic (1.11e-2)"	"unprognostic (3.23e-1)"	"unprognostic (4.88e-2)"	"unprognostic (2.95e-1)"	"potential prognostic favorable (4.80e-5)"	"unprognostic (3.73e-2)"	"unprognostic (6.78e-2)"	"validated prognostic favorable (2.53e-10)"	"validated prognostic favorable (1.24e-4)"	"unprognostic (2.09e-1)"	"validated prognostic favorable (3.06e-6)"	"validated prognostic favorable (1.71e-4)"		"unprognostic (2.92e-2)"	"unprognostic (1.51e-1)"	"unprognostic (8.98e-2)"	"unprognostic (5.90e-2)"		"unprognostic (2.97e-3)"	"unprognostic (3.57e-2)"	"unprognostic (8.96e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.27e-1)"		"unprognostic (5.69e-3)"	"unprognostic (1.43e-1)"	"potential prognostic unfavorable (6.29e-4)"	
GIP		ENSG00000159224	"Gastric inhibitory polypeptide"	P09681	17	48958554-48968596	"FDA approved drug targets, Plasma proteins, Predicted secreted proteins"		Hormone	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	208	"intestine: 251.8"	"Cell type enriched"	"Detected in single"	35	"Enteroendocrine cells: 19.5"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	53	"Testicular Germ Cell Tumor (TCGA): 116.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"liver cancer: 2.8"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA021612, HPA064596"	Enhanced				"Secreted to blood"	Hormone	NA	NA	33900	380000		"Cluster 25: Small intestine - Absorption"		"Cluster 1: Neuronal - Visual perception"	"Cluster 20: Enteroendocrine cells - Hormone signaling"	15			"HPA021612: AB_1849506, HPA064596: "																						"unprognostic (5.62e-3)"							"unprognostic (2.42e-1)"		
IDE		ENSG00000119912	"Insulin degrading enzyme"	P14735	10	92451684-92574096	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Host-virus interaction"	"Allosteric enzyme, Host cell receptor for virus entry, Hydrolase, Metalloprotease, Protease, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adrenal gland - Adrenal cortex cells, Skin - Keratinocyte (granular), Testis - Early spermatids"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063478	Approved				"Secreted in other tissues"	Receptor	NA	NA		230000	"Cluster 33: Non-specific - ATP binding"	"Cluster 21: Testis - Unknown function"	"Cluster 21: Non-specific - Metabolism"	"Cluster 52: Non-specific - Mitochondria"	"Cluster 70: Spermatocytes & Spermatids - Spermatid development"	24			"HPA063478: AB_2685020"	"unprognostic (1.35e-1)"	"unprognostic (2.25e-3)"	"unprognostic (2.34e-1)"	"unprognostic (4.72e-2)"	"unprognostic (3.87e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.48e-2)"	"unprognostic (3.70e-1)"	"unprognostic (1.22e-1)"	"unprognostic (5.15e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.14e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.37e-1)"	"unprognostic (5.49e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.19e-3)"	"unprognostic (3.22e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.69e-2)"	"unprognostic (8.05e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.91e-1)"	"unprognostic (8.85e-2)"	"unprognostic (2.56e-2)"
IFNAR2	IFNABR	ENSG00000159110	"Interferon alpha and beta receptor subunit 2"	P48551	21	33205282-33265675	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		Receptor	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 86.2;Plasma cells: 86.7"	"Cell type enhanced"	"Detected in all"		"endothelial cell: 336.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cancer enhanced"	"Detected in all"		"Myeloma: 108.5"	"Colon - Endothelial cells, Heart muscle - Endothelial cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to blood"	Receptor	NA	NA		1200000	"Cluster 10: Non-specific - Membrane trafficking"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 47: Endothelial cells - Vasculature"	"Cluster 51: Myeloma - Immunoglobulins"	"Cluster 77: Plasma cells - Protein processing"	21				"unprognostic (5.14e-2)"	"unprognostic (2.13e-1)"	"unprognostic (3.23e-2)"	"potential prognostic unfavorable (3.54e-4)"	"unprognostic (4.46e-1)"	"unprognostic (4.34e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.37e-1)"	"unprognostic (3.10e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.58e-1)"	"unprognostic (5.76e-2)"	"unprognostic (1.40e-3)"	"unprognostic (6.89e-2)"	"unprognostic (2.81e-2)"	"potential prognostic unfavorable (8.05e-4)"	"unprognostic (6.00e-2)"	"unprognostic (7.16e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.66e-2)"	"unprognostic (3.94e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.32e-1)"	"unprognostic (3.06e-1)"	"potential prognostic favorable (9.75e-4)"	"unprognostic (9.23e-2)"	"unprognostic (8.08e-2)"	"unprognostic (4.02e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.22e-1)"
IFNG		ENSG00000111537	"Interferon gamma"	P01579	12	68154768-68159740	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Antiviral defense, Growth regulation"	Cytokine	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"bone marrow: 11.4;lymphoid tissue: 7.3"	"Group enriched"	"Detected in many"	15	"NK-cells: 81.0;T-cells: 211.4"	"Cell type enriched"	"Detected in single"	86	"leukocyte: 37.1"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"gdT-cell: 5.5;memory CD4 T-cell: 2.4;memory CD8 T-cell: 6.6;naive CD8 T-cell: 3.7"	"Lineage enriched"	"Detected in single"	7	"T-cells: 6.6"	"Not detected"	"Not detected"			"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Thyroid gland - T-cells"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB010344	Approved				"Secreted to blood"	Interferon	NA	NA			"Cluster 24: Non-specific - Transcription"	"Cluster 81: Lymphoid tissue & Bone marrow - Innate immune response"		"Cluster 59: Leukemia - T-cell receptor"	"Cluster 19: NK-cells - Adaptive immune response"	11			"CAB010344: AB_2123447"			"unprognostic (5.88e-2)"	"unprognostic (2.75e-3)"							"unprognostic (2.63e-3)"	"unprognostic (2.89e-1)"			"unprognostic (2.68e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.76e-1)"		"unprognostic (4.17e-2)"									"unprognostic (8.39e-2)"	"unprognostic (2.70e-1)"		
IGHG1		ENSG00000211896	"Immunoglobulin heavy constant gamma 1 (G1m marker)"	P01857	14	105736343-105743071	"Disease related genes, FDA approved drug targets, Immunoglobulin genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"lymphoid tissue: 5665.1;urinary bladder: 3867.4"	"Cell type enriched"	"Detected in many"	5	"Plasma cells: 12047.8"	"Cell type enriched"	"Detected in some"	10	"leukocyte: 12.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	6	"memory B-cell: 768.6"	"Lineage enriched"	"Detected in many"	122	"B-cells: 768.6"	"Cancer enriched"	"Detected in some"	8	"Myeloma: 1184.5"	"Adipose subcutaneous - Plasma cells, Adipose visceral - Plasma cells, Adrenal gland - Plasma cells, Breast - Plasma cells, Colon - Plasma cells, Heart muscle - Plasma cells, Kidney - Plasma cells, Liver - Plasma cells, Lung - Plasma cells, Pancreas - Plasma cells, Pituitary gland - Plasma cells, Prostate - Plasma cells, Skeletal muscle - Plasma cells, Skin - Plasma cells, Spleen - Plasma cells, Stomach - Plasma cells, Thyroid gland - Plasma cells"									"HPA001245, CAB008642"	Supported				"Immunoglobulin genes"	Immunity	NA	NA		220000000000	"Cluster 17: B-cells - Immunoglobulins"		"Cluster 8: Immune cells - Immune response"	"Cluster 51: Myeloma - Immunoglobulins"	"Cluster 77: Plasma cells - Protein processing"	36			"CAB008642: AB_1617595, HPA001245: AB_1079121"	"unprognostic (3.44e-3)"	"unprognostic (4.44e-3)"		"unprognostic (2.33e-3)"	"unprognostic (1.17e-1)"	"unprognostic (3.60e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.87e-1)"	"potential prognostic favorable (2.46e-4)"	"unprognostic (1.14e-1)"	"potential prognostic unfavorable (3.50e-4)"	"unprognostic (9.46e-2)"	"unprognostic (3.38e-3)"	"unprognostic (3.58e-2)"		"unprognostic (5.34e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.26e-2)"	"unprognostic (2.14e-2)"	"unprognostic (7.20e-2)"	"unprognostic (4.54e-3)"	"unprognostic (1.19e-1)"	"unprognostic (6.07e-2)"	"unprognostic (2.70e-3)"	"unprognostic (4.48e-2)"	"unprognostic (2.77e-1)"	"unprognostic (3.97e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.65e-2)"
IGHG2		ENSG00000211893	"Immunoglobulin heavy constant gamma 2 (G2m marker)"	P01859	14	105639559-105644790	"FDA approved drug targets, Immunoglobulin genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 189.5;urinary bladder: 108.3"	"Cell type enriched"	"Detected in some"	11	"Plasma cells: 4935.4"	"Cell type enriched"	"Detected in single"	11	"leukocyte: 4.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	460	"memory B-cell: 344.6;naive B-cell: 128.5"	"Lineage enriched"	"Detected in single"	670	"B-cells: 344.6"	"Group enriched"	"Detected in some"	9	"lymphoma: 19.2;Myeloma: 54.1"	"Adipose subcutaneous - Plasma cells, Adipose visceral - Plasma cells, Adrenal gland - Plasma cells, Breast - Plasma cells, Colon - Plasma cells, Heart muscle - Plasma cells, Kidney - Plasma cells, Liver - Plasma cells, Lung - Plasma cells, Minor Salivary Gland - Plasma cells, Pancreas - Plasma cells, Pituitary gland - Plasma cells, Prostate - Plasma cells, Skeletal muscle - Plasma cells, Skin - Plasma cells, Spleen - Plasma cells, Stomach - Plasma cells, Thyroid gland - Plasma cells"									HPA001245	Approved				"Immunoglobulin genes"	Immunity	NA	NA		260000000000	"Cluster 17: B-cells - Immunoglobulins"		"Cluster 8: Immune cells - Immune response"	"Cluster 51: Myeloma - Immunoglobulins"	"Cluster 77: Plasma cells - Protein processing"	28			"HPA001245: AB_1079121"	"unprognostic (9.17e-3)"	"unprognostic (1.01e-1)"		"potential prognostic favorable (3.62e-5)"	"unprognostic (3.20e-1)"	"unprognostic (8.89e-2)"	"unprognostic (2.85e-3)"	"unprognostic (1.78e-3)"	"potential prognostic favorable (8.19e-5)"	"unprognostic (2.87e-2)"	"potential prognostic unfavorable (3.60e-4)"	"unprognostic (6.22e-3)"	"unprognostic (1.44e-2)"	"unprognostic (4.10e-2)"		"unprognostic (3.87e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.76e-2)"	"unprognostic (2.21e-2)"	"unprognostic (6.18e-2)"	"unprognostic (3.02e-1)"	"unprognostic (4.52e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.27e-2)"	"unprognostic (8.39e-2)"	"unprognostic (3.90e-3)"	"unprognostic (8.31e-2)"	"unprognostic (2.96e-1)"	"unprognostic (3.81e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.65e-2)"
IGHG4		ENSG00000211892	"Immunoglobulin heavy constant gamma 4 (G4m marker)"	P01861	14	105620506-105626066	"FDA approved drug targets, Immunoglobulin genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 2402.4"	"Group enriched"	"Detected in some"	4	"B-cells: 423.0;Plasma cells: 595.5"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	457	"memory B-cell: 123.0;naive B-cell: 74.3"	"Lineage enriched"	"Detected in single"	569	"B-cells: 123.0"	"Group enriched"	"Detected in some"	43	"lymphoma: 133.6;Myeloma: 34.1"	"Adipose subcutaneous - Plasma cells, Adipose visceral - Mesothelial cells, Adrenal gland - Plasma cells, Breast - Plasma cells, Colon - Plasma cells, Heart muscle - Plasma cells, Kidney - Plasma cells, Lung - Plasma cells, Pituitary gland - Plasma cells, Prostate - Plasma cells, Skeletal muscle - Plasma cells, Skin - Plasma cells, Spleen - Plasma cells"									HPA001245	Approved				"Immunoglobulin genes"	Immunity	NA	NA		170000000000	"Cluster 17: B-cells - Immunoglobulins"		"Cluster 43: Hindbrain - Mixed function"	"Cluster 46: Lymphoma - Humoral immune response"	"Cluster 77: Plasma cells - Protein processing"	20			"HPA001245: AB_1079121"	"unprognostic (3.88e-2)"	"unprognostic (4.37e-3)"		"unprognostic (5.42e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.47e-1)"	"unprognostic (3.18e-3)"	"unprognostic (5.65e-2)"	"potential prognostic favorable (6.88e-4)"	"unprognostic (2.10e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.31e-2)"	"potential prognostic unfavorable (6.78e-5)"	"unprognostic (3.95e-1)"		"unprognostic (6.49e-3)"	"unprognostic (9.67e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.57e-1)"	"unprognostic (4.76e-2)"	"unprognostic (7.83e-3)"	"unprognostic (1.12e-1)"	"unprognostic (5.38e-2)"	"potential prognostic favorable (4.51e-6)"	"unprognostic (2.15e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.23e-1)"	"unprognostic (6.43e-2)"	"unprognostic (3.77e-1)"
IL11RA		ENSG00000137070	"Interleukin 11 receptor subunit alpha"	Q14626	9	34652162-34661902	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Predicted secreted proteins"		Receptor	"Craniosynostosis, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 49.2;Late spermatids: 98.4;Sertoli cells: 40.8"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cancer enhanced"	"Detected in many"		"Neuroblastoma: 14.6"	"Adipose subcutaneous - Adipose progenitor cells, Heart muscle - Cardiomyocytes, Liver - Hepatocytes, Thyroid gland - Fibroblasts"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013162, CAB032830, HPA036652, HPA036653"	Supported		Approved	"Vesicles,Plasma membrane"	"Secreted to blood"	Receptor	NA	NA			"Cluster 5: Non-specific - Cell proliferation"	"Cluster 66: Non-specific - Transcription"	"Cluster 13: Oligodendrocytes - Mixed function"	"Cluster 1: Neuronal - Visual perception"	"Cluster 53: Fibroblasts - ECM organization"	1	"Vesicles, Plasma membrane"		"CAB032830: AB_2123745, HPA013162: AB_2668790, HPA036652: AB_2675229, HPA036653: "	"unprognostic (1.71e-1)"	"unprognostic (1.91e-1)"	"unprognostic (5.88e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.49e-2)"	"unprognostic (9.19e-2)"	"unprognostic (8.27e-2)"	"unprognostic (2.77e-2)"	"potential prognostic unfavorable (5.81e-5)"	"unprognostic (3.87e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.57e-2)"	"unprognostic (8.82e-2)"	"unprognostic (5.17e-3)"	"unprognostic (1.38e-3)"	"unprognostic (6.81e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.02e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.69e-2)"	"potential prognostic favorable (9.36e-4)"	"unprognostic (2.85e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.32e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.95e-2)"	"unprognostic (5.60e-2)"
IL12B	"CLMF, CLMF2, IL-12B, NKSF, NKSF2"	ENSG00000113302	"Interleukin 12B"	P29460	5	159314780-159330863	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		Cytokine	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"lymphoid tissue: 1.3"	"Cell type enriched"	"Detected in single"	4	"Langerhans cells: 2.0"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	5	"Testicular Germ Cell Tumor (TCGA): 5.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	13	"lymphoma: 4.0"	"Minor Salivary Gland - Minor salivary gland ductal cells, Pituitary gland - Somatotropes"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA040970	Supported				"Secreted to blood"	Interleukin	NA	NA	140000			"Cluster 36: Lymphoid tissue - Cytokine signaling"	"Cluster 48: Non-specific - Mixed function"	"Cluster 55: Lymphoma - Immune response"	"Cluster 14: Langerhans cells - Innate immune response"	4			"HPA040970: AB_10796234"			"unprognostic (6.32e-2)"							"unprognostic (9.15e-2)"																			"unprognostic (6.01e-2)"		
IL13	"ALRH, BHR1, IL-13, MGC116786, MGC116788, MGC116789, P600"	ENSG00000169194	"Interleukin 13"	P35225	5	132656263-132661110	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"		Cytokine	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	44	"testis: 23.6"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 103.1;granulocytes: 122.5;Late spermatids: 199.5;Spermatocytes: 35.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	45	"lymphoma: 4.8"	"Testis - Early spermatids, Testis - Late spermatids"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to blood"	Interleukin	NA	NA	40000			"Cluster 32: Endocrine & Neural - Unknown function"		"Cluster 59: Leukemia - T-cell receptor"	"Cluster 36: Late spermatids - Unknown function"	10																																		
IL17A	"CTLA8, IL-17, IL-17A, IL17"	ENSG00000112115	"Interleukin 17A"	Q16552	6	52186375-52190638	"Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity, Inflammatory response, Innate immunity"	Cytokine	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"lymphoid tissue: 1.4"	"Cell type enriched"	"Detected in some"	10	"T-cells: 23.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"				"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA052258	Uncertain				"Secreted to blood"	Interleukin	NA	NA	9920			"Cluster 36: Lymphoid tissue - Cytokine signaling"		"Cluster 20: Myeloma - Immune response"	"Cluster 78: NK-cells & T-cells - Immune system & Transcription"	5			"HPA052258: "																															
IL17F	"IL-17F, ML-1, ML1"	ENSG00000112116	"Interleukin 17F"	Q96PD4	6	52236681-52245689	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted secreted proteins"	"Adaptive immunity, Immunity, Inflammatory response, Innate immunity"	Cytokine	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"lymphoid tissue: 2.1"	"Cell type enriched"	"Detected in single"	6	"T-cells: 4.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	85	"lymphoma: 18.6"	"Testis - Early spermatids, Testis - Late spermatids"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to blood"	Interleukin	NA	NA	30000			"Cluster 36: Lymphoid tissue - Cytokine signaling"		"Cluster 71: Lymphoma - Inflammatory response"	"Cluster 78: NK-cells & T-cells - Immune system & Transcription"	5																																		
IL1B	"IL-1B, IL1-BETA, IL1F2"	ENSG00000125538	"Interleukin 1 beta"	P01584	2	112829751-112836816	"Cancer-related genes, Candidate cardiovascular disease genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Inflammatory response"	"Cytokine, Mitogen, Pyrogen"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 198.6;urinary bladder: 121.6"	"Cell type enriched"	"Detected in many"	5	"monocytes: 11738.5"	"Group enriched"	"Detected in some"	39	"central nervous system macrophage: 27.1;leukocyte: 6.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"neutrophil: 94.5"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 94.5"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 177.9;Sarcoma: 319.5"		"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted to blood"	Interleukin	NA	NA	2330		"Cluster 28: Neutrophils - Unknown function"	"Cluster 77: Bone marrow - Cell proliferation"	"Cluster 44: Non-specific - Mixed function"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 29: Monocytes - Innate immune response"	7				"unprognostic (2.08e-1)"	"unprognostic (2.39e-2)"	"unprognostic (9.31e-2)"	"potential prognostic unfavorable (5.36e-5)"	"unprognostic (5.84e-3)"	"unprognostic (6.84e-2)"	"unprognostic (4.71e-2)"	"unprognostic (6.12e-2)"	"unprognostic (6.92e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.01e-1)"	"unprognostic (3.34e-1)"	"unprognostic (9.36e-3)"	"unprognostic (2.00e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.93e-3)"	"unprognostic (1.16e-3)"	"unprognostic (3.19e-2)"	"unprognostic (2.24e-2)"	"unprognostic (2.24e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.52e-2)"	"unprognostic (3.66e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.33e-2)"	"unprognostic (3.61e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.09e-1)"
IL1R1	"CD121A, D2S1473, IL1R, IL1RA"	ENSG00000115594	"Interleukin 1 receptor type 1"	P14778	2	102064544-102179874	"Cancer-related genes, CD markers, Enzymes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Inflammatory response"	"Hydrolase, Receptor"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 303.4;Glandular and luminal cells: 312.5;Langerhans cells: 221.8;Mesothelial cells: 245.0;Prostatic glandular cells: 291.9"	"Cell type enhanced"	"Detected in many"		"endothelial cell: 312.2;fibroblast: 120.4;pericyte: 102.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.1"	"Low lineage specificity"	"Detected in single"			"Low cancer specificity"	"Detected in many"			"Kidney - Endothelial cells, Pituitary gland - Endothelial cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001237, HPA005823, CAB007779, HPA029560"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"	"Secreted to blood"	Receptor	NA	NA		870000	"Cluster 35: Neutrophils - Protein binding"	"Cluster 62: Connective tissue - ECM organization"	"Cluster 12: Non-specific - Vasculature"	"Cluster 44: Connective tissue cells - ECM organization"	"Cluster 37: Glandular & Luminal cells - Unknown function"	13	"Nucleoplasm, Vesicles"	"Plasma membrane, Cytosol"	"CAB007779: AB_562073, HPA001237: , HPA005823: AB_2667445, HPA029560: AB_2673094"	"unprognostic (2.65e-2)"	"unprognostic (4.67e-3)"	"unprognostic (2.16e-2)"	"unprognostic (6.26e-2)"	"unprognostic (3.31e-1)"	"unprognostic (2.24e-2)"	"potential prognostic unfavorable (8.74e-4)"	"unprognostic (2.42e-1)"	"unprognostic (7.75e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.41e-2)"	"unprognostic (8.22e-3)"	"unprognostic (1.69e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.53e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.04e-1)"	"unprognostic (5.34e-3)"	"unprognostic (2.02e-2)"	"unprognostic (2.79e-1)"	"unprognostic (4.86e-2)"	"unprognostic (5.11e-2)"	"unprognostic (9.99e-2)"	"unprognostic (3.78e-2)"	"unprognostic (9.79e-3)"	"unprognostic (7.90e-2)"	"unprognostic (6.69e-2)"	"unprognostic (2.78e-1)"
IL23A	"IL-23, IL-23A, IL23P19, P19, SGRF"	ENSG00000110944	"Interleukin 23 subunit alpha"	Q9NPF7	12	56334174-56340410	"FDA approved drug targets, Predicted secreted proteins"	"Antiviral defense, Immunity, Inflammatory response, Innate immunity, Tissue remodeling"	Cytokine	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"urinary bladder: 42.8"	"Cell type enriched"	"Detected in many"	4	"Langerhans cells: 205.4"	"Low cell type specificity"	"Detected in some"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"MAIT T-cell: 14.2;memory B-cell: 19.0;memory CD4 T-cell: 25.8;memory CD8 T-cell: 12.5;naive B-cell: 21.6;naive CD4 T-cell: 28.2;naive CD8 T-cell: 17.7;T-reg: 15.6"	"Group enriched"	"Detected in many"	12	"B-cells: 21.6;T-cells: 28.2"	"Low cancer specificity"	"Detected in many"			"Testis - Early spermatids"	"Region enhanced"	"Detected in some"		"white matter: 3.9"	"Not detected"	"Not detected"			HPA001554	Approved		Approved	Cytosol	"Secreted to blood"	Interleukin	NA	NA	11000		"Cluster 43: Non-specific - Transcription & Translation"	"Cluster 29: Squamous epithelium - Innate immune response"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 45: Non-specific - Mixed function"	5	Cytosol		"HPA001554: AB_1079135"	"unprognostic (8.92e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.56e-2)"		"unprognostic (1.11e-1)"	"unprognostic (7.39e-3)"		"potential prognostic unfavorable (7.16e-10)"	"unprognostic (5.04e-3)"	"unprognostic (1.15e-2)"		"unprognostic (1.27e-1)"	"potential prognostic unfavorable (1.30e-4)"	"unprognostic (4.19e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.69e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.70e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.80e-1)"	"unprognostic (3.62e-1)"		"unprognostic (8.08e-2)"	"unprognostic (4.35e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.50e-1)"
IL4	"BCGF-1, BCGF1, BSF1, IL-4, MGC79402"	ENSG00000113520	"Interleukin 4"	P05112	5	132673986-132682678	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"B-cell activation"	"Cytokine, Growth factor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"T-cells: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in single"	862	"basophil: 476.8"	"Lineage enriched"	"Detected in single"	862	"granulocytes: 476.8"	"Cancer enhanced"	"Detected in single"		"lymphoma: 1.8"		"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA072995, CAB078477"	Approved				"Secreted to blood"	Interleukin	NA	NA	13600		"Cluster 46: Basophils - Proteolysis"		"Cluster 10: Cerebellum - Nucleic acid binding"	"Cluster 50: Lymphoma - Unknown function"	"Cluster 78: NK-cells & T-cells - Immune system & Transcription"	3			"CAB078477: AB_417057, HPA072995: AB_2732215"																															
IL4R	CD124	ENSG00000077238	"Interleukin 4 receptor"	P24394	16	27313668-27364778	"Cancer-related genes, CD markers, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	Immunity	Receptor	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"B-cells: 71.7;granulocytes: 115.8"	"Cell type enhanced"	"Detected in many"		"central nervous system macrophage: 90.5;endothelial cell: 197.2;vascular associated smooth muscle cell: 79.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"naive B-cell: 77.1"	"Group enriched"	"Detected in all"	5	"B-cells: 77.1;granulocytes: 31.1"	"Cancer enhanced"	"Detected in all"		"Gallbladder cancer: 139.2"	"Adrenal gland - Neutrophils, Kidney - Endothelial cells, Skeletal muscle - Endothelial cells"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB004451, HPA050124, HPA070380"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Centriolar satellite"	"Secreted to blood"	Receptor	NA	NA	38500	59000	"Cluster 34: B-cells - Unknown function"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 46: Lymphoma - Humoral immune response"	"Cluster 74: Neutrophils - Degranulation"	12	"Plasma membrane"	"Nucleoplasm, Centriolar satellite"	"CAB004451: AB_626889, HPA050124: AB_2681026, HPA070380: "	"unprognostic (1.22e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.80e-3)"	"unprognostic (2.44e-3)"	"unprognostic (2.15e-1)"	"unprognostic (6.86e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.53e-1)"	"unprognostic (6.16e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.97e-1)"	"unprognostic (8.28e-2)"	"unprognostic (2.76e-1)"	"unprognostic (7.42e-2)"	"potential prognostic favorable (2.13e-4)"	"unprognostic (7.35e-2)"	"unprognostic (2.36e-2)"	"unprognostic (2.99e-3)"	"potential prognostic unfavorable (3.26e-4)"	"unprognostic (4.67e-2)"	"unprognostic (1.67e-1)"	"unprognostic (9.43e-2)"	"unprognostic (1.50e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.21e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.69e-1)"	"unprognostic (5.20e-2)"
IL5	"EDF, IL-5, TRF"	ENSG00000113525	"Interleukin 5"	P05113	5	132541445-132556838	"Cancer-related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Cytokine, Growth factor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	6	"testis: 4.9"	"Group enriched"	"Detected in some"	9	"granulocytes: 6.7;Spermatocytes: 17.3"	"Low cell type specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	8	"memory B-cell: 1.4"	"Lineage enriched"	"Detected in single"	8	"B-cells: 1.4"	"Cancer enriched"	"Detected in single"	4	"lymphoma: 1.5"		"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			CAB010304	Approved				"Secreted to blood"	Interleukin	NA	NA	4130			"Cluster 46: Testis - Spermatogenesis"	"Cluster 4: Non-specific - mRNA splicing & Cell cycle"	"Cluster 59: Leukemia - T-cell receptor"	"Cluster 31: Spermatocytes - Spermatogenesis"	4			"CAB010304: AB_2296159"																															
IL6	"BSF2, HGF, HSF, IFNB2, IL-6"	ENSG00000136244	"Interleukin 6"	P05231	7	22725884-22732002	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Acute phase"	"Cytokine, Growth factor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 210.6;urinary bladder: 265.7"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 182.3;Endothelial cells: 239.2;Fibroblasts: 109.1;Glandular and luminal cells: 328.1;monocytes: 160.7;Smooth muscle cells: 310.9"	"Group enriched"	"Detected in some"	12	"central nervous system macrophage: 3.4;choroid plexus epithelial cell: 2.1;endothelial cell: 3.1;vascular associated smooth muscle cell: 5.1"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"choroid plexus: 15.1"	"Group enriched"	"Detected in some"	47	"memory B-cell: 4.1;naive B-cell: 5.2"	"Lineage enriched"	"Detected in single"	52	"B-cells: 5.2"	"Cancer enhanced"	"Detected in many"		"Kidney cancer: 219.1"	"Colon - Neutrophils"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB023406, CAB072821"	Supported		Approved	Vesicles	"Secreted to blood"	"Acute phase"	NA	NA	5700	91000	"Cluster 14: Non-specific - Unknown function"	"Cluster 7: Adipose tissue - Mixed function"	"Cluster 36: Choroid plexus - Mixed function"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 48: Smooth muscle cells - Signal transduction"	7	Vesicles		"CAB023406: AB_617317, CAB072821: "	"unprognostic (3.09e-1)"	"unprognostic (2.74e-2)"	"unprognostic (5.92e-3)"	"unprognostic (2.89e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.00e-1)"	"unprognostic (3.88e-3)"	"unprognostic (7.66e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.11e-1)"	"potential prognostic unfavorable (2.42e-6)"	"unprognostic (3.56e-2)"	"unprognostic (3.64e-2)"		"unprognostic (1.64e-2)"	"unprognostic (6.65e-2)"	"unprognostic (2.31e-2)"	"unprognostic (6.49e-3)"	"unprognostic (4.43e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.00e-2)"	"unprognostic (1.43e-2)"	"unprognostic (4.08e-2)"	"unprognostic (2.84e-1)"	"unprognostic (5.49e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.44e-3)"	"unprognostic (1.28e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.51e-2)"
IL6R	"CD126, gp80, IL-1Ra, IL-6R, IL6RA"	ENSG00000160712	"Interleukin 6 receptor"	P08887	1	154405193-154469450	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		Receptor	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 56.9;skeletal muscle: 90.8"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 86.2;Langerhans cells: 91.5"	"Cell type enhanced"	"Detected in many"		"central nervous system macrophage: 194.2;endothelial cell: 88.4;fibroblast: 101.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 89.4"	"Low lineage specificity"	"Detected in all"			"Cancer enhanced"	"Detected in all"		"Myeloma: 83.8"	"Pituitary gland - Corticotropes, Spleen - Neutrophils"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Secreted to blood"	Receptor	NA	NA	24800000	19000000	"Cluster 7: Non-specific - Innate immune response"	"Cluster 19: Non-specific - Basic cellular processes"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 51: Myeloma - Immunoglobulins"	"Cluster 29: Monocytes - Innate immune response"	7				"unprognostic (1.11e-1)"	"unprognostic (1.75e-1)"	"unprognostic (5.77e-2)"	"unprognostic (2.50e-1)"	"unprognostic (3.95e-2)"	"unprognostic (2.54e-1)"	"unprognostic (8.01e-2)"	"unprognostic (7.43e-3)"	"unprognostic (4.60e-2)"	"unprognostic (5.42e-2)"	"potential prognostic favorable (6.13e-6)"	"unprognostic (7.34e-3)"	"unprognostic (1.54e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.09e-2)"	"unprognostic (7.06e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.06e-1)"	"unprognostic (7.01e-2)"	"unprognostic (8.25e-2)"	"potential prognostic favorable (3.20e-4)"	"unprognostic (2.03e-2)"	"unprognostic (3.80e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.04e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.87e-1)"	"unprognostic (7.90e-2)"
KLK3	"APS, PSA"	ENSG00000142515	"Kallikrein related peptidase 3"	P07288	19	50854915-50860764	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	320	"prostate: 7740.7"	"Cell type enriched"	"Detected in some"	900	"Prostatic glandular cells: 23789.4"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in many"	1441	"Prostate Adenocarcinoma (TCGA): 19654.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	1800	"prostate cancer: 2405.5"	"Minor Salivary Gland - Minor salivary gland ductal cells, Prostate - Prostate glandular cells, Testis - Late spermatids"									"CAB000070, HPA000764"	Enhanced				"Secreted in male reproductive system"	Enzyme	NA	NA		9000000		"Cluster 64: Neuronal - Transcription"		"Cluster 60: Prostate cancer - Unknown function"	"Cluster 40: Prostatic glandular cells - Transcription"	22			"CAB000070: , HPA000764: AB_1079700"	"unprognostic (3.82e-2)"	"unprognostic (1.29e-1)"	"unprognostic (9.69e-2)"	"unprognostic (1.18e-1)"						"unprognostic (3.01e-1)"			"unprognostic (5.88e-1)"									"unprognostic (8.51e-2)"		"unprognostic (8.70e-2)"	"unprognostic (1.53e-1)"	"potential prognostic unfavorable (4.00e-4)"			"unprognostic (2.44e-1)"	"unprognostic (2.76e-1)"	"unprognostic (5.53e-2)"
KLKB1	KLK3	ENSG00000164344	"Kallikrein B1"	P03952	4	186226438-186258471	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Fibrinolysis, Hemostasis, Inflammatory response"	"Hydrolase, Protease, Serine protease"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	28	"liver: 318.1"	"Cell type enriched"	"Detected in many"	4	"Hepatocytes: 223.6"	"Cell type enhanced"	"Detected in all"		"astrocyte: 107.4"	"Cancer enriched"	"Detected in some"	14	"Liver Hepatocellular Carcinoma (TCGA): 45.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Liver - Hepatocytes"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted to blood"	"Blood coagulation"	NA	NA	28900000000	7400000000		"Cluster 31: Liver - Plasma proteins"	"Cluster 23: Choroid plexus - Mixed function"	"Cluster 12: Bone cancer - Neuronal signaling"	"Cluster 62: Hepatocytes - Metabolism"	9						"unprognostic (2.68e-2)"					"unprognostic (3.20e-1)"			"unprognostic (9.13e-2)"	"unprognostic (7.11e-3)"	"unprognostic (3.86e-2)"	"unprognostic (8.81e-3)"	"potential prognostic favorable (8.52e-5)"							"unprognostic (4.06e-3)"									
LIPF	"HGL, HLAL"	ENSG00000182333	"Lipase F, gastric type"	P07098	10	88664441-88678814	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	142	"stomach 1: 36201.8"	"Cell type enriched"	"Detected in some"	316	"Gastric mucus-secreting cells: 1628.3"	"Cell type enriched"	"Detected in single"	28	"ependymal cell: 6.1"	"Cancer enriched"	"Detected in some"	59	"Stomach Adenocarcinoma (TCGA): 595.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Stomach - Chief cells"	"Region enriched"	"Detected in single"	77	"olfactory bulb: 7.6"					HPA045930	Enhanced				"Secreted to digestive system"	Enzyme	NA	NA				"Cluster 48: Stomach - Proteolysis"		"Cluster 27: Breast cancer - Unknown function"	"Cluster 46: Gastric mucus-secreting cells - Digestion"	1			"HPA045930: AB_10959518"																												"unprognostic (2.52e-1)"			
LPL	LIPD	ENSG00000175445	"Lipoprotein lipase"	P06858	8	19901717-19967259	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	"Heparin-binding, Hydrolase"	"Disease variant, FDA approved drug targets, Hyperlipidemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 904.9;heart muscle: 394.5"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 404.3;Breast glandular cells: 110.6;Cardiomyocytes: 655.2;Schwann cells: 154.4"	"Group enriched"	"Detected in many"	9	"cerebellar inhibitory: 150.9;medium spiny neuron: 166.6;pericyte: 236.7"	"Cancer enhanced"	"Detected in many"		"Glioblastoma Multiforme (TCGA): 62.0"	"Region enhanced"	"Detected in all"		"basal ganglia: 106.9"	"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 4.2"	"Lineage enriched"	"Detected in single"	6	"monocytes: 4.2"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 15.6"	"Adipose subcutaneous - Adipocytes (Subcutaneous), Adipose visceral - Adipocytes (Visceral), Breast - Adipocytes (Breast), Minor Salivary Gland - Adipocytes (Minor salivary gland), Skin - Adipocytes (Skin), Testis - Endothelial cells"	"Region enhanced"	"Detected in many"		"basal ganglia: 45.3"	"Group enriched"	"Detected in all"	4	"basal ganglia: 101.9;spinal cord: 74.2"	HPA048749			Approved	Vesicles	"Secreted to blood"	Enzyme	NA	NA		45000000	"Cluster 40: Monocytes - Innate immune response"	"Cluster 7: Adipose tissue - Mixed function"	"Cluster 10: Cerebellum - Nucleic acid binding"	"Cluster 12: Bone cancer - Neuronal signaling"	"Cluster 17: Breast glandular cells - Lactation"	12	Vesicles		"HPA048749: AB_2680511"	"unprognostic (1.40e-1)"	"unprognostic (1.38e-1)"	"unprognostic (7.05e-3)"	"unprognostic (9.02e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.71e-1)"	"unprognostic (9.05e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.88e-2)"	"validated prognostic favorable (2.81e-6)"	"validated prognostic favorable (5.95e-5)"	"unprognostic (2.19e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.23e-3)"	"unprognostic (7.53e-2)"	"unprognostic (6.01e-3)"	"unprognostic (1.90e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.78e-2)"	"unprognostic (8.05e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.97e-1)"	"unprognostic (4.34e-1)"	"unprognostic (4.89e-2)"	"potential prognostic unfavorable (1.21e-4)"	"unprognostic (3.55e-3)"	"unprognostic (2.43e-1)"	
LTA	"LT, TNFB, TNFSF1"	ENSG00000226979	"Lymphotoxin alpha"	P01374	6	31572054-31574324	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted secreted proteins"		Cytokine	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"intestine: 1.9;lymphoid tissue: 5.5;testis: 4.1"	"Cell type enhanced"	"Detected in some"		"B-cells: 11.3;dendritic cells: 3.4;NK-cells: 3.2;T-cells: 14.5"	"Cell type enriched"	"Detected in single"	12	"leukocyte: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	9	"lymphoma: 17.1"	"Adipose visceral - T-cells, Breast - T-cells, Thyroid gland - T-cells"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA007729	Uncertain				"Secreted to blood"	Cytokine	NA	NA	8150			"Cluster 70: Lymphoid tissue - Immune response"		"Cluster 50: Lymphoma - Unknown function"	"Cluster 7: T-cells - T-cell receptor"	19			"HPA007729: AB_1852906"			"unprognostic (5.13e-3)"																												
MAPT	"DDPAC, FLJ31424, FTDP-17, MAPTL, MGC138549, MSTD, MTBT1, MTBT2, PPND, PPP1R103, tau, tau-40"	ENSG00000186868	"Microtubule associated protein tau"	P10636	17	45894527-46028334	"Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Alzheimer disease, Disease variant, FDA approved drug targets, Neurodegeneration, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 135.5;skeletal muscle: 76.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 135.0;Bipolar cells: 278.2;Early spermatids: 130.2;Excitatory neurons: 182.9;Horizontal cells: 226.6;Inhibitory neurons: 147.3;Late spermatids: 428.0;Muller glia cells: 123.3;Oligodendrocyte precursor cells: 121.7;Oligodendrocytes: 152.5"	"Low cell type specificity"	"Detected in all"			"Cancer enhanced"	"Detected in many"		"Breast Invasive Carcinoma (TCGA): 30.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"non-classical monocyte: 1.7"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in many"	4	"Bone cancer: 46.4;Neuroblastoma: 13.7"	"Adipose subcutaneous - Adipocytes (Subcutaneous), Adipose visceral - Adipocytes (Visceral), Heart muscle - Cardiomyocytes, Kidney - Proximal tubular cells, Thyroid gland - Fibroblasts"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000151, HPA048895, HPA069524, HPA069570, CAB072344"	Enhanced		Supported	"Nuclear speckles,Plasma membrane,End piece"	"Secreted to blood"	"No annotated function"	NA	NA		53000		"Cluster 22: Brain - Synaptic signal transduction"	"Cluster 14: Neurons - Synaptic function"	"Cluster 12: Bone cancer - Neuronal signaling"	"Cluster 25: Bipolar cells - Visual perception"	218	"Plasma membrane, End piece"	"Nuclear speckles"	"CAB000151: , CAB072344: , HPA048895: AB_2680550, HPA069524: AB_2686145, HPA069570: AB_2686155"	"unprognostic (1.23e-1)"	"unprognostic (8.49e-3)"	"unprognostic (1.19e-1)"				"unprognostic (2.85e-1)"	"potential prognostic favorable (6.46e-4)"		"unprognostic (1.10e-1)"	"potential prognostic favorable (6.36e-9)"	"unprognostic (1.27e-3)"	"unprognostic (7.13e-2)"	"potential prognostic unfavorable (6.92e-5)"	"unprognostic (5.22e-2)"							"unprognostic (2.30e-2)"		"unprognostic (3.42e-2)"			"unprognostic (9.86e-2)"		"unprognostic (7.28e-2)"		
MET	"DFNB97, HGFR, RCCP2"	ENSG00000105976	"MET proto-oncogene, receptor tyrosine kinase"	P08581	7	116672196-116798377	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins, Transporters"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Deafness, Disease variant, FDA approved drug targets, Non-syndromic deafness, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 41.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 95.5;Cytotrophoblasts: 75.8;Glandular and luminal cells: 138.4;Mesothelial cells: 72.0;Salivary duct cells: 113.4"	"Cell type enhanced"	"Detected in many"		"choroid plexus epithelial cell: 64.5;hippocampal CA1-3: 48.0;oligodendrocyte: 44.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Gastric cancer: 289.3"	"Adipose visceral - Mesothelial cells, Lung - Alveolar cells type 2, Testis - Endothelial cells"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB005282, HPA055607"	Approved		Approved	"Plasma membrane,Cytosol"	"Secreted to blood"	Receptor	NA	NA	179000000	72000000		"Cluster 11: Liver - Plasma proteins"	"Cluster 53: Neurons - Mixed function"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 37: Glandular & Luminal cells - Unknown function"	76	"Plasma membrane"	Cytosol	"CAB005282: AB_631940, HPA055607: AB_2682860"	"unprognostic (1.50e-1)"	"unprognostic (3.09e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.67e-2)"	"unprognostic (5.15e-2)"	"unprognostic (2.01e-1)"	"unprognostic (6.21e-3)"	"unprognostic (8.75e-2)"	"potential prognostic unfavorable (2.97e-4)"	"unprognostic (2.45e-2)"	"unprognostic (7.22e-3)"	"unprognostic (1.55e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.01e-2)"	"unprognostic (3.73e-2)"	"unprognostic (7.01e-3)"	"unprognostic (2.15e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.05e-2)"	"potential prognostic unfavorable (6.80e-6)"	"unprognostic (3.17e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.96e-2)"	"unprognostic (5.90e-3)"	"unprognostic (9.20e-2)"	"unprognostic (8.35e-2)"	"unprognostic (5.32e-2)"	"unprognostic (3.05e-2)"	"unprognostic (9.39e-2)"
NPY	PYY4	ENSG00000122585	"Neuropeptide Y"	P01303	7	24284188-24291862	"FDA approved drug targets, Plasma proteins, Predicted secreted proteins"		Neuropeptide	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"adrenal gland: 118.5;brain: 285.3;prostate: 321.4"	"Cell type enriched"	"Detected in some"	14	"Prostatic glandular cells: 1630.9"	"Cell type enriched"	"Detected in many"	8	"splatter: 1711.7"	"Cancer enriched"	"Detected in many"	174	"Prostate Adenocarcinoma (TCGA): 3813.8"	"Region enriched"	"Detected in many"	9	"hypothalamus: 885.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	15	"Neuroblastoma: 353.3;prostate cancer: 285.9"	"Adrenal gland - Adrenal medulla cells, Prostate - Prostate glandular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB016733, CAB034368, HPA036636, HPA044572, HPA056798"	Supported	Supported	Supported	"Golgi apparatus"	"Secreted to blood"	Neuropeptide	NA	NA	30700000	12000		"Cluster 33: Brain - Neuronal signaling"	"Cluster 56: Hypothalamus - Neuropeptide signaling"	"Cluster 64: Connective tissue cells - ECM organization"	"Cluster 40: Prostatic glandular cells - Transcription"	2	"Golgi apparatus"		"CAB016733: , CAB034368: AB_2298657, HPA036636: , HPA044572: AB_2678996, HPA056798: AB_2630371"	"unprognostic (8.24e-3)"	"unprognostic (2.76e-2)"					"unprognostic (7.53e-2)"	"unprognostic (3.81e-1)"		"unprognostic (8.69e-1)"						"unprognostic (2.63e-1)"		"unprognostic (1.87e-1)"		"unprognostic (2.83e-2)"	"unprognostic (9.01e-3)"	"unprognostic (2.41e-2)"	"unprognostic (1.25e-1)"	"unprognostic (8.53e-2)"	"unprognostic (5.79e-2)"	"unprognostic (9.59e-2)"		"unprognostic (1.73e-3)"	"unprognostic (2.86e-1)"	"unprognostic (2.56e-1)"	"unprognostic (4.21e-2)"
ORM1		ENSG00000229314	"Orosomucoid 1"	P02763	9	114323098-114326479	"Cancer-related genes, Candidate cardiovascular disease genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Acute phase, Transport"		"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	177	"liver: 41892.9"	"Cell type enriched"	"Detected in some"	53	"Hepatocytes: 54806.5"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in many"	13	"Liver Hepatocellular Carcinoma (TCGA): 7670.7"	"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in some"	47	"neutrophil: 201.8"	"Lineage enriched"	"Detected in many"	47	"granulocytes: 201.8"	"Cancer enriched"	"Detected in many"	4	"liver cancer: 243.4"	"Liver - Hepatocytes, Lung - Neutrophil_2"									"CAB006265, HPA046438, HPA047725, HPA057726"	Approved		Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"	"Acute phase"	NA	NA	945000000000	45000000000	"Cluster 4: Neutrophils - Degranulation"	"Cluster 31: Liver - Plasma proteins"	"Cluster 54: Immune cells - T cell receptor"	"Cluster 18: Liver cancer - Metabolism"	"Cluster 43: Hepatocytes - Metabolism"	22	Vesicles	"Golgi apparatus"	"CAB006265: AB_425575, HPA046438: AB_2679666, HPA047725: AB_2680133, HPA057726: AB_2683512"	"unprognostic (3.25e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.16e-3)"	"unprognostic (9.91e-3)"	"unprognostic (1.59e-2)"					"unprognostic (1.86e-2)"			"unprognostic (2.66e-1)"	"potential prognostic favorable (1.16e-4)"	"unprognostic (6.02e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.59e-3)"	"unprognostic (3.24e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.25e-1)"	"unprognostic (6.24e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.20e-2)"	"unprognostic (9.18e-2)"
ORM2	"AGP-B, AGP-B', AGP2"	ENSG00000228278	"Orosomucoid 2"	P19652	9	114329869-114333251	"FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Acute phase, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	297	"liver: 8652.9"	"Cell type enriched"	"Detected in some"	44	"Hepatocytes: 9678.3"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in many"	33	"Liver Hepatocellular Carcinoma (TCGA): 2268.7"	"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in single"	39	"neutrophil: 13.2"	"Lineage enriched"	"Detected in single"	39	"granulocytes: 13.2"	"Cancer enriched"	"Detected in some"	27	"liver cancer: 95.6"	"Liver - Hepatocytes, Testis - Late spermatids"									"HPA046438, HPA047725, HPA057726"	Approved		Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"	"Acute phase"	NA	NA	422000000	29000000000	"Cluster 4: Neutrophils - Degranulation"	"Cluster 31: Liver - Plasma proteins"	"Cluster 33: Neurons - Mixed function"	"Cluster 18: Liver cancer - Metabolism"	"Cluster 43: Hepatocytes - Metabolism"	5	Vesicles	"Golgi apparatus"	"HPA046438: AB_2679666, HPA047725: AB_2680133, HPA057726: AB_2683512"		"unprognostic (2.88e-3)"	"unprognostic (3.41e-1)"								"potential prognostic unfavorable (5.27e-6)"			"unprognostic (6.53e-2)"	"unprognostic (8.21e-3)"	"unprognostic (9.83e-2)"	"unprognostic (4.84e-3)"	"unprognostic (1.47e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.81e-1)"		"unprognostic (6.38e-3)"	"unprognostic (5.16e-1)"	"unprognostic (5.21e-2)"	"unprognostic (1.09e-1)"		"unprognostic (6.66e-1)"	"unprognostic (3.28e-1)"			"unprognostic (5.20e-1)"
PCSK9	"FH3, HCHOLA3, NARC-1"	ENSG00000169174	"Proprotein convertase subtilisin/kexin type 9"	Q8NBP7	1	55039447-55064852	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Apoptosis, Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Hydrolase, Protease, Serine protease"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 47.6"	"Group enriched"	"Detected in some"	4	"Alveolar cells type 2: 31.1;Hepatocytes: 28.2;Kupffer cells: 13.4"	"Group enriched"	"Detected in some"	5	"lower rhombic lip: 10.3;upper rhombic lip: 8.0"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"cerebellum: 7.1;medulla oblongata: 1.8;pons: 4.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Lung - Alveolar cells type 2, Spleen - Neutrophils"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"								"Secreted to blood"	Enzyme	NA	NA	143000000	320000000		"Cluster 83: Liver - Metabolism"	"Cluster 37: Neurons - Mixed function"	"Cluster 57: Stomach & Colon cancer - Digestion"	"Cluster 62: Hepatocytes - Metabolism"	36				"unprognostic (8.78e-3)"		"unprognostic (7.09e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.39e-1)"	"unprognostic (1.00e-1)"			"unprognostic (9.55e-2)"					"potential prognostic unfavorable (1.70e-4)"	"unprognostic (2.23e-1)"	"unprognostic (7.23e-3)"	"unprognostic (3.63e-2)"	"unprognostic (2.03e-1)"	"unprognostic (7.04e-3)"			"unprognostic (3.53e-3)"	"unprognostic (4.80e-2)"		"unprognostic (2.25e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.20e-1)"		"unprognostic (3.15e-1)"
PGA5		ENSG00000256713	"Pepsinogen A5"	P0DJD9	11	61241175-61251444	"Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted secreted proteins"	Digestion	"Aspartyl protease, Hydrolase, Protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	2028	"stomach 1: 38780.0"	"Cell type enriched"	"Detected in some"	22	"Exocrine glandular cells: 1696.1"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in many"	33	"Stomach Adenocarcinoma (TCGA): 298.4"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	29	"classical monocyte: 1.8;intermediate monocyte: 4.3;non-classical monocyte: 2.4"	"Lineage enriched"	"Detected in single"	44	"monocytes: 4.3"	"Not detected"	"Not detected"			"Stomach - Chief cells"									HPA046875	Supported				"Secreted to digestive system"	Enzyme	NA	NA			"Cluster 40: Monocytes - Innate immune response"	"Cluster 48: Stomach - Proteolysis"	"Cluster 51: Neurons - Mixed function"	"Cluster 64: Connective tissue cells - ECM organization"	"Cluster 45: Non-specific - Mixed function"				"HPA046875: AB_2679851"							"unprognostic (3.38e-2)"				"unprognostic (4.21e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.49e-2)"							"unprognostic (9.99e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.60e-2)"						"unprognostic (1.42e-2)"		"unprognostic (2.08e-2)"	
PGF	"D12S1900, PGFL, PIGF, PLGF, PlGF-2, SHGC-10760"	ENSG00000119630	"Placental growth factor"	P49763	14	74941834-74955626	"Cancer-related genes, Candidate cardiovascular disease genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins, RAS pathway related proteins"	"Angiogenesis, Differentiation"	"Developmental protein, Growth factor, Heparin-binding, Mitogen"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 50.6;thyroid gland: 51.0"	"Group enriched"	"Detected in many"	21	"Extravillous trophoblasts: 1887.4;Syncytiotrophoblasts: 2188.7"	"Group enriched"	"Detected in some"	5	"pericyte: 117.7;vascular associated smooth muscle cell: 79.9"	"Cancer enhanced"	"Detected in all"		"Kidney Renal Clear Cell Carcinoma (TCGA): 138.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Sarcoma: 41.1"		"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"spinal cord: 12.2"	HPA041624			Approved	Nucleoplasm,Mitochondria,Cytosol	"Secreted to blood"	"Growth factor"	No	No	20800			"Cluster 60: Choroid plexus - Transmembrane transport"	"Cluster 44: Non-specific - Mixed function"	"Cluster 34: Testis cancer - Unknown function"	"Cluster 4: Extravillous trophoblasts - Unknown function"	2	Nucleoplasm	"Mitochondria, Cytosol"	"HPA041624: AB_10794522"	"unprognostic (6.22e-2)"	"unprognostic (2.41e-3)"	"unprognostic (2.76e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.96e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.70e-3)"	"unprognostic (1.09e-1)"	"unprognostic (3.70e-2)"	"potential prognostic unfavorable (7.33e-4)"	"unprognostic (2.33e-2)"	"potential prognostic unfavorable (2.67e-5)"	"potential prognostic unfavorable (3.18e-4)"	"unprognostic (2.14e-1)"	"unprognostic (5.53e-2)"	"potential prognostic unfavorable (6.21e-5)"	"unprognostic (6.96e-3)"	"unprognostic (5.08e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.30e-3)"	"unprognostic (6.48e-3)"	"unprognostic (1.72e-2)"	"unprognostic (5.25e-3)"	"unprognostic (9.52e-3)"	"unprognostic (8.82e-3)"	"unprognostic (1.97e-1)"	"unprognostic (3.42e-3)"	"unprognostic (9.40e-2)"	"unprognostic (2.93e-2)"	"unprognostic (4.33e-2)"
PLA2G10	GXPLA2	ENSG00000069764	"Phospholipase A2 group X"	O15496	16	14672548-14694308	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted secreted proteins, RAS pathway related proteins"	"Lipid metabolism, Phospholipid metabolism"	Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 26.2;stomach 1: 40.8"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 230.7;Enteroendocrine cells: 55.2;Exocrine glandular cells: 52.6;Extravillous trophoblasts: 64.7;Gastric mucus-secreting cells: 73.7;Intestinal goblet cells: 144.6;Paneth cells: 68.2"	"Low cell type specificity"	"Detected in some"			"Group enriched"	"Detected in many"	6	"Colon Adenocarcinoma (TCGA): 18.7;Lung Adenocarcinoma (TCGA): 46.2;Pancreatic Adenocarcinoma (TCGA): 42.7;Rectum Adenocarcinoma (TCGA): 20.1;Stomach Adenocarcinoma (TCGA): 33.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Gallbladder cancer: 6.0;Gastric cancer: 4.1;pancreatic cancer: 4.4"	"Colon - Colon enterocytes, Stomach - Gastric mucous cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA041893	Uncertain				"Secreted in other tissues"	Enzyme	NA	NA				"Cluster 45: Intestine - Digestion"		"Cluster 57: Stomach & Colon cancer - Digestion"	"Cluster 5: Enterocytes - Absorption"	42			"HPA041893: AB_10794495"	"unprognostic (3.98e-2)"	"unprognostic (1.45e-2)"	"unprognostic (4.29e-2)"	"unprognostic (9.33e-2)"	"unprognostic (3.73e-2)"	"unprognostic (2.28e-1)"										"unprognostic (5.96e-2)"	"unprognostic (4.65e-2)"	"unprognostic (2.24e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.81e-1)"		"unprognostic (7.78e-2)"	"unprognostic (1.37e-3)"	"unprognostic (2.67e-1)"	"unprognostic (2.51e-2)"	"unprognostic (3.12e-2)"		"unprognostic (6.39e-3)"	"unprognostic (1.95e-1)"	"unprognostic (3.97e-2)"	"unprognostic (2.51e-1)"
PLA2G1B	"PLA2, PLA2A, PPLA2"	ENSG00000170890	"Phospholipase A2 group IB"	P04054	12	120322115-120327779	"Candidate cardiovascular disease genes, Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"	"Lipid metabolism, Phospholipid metabolism"	Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	2908	"pancreas: 113918.1"	"Cell type enriched"	"Detected in some"	39	"Exocrine glandular cells: 9563.7"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in many"	82	"Pancreatic Adenocarcinoma (TCGA): 1402.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Lung - Alveolar cells type 2, Pancreas - Exocrine glandular cells, Testis - Late spermatids"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA047822, HPA060803"	Enhanced				"Secreted to digestive system"	Enzyme	NA	NA		2100000	"Cluster 43: Non-specific - Transcription & Translation"	"Cluster 15: Pancreas - Proteolysis"		"Cluster 7: Liver cancer - Metabolism"	"Cluster 60: Pancreatic exocrine cells - Proteolysis"	1			"HPA047822: AB_2680169, HPA060803: AB_2684369"			"unprognostic (1.47e-2)"								"unprognostic (1.75e-2)"	"unprognostic (1.72e-1)"		"unprognostic (1.47e-1)"	"unprognostic (5.57e-3)"	"unprognostic (1.23e-3)"	"unprognostic (2.66e-2)"	"unprognostic (2.87e-3)"	"unprognostic (2.25e-1)"	"unprognostic (7.91e-2)"		"unprognostic (1.27e-1)"	"unprognostic (5.36e-2)"					"unprognostic (2.11e-1)"			
PLA2G2A	"PLA2B, PLA2L"	ENSG00000188257	"Phospholipase A2 group IIA"	P14555	1	19975431-19980416	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"	"Inflammatory response, Lipid metabolism, Phospholipid metabolism"	"Antimicrobial, Bacteriolytic enzyme, Hydrolase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adipose tissue: 904.0;intestine: 1462.3;placenta: 558.1;urinary bladder: 630.6"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 640.8;Exocrine glandular cells: 430.1;Fibroblasts: 1056.7;Mesothelial cells: 1444.4;Proximal enterocytes: 427.4;Undifferentiated cells: 2509.4"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in all"		"Prostate Adenocarcinoma (TCGA): 3345.8"	"Region enhanced"	"Detected in some"		"choroid plexus: 6.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"colorectal cancer: 84.8;Gastric cancer: 164.6"	"Colon - Macrophages, Lung - Fibroblast_2, Thyroid gland - Macrophages"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA015236	Enhanced				"Secreted to blood"	Enzyme	NA	NA	1000000	650000		"Cluster 45: Intestine - Digestion"	"Cluster 12: Non-specific - Vasculature"	"Cluster 57: Stomach & Colon cancer - Digestion"	"Cluster 16: Intestinal goblet cells - Mucin production"	1			"HPA015236: AB_10601047"	"unprognostic (2.93e-2)"	"unprognostic (1.56e-2)"	"potential prognostic favorable (2.23e-4)"	"unprognostic (1.78e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.44e-3)"	"unprognostic (9.16e-2)"	"potential prognostic unfavorable (3.59e-4)"	"unprognostic (4.42e-2)"	"unprognostic (3.83e-1)"	"potential prognostic unfavorable (7.49e-9)"		"potential prognostic unfavorable (1.56e-4)"	"unprognostic (1.46e-1)"	"unprognostic (8.48e-3)"	"unprognostic (6.20e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.89e-1)"	"unprognostic (8.86e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.67e-1)"	"unprognostic (5.08e-3)"	"unprognostic (5.90e-2)"	"potential prognostic unfavorable (6.51e-4)"	"unprognostic (3.16e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.78e-1)"
PLAT		ENSG00000104368	"Plasminogen activator, tissue type"	P00750	8	42174718-42207709	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Plasminogen activation"	"Hydrolase, Protease, Serine protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 237.9;urinary bladder: 174.7"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 133.4;Breast glandular cells: 99.1;Endometrial stromal cells: 101.4;Endothelial cells: 108.9;Fibroblasts: 93.6;granulocytes: 135.2;Lymphatic endothelial cells: 87.5"	"Group enriched"	"Detected in all"	4	"central nervous system macrophage: 78.9;endothelial cell: 233.4;oligodendrocyte precursor cell: 69.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"skin cancer: 246.4"	"Kidney - Endothelial cells, Minor Salivary Gland - Endothelial cells, Pituitary gland - Fibroblasts, Prostate - Urothelial cells, Testis - Sertoli cells, Thyroid gland - Fibroblasts"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003412, CAB009335"	Supported		Approved	"Actin filaments"	"Secreted to blood"	Enzyme	NA	NA	9900000	620000		"Cluster 24: Parathyroid gland - Vesicular transport"	"Cluster 47: Endothelial cells - Vasculature"	"Cluster 64: Connective tissue cells - ECM organization"	"Cluster 41: Adipocytes & Endothelial cells - Mixed function"	5	"Actin filaments"		"CAB009335: AB_2237146, HPA003412: AB_1858205"	"unprognostic (5.66e-2)"	"unprognostic (1.15e-3)"	"unprognostic (3.43e-2)"	"unprognostic (6.21e-2)"	"unprognostic (2.13e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.49e-3)"	"unprognostic (9.18e-2)"	"unprognostic (2.57e-1)"	"validated prognostic favorable (4.77e-4)"	"validated prognostic favorable (7.71e-4)"	"unprognostic (3.62e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.98e-3)"	"unprognostic (1.25e-1)"	"potential prognostic unfavorable (1.83e-4)"	"unprognostic (1.34e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.74e-2)"	"unprognostic (2.28e-2)"	"unprognostic (5.11e-3)"	"unprognostic (2.84e-1)"	"unprognostic (4.16e-1)"	"unprognostic (2.58e-1)"	"unprognostic (8.58e-2)"	"unprognostic (2.54e-1)"	"unprognostic (3.97e-3)"	"unprognostic (9.14e-2)"	"unprognostic (1.97e-2)"	"unprognostic (2.85e-1)"
PLG		ENSG00000122194	Plasminogen	P00747	6	160702194-160754097	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Fibrinolysis, Hemostasis, Tissue remodeling"	"Hydrolase, Protease, Serine protease"	"Cancer-related genes, Disease variant, FDA approved drug targets, Thrombophilia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"liver: 2571.0"	"Cell type enriched"	"Detected in some"	8	"Hepatocytes: 1618.7"	"Low cell type specificity"	"Detected in some"			"Cancer enriched"	"Detected in some"	41	"Liver Hepatocellular Carcinoma (TCGA): 397.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"liver cancer: 2.6"	"Kidney - Proximal tubular cells, Kidney - Proximal tubular cells, Liver - Hepatocytes, Lung - Respiratory ciliated cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB000668, CAB016678, HPA021602, HPA048823, HPA053770"	Supported		Approved	Vesicles	"Secreted to blood"	"Blood coagulation"	NA	NA	140000000000	54000000000		"Cluster 1: Liver & Kidney - Metabolism"	"Cluster 14: Neurons - Synaptic function"	"Cluster 18: Liver cancer - Metabolism"	"Cluster 62: Hepatocytes - Metabolism"	16	Vesicles		"CAB000668: , CAB016678: AB_1621208, HPA021602: AB_1855453, HPA048823: AB_2680532, HPA053770: AB_2682256"											"potential prognostic favorable (5.22e-8)"	"unprognostic (3.27e-3)"		"unprognostic (2.54e-3)"	"potential prognostic favorable (7.62e-4)"								"potential prognostic unfavorable (5.74e-4)"								
PNLIP	PL	ENSG00000175535	"Pancreatic lipase"	P16233	10	116545931-116567855	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4811	"pancreas: 430750.5"	"Cell type enriched"	"Detected in some"	15	"Exocrine glandular cells: 2323.2"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	4399	"Pancreatic Adenocarcinoma (TCGA): 3428.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Pancreas - Exocrine glandular cells"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA062430, HPA062494"	Enhanced				"Secreted to digestive system"	Enzyme	NA	NA		8000000		"Cluster 15: Pancreas - Proteolysis"		"Cluster 66: Non-specific - Mitochondria"	"Cluster 60: Pancreatic exocrine cells - Proteolysis"				"HPA062430: AB_2684761, HPA062494: AB_2684782"																						"unprognostic (1.68e-2)"	"unprognostic (6.04e-2)"								
PPIA	CYPA	ENSG00000196262	"Peptidylprolyl isomerase A"	P62937	7	44796680-44824564	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Apoptosis, Host-virus interaction"	"Isomerase, Rotamase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"												"CAB004655, HPA058345"	Uncertain				"Secreted to blood"	Enzyme	NA	NA		210000000	"Cluster 13: Non-specific - Mitochondria"	"Cluster 33: Brain - Neuronal signaling"	"Cluster 14: Neurons - Synaptic function"	"Cluster 67: Non-specific - Unknown function"	"Cluster 49: Non-specific - Transcription"	52			"CAB004655: AB_425607, HPA058345: AB_2683685"	"unprognostic (9.63e-3)"	"unprognostic (6.63e-2)"	"unprognostic (2.39e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.39e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.11e-3)"	"unprognostic (8.90e-3)"	"unprognostic (7.13e-2)"	"potential prognostic unfavorable (4.53e-4)"	"unprognostic (4.48e-2)"	"validated prognostic unfavorable (1.91e-5)"	"validated prognostic unfavorable (4.99e-9)"	"potential prognostic unfavorable (8.07e-6)"	"unprognostic (1.46e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.80e-2)"	"unprognostic (7.52e-2)"	"potential prognostic unfavorable (6.29e-5)"	"unprognostic (8.07e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.71e-1)"	"unprognostic (5.77e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.13e-1)"	"unprognostic (2.18e-1)"	"unprognostic (6.18e-2)"	"unprognostic (5.99e-2)"
PRG2	"BMPG, MBP, proMBP"	ENSG00000186652	"Proteoglycan 2, pro eosinophil major basic protein"	P13727	11	57386780-57390650	"FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	Immunity	"Antibiotic, Antimicrobial, Heparin-binding"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"placenta: 2526.3"	"Group enriched"	"Detected in some"	21	"Erythroid cells: 34.9;Extravillous trophoblasts: 106.5"	"Cell type enhanced"	"Detected in single"		"pericyte: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	36	"basophil: 7.3"	"Lineage enriched"	"Detected in single"	74	"granulocytes: 7.3"	"Cancer enriched"	"Detected in some"	47	"Leukemia: 370.8"	"Lung - Neutrophil_1, Spleen - Hematopoietic stem cells"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA038515	Supported				"Secreted in female reproductive system"	Immunity	NA	NA		74000000		"Cluster 58: Placenta - Pregnancy"		"Cluster 49: HMC-1 - Innate immune response"	"Cluster 4: Extravillous trophoblasts - Unknown function"	146			"HPA038515: AB_10675800"			"unprognostic (1.38e-1)"												"potential prognostic favorable (7.58e-5)"																
PROC		ENSG00000115718	"Protein C, inactivator of coagulation factors Va and VIIIa"	P04070	2	127418427-127429242	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Hydrolase, Protease, Serine protease"	"Cancer-related genes, Disease variant, FDA approved drug targets, Thrombophilia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	40	"liver: 584.1"	"Cell type enriched"	"Detected in some"	4	"Hepatocytes: 339.4"	"Cell type enhanced"	"Detected in some"		"deep-layer near-projecting: 3.9;lower rhombic lip: 6.0"	"Cancer enriched"	"Detected in many"	7	"Liver Hepatocellular Carcinoma (TCGA): 301.0"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	9	"plasmacytoid DC: 59.8"	"Lineage enriched"	"Detected in many"	9	"dendritic cells: 59.8"	"Cancer enriched"	"Detected in many"	6	"liver cancer: 28.4"	"Kidney - Proximal tubular cells, Kidney - Proximal tubular cells, Liver - Hepatocytes, Skin - Outer root sheath cells"					"Not detected"	"Not detected"			"HPA005550, CAB016721, CAB016792"	Approved				"Secreted to blood"	"Blood coagulation"	NA	NA		3100000000	"Cluster 8: Plasmacytoid DCs - Unknown function"	"Cluster 31: Liver - Plasma proteins"	"Cluster 26: Oligodendrocytes - Mixed function"	"Cluster 18: Liver cancer - Metabolism"	"Cluster 43: Hepatocytes - Metabolism"	2			"CAB016721: , CAB016792: , HPA005550: AB_1079687"	"unprognostic (7.94e-3)"	"unprognostic (2.01e-2)"	"unprognostic (3.70e-1)"	"unprognostic (1.49e-3)"	"unprognostic (1.09e-1)"	"unprognostic (7.90e-2)"	"unprognostic (3.68e-1)"		"unprognostic (1.67e-2)"		"unprognostic (4.80e-3)"	"unprognostic (1.54e-2)"	"unprognostic (4.75e-3)"	"unprognostic (7.99e-3)"	"potential prognostic favorable (9.35e-4)"	"unprognostic (4.14e-1)"	"unprognostic (1.95e-2)"	"unprognostic (5.99e-2)"		"unprognostic (3.90e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.29e-1)"	"unprognostic (6.63e-2)"	"unprognostic (2.81e-2)"	"unprognostic (4.92e-2)"		"unprognostic (3.76e-3)"	"unprognostic (3.37e-1)"	"unprognostic (1.73e-2)"	"unprognostic (9.58e-3)"
PROS1	PROS	ENSG00000184500	"Protein S"	P07225	3	93873051-93980003	"Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Fibrinolysis, Hemostasis"		"Disease variant, FDA approved drug targets, Thrombophilia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 137.3;liver: 274.9"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 261.3;Mesothelial cells: 85.9"	"Group enriched"	"Detected in all"	4	"choroid plexus epithelial cell: 939.1;ependymal cell: 337.2"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	34	"choroid plexus: 214.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"skin cancer: 46.7"	"Adrenal gland - Fibroblasts, Breast - Fibroblasts, Liver - Hepatocytes, Minor Salivary Gland - Macrophages"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007724, HPA023974, CAB032610"	Approved				"Secreted to blood"	"Blood coagulation"	NA	NA	22500000000	8100000000		"Cluster 83: Liver - Metabolism"	"Cluster 36: Choroid plexus - Mixed function"	"Cluster 15: Kidney cancer - Membrane components"	"Cluster 53: Fibroblasts - ECM organization"	19			"CAB032610: AB_2237647, HPA007724: AB_1079688, HPA023974: AB_1855738"	"unprognostic (3.93e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.41e-1)"	"potential prognostic unfavorable (1.88e-4)"	"unprognostic (2.02e-2)"	"unprognostic (6.63e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.82e-3)"	"potential prognostic favorable (3.02e-7)"	"unprognostic (5.17e-3)"	"unprognostic (1.34e-1)"	"unprognostic (7.58e-2)"	"unprognostic (4.64e-1)"	"unprognostic (6.34e-2)"	"unprognostic (3.68e-1)"	"unprognostic (6.29e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.91e-2)"	"unprognostic (4.28e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.44e-2)"	"unprognostic (6.81e-2)"	"unprognostic (7.35e-2)"	"potential prognostic unfavorable (1.52e-4)"	"unprognostic (1.80e-1)"	"unprognostic (7.22e-2)"	"unprognostic (2.94e-1)"
REN		ENSG00000143839	Renin	P00797	1	204154819-204190324	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"		"Aspartyl protease, Hydrolase, Protease"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"kidney: 157.7"	"Group enriched"	"Detected in some"	5	"Club cells: 33.8;Late spermatids: 27.8;Smooth muscle cells: 14.8"	"Cell type enhanced"	"Detected in some"		"choroid plexus epithelial cell: 16.8;ependymal cell: 7.2"	"Cancer enriched"	"Detected in many"	9	"Kidney Renal Clear Cell Carcinoma (TCGA): 94.7"	"Region enhanced"	"Detected in many"		"choroid plexus: 7.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"Bladder cancer: 22.1;colorectal cancer: 8.4"	"Lung - Alveolar cells type 2, Testis - Late spermatids"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA005131	Approved				"Secreted to blood"	Enzyme	NA	NA	692000	9600		"Cluster 52: Kidney - Transmembrane transport"	"Cluster 36: Choroid plexus - Mixed function"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 50: Connective tissue cells - ECM organization"	5			"HPA005131: AB_1079174"	"unprognostic (6.94e-2)"		"unprognostic (1.19e-2)"		"unprognostic (1.18e-1)"	"unprognostic (2.37e-1)"				"unprognostic (1.77e-1)"	"potential prognostic favorable (8.68e-6)"	"unprognostic (2.00e-2)"	"potential prognostic unfavorable (3.47e-5)"	"unprognostic (2.05e-2)"	"unprognostic (1.63e-1)"		"unprognostic (1.42e-1)"			"unprognostic (1.72e-2)"	"unprognostic (2.18e-2)"				"unprognostic (1.13e-1)"	"unprognostic (5.58e-3)"			"unprognostic (2.11e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.25e-1)"
SCN1B		ENSG00000105711	"Sodium voltage-gated channel beta subunit 1"	Q07699	19	35030470-35040449	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion, Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Atrial fibrillation, Brugada syndrome, Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 278.8;skeletal muscle: 551.8;tongue: 218.9"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 65.8;Excitatory neurons: 48.8;Horizontal cells: 63.6;Inhibitory neurons: 46.5;Skeletal myocytes: 151.2"	"Cell type enhanced"	"Detected in all"		"cerebellar inhibitory: 205.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"thyroid cancer: 23.5"	"Minor Salivary Gland - Endothelial cells, Spleen - Macrophages"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebral cortex: 536.8"						"Secreted in other tissues"	Transport	NA	NA				"Cluster 79: Non-specific - Transcription"	"Cluster 52: Neurons & Synapses - Synaptic function"	"Cluster 72: Neuronal - Signal transduction"	"Cluster 57: Platelets - Hemostasis"	1				"unprognostic (2.34e-2)"	"unprognostic (1.81e-1)"	"unprognostic (8.87e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.72e-2)"	"unprognostic (3.28e-3)"	"unprognostic (1.84e-1)"	"unprognostic (4.04e-2)"	"unprognostic (6.10e-2)"	"unprognostic (3.26e-3)"	"unprognostic (4.37e-3)"	"potential prognostic favorable (1.85e-4)"	"unprognostic (8.76e-3)"	"unprognostic (1.06e-1)"	"unprognostic (8.55e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.77e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.24e-3)"	"unprognostic (2.22e-2)"	"potential prognostic favorable (3.80e-5)"	"unprognostic (1.91e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.24e-2)"	"unprognostic (6.25e-3)"	"unprognostic (1.95e-1)"	"unprognostic (3.72e-2)"	"unprognostic (7.88e-2)"
SERPINC1	"AT3, ATIII, MGC22579"	ENSG00000117601	"Serpin family C member 1"	P01008	1	173903800-173917327	"Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Heparin-binding, Protease inhibitor, Serine protease inhibitor"	"Disease variant, FDA approved drug targets, Thrombophilia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	1350	"liver: 4902.3"	"Cell type enriched"	"Detected in some"	36	"Hepatocytes: 2537.3"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	629	"Liver Hepatocellular Carcinoma (TCGA): 2227.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"Gastric cancer: 1.6;liver cancer: 5.7"	"Kidney - Proximal tubular cells, Liver - Hepatocytes"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA001816, CAB016790, HPA024007"	Supported				"Secreted to blood"	"Blood coagulation"	NA	NA		110000000000		"Cluster 31: Liver - Plasma proteins"		"Cluster 18: Liver cancer - Metabolism"	"Cluster 43: Hepatocytes - Metabolism"				"CAB016790: , HPA001816: AB_1079926, HPA024007: AB_1856732"			"unprognostic (4.53e-2)"								"unprognostic (4.40e-2)"			"validated prognostic favorable (3.41e-5)"	"validated prognostic favorable (4.37e-5)"														"unprognostic (6.24e-2)"		
SERPIND1	"D22S673, HC-II, HC2, HCF2, HLS2"	ENSG00000099937	"Serpin family D member 1"	P05546	22	20774113-20787720	"Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Chemotaxis, Hemostasis"	"Heparin-binding, Protease inhibitor, Serine protease inhibitor"	"Disease variant, FDA approved drug targets, Thrombophilia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 1214.6"	"Cell type enriched"	"Detected in some"	13	"Hepatocytes: 238.0"	"Cell type enhanced"	"Detected in all"		"choroid plexus epithelial cell: 13.3"	"Cancer enriched"	"Detected in many"	44	"Liver Hepatocellular Carcinoma (TCGA): 487.1"	"Region enriched"	"Detected in all"	21	"choroid plexus: 191.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	15	"liver cancer: 30.6;ovarian cancer: 66.9"	"Liver - Hepatocytes, Thyroid gland - Fibroblasts"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"CAB008639, HPA055767"	Supported		Approved	Vesicles	"Secreted to blood"	"Blood coagulation"	NA	NA		40000000000	"Cluster 30: Non-specific - DNA binding"	"Cluster 31: Liver - Plasma proteins"	"Cluster 36: Choroid plexus - Mixed function"	"Cluster 66: Non-specific - Mitochondria"	"Cluster 62: Hepatocytes - Metabolism"	4	Vesicles		"CAB008639: AB_1618010, HPA055767: AB_2682912"					"unprognostic (1.60e-2)"	"unprognostic (5.58e-3)"					"potential prognostic unfavorable (8.85e-4)"			"unprognostic (1.08e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.09e-1)"	"potential prognostic unfavorable (2.39e-4)"	"unprognostic (2.85e-1)"			"unprognostic (2.59e-2)"	"unprognostic (8.58e-3)"		"unprognostic (2.06e-1)"	"unprognostic (1.45e-1)"		"unprognostic (1.19e-1)"	"unprognostic (5.35e-2)"		
SERPINE1	"PAI, PAI1, PLANH1"	ENSG00000106366	"Serpin family E member 1"	P05121	7	101127104-101139247	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"gallbladder: 348.4;placenta: 403.7"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 212.1;Ovarian stromal cells: 138.1;Pancreatic endocrine cells: 466.9;Syncytiotrophoblasts: 739.0"	"Group enriched"	"Detected in many"	4	"central nervous system macrophage: 99.2;endothelial cell: 130.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	25	"NK-cell: 9.5"	"Lineage enriched"	"Detected in single"	25	"NK-cells: 9.5"	"Cancer enhanced"	"Detected in all"		"Kidney cancer: 1620.4"	"Colon - Neutrophils"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			CAB068501	Uncertain				"Secreted to blood"	"Enzyme inhibitor"	NA	No	142000000	20000000	"Cluster 14: Non-specific - Unknown function"	"Cluster 11: Liver - Plasma proteins"	"Cluster 12: Non-specific - Vasculature"	"Cluster 15: Kidney cancer - Membrane components"	"Cluster 45: Non-specific - Mixed function"	15			"CAB068501: AB_1642775"	"unprognostic (1.72e-2)"	"unprognostic (2.62e-2)"	"unprognostic (6.80e-2)"	"unprognostic (4.90e-3)"	"unprognostic (3.34e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.57e-2)"	"potential prognostic unfavorable (1.69e-4)"	"potential prognostic unfavorable (2.87e-5)"	"unprognostic (3.77e-3)"	"unprognostic (9.10e-3)"	"unprognostic (1.35e-1)"	"unprognostic (3.14e-3)"	"unprognostic (1.90e-3)"	"unprognostic (1.94e-1)"	"potential prognostic unfavorable (4.74e-4)"	"unprognostic (1.34e-3)"	"validated prognostic unfavorable (1.13e-4)"	"validated prognostic unfavorable (4.14e-5)"	"unprognostic (5.39e-2)"	"unprognostic (2.82e-1)"	"potential prognostic unfavorable (4.02e-4)"	"unprognostic (1.93e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.12e-1)"	"potential prognostic unfavorable (7.06e-6)"	"unprognostic (2.98e-1)"	"unprognostic (1.03e-2)"	"unprognostic (5.80e-3)"
SHBG	"ABP, MGC126834, MGC138391, TEBG"	ENSG00000129214	"Sex hormone binding globulin"	P04278	17	7613946-7633382	"Cancer-related genes, Candidate cardiovascular disease genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 61.5"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 51.9;Late spermatids: 124.0;Proximal enterocytes: 28.6"	"Low cell type specificity"	"Detected in many"			"Cancer enriched"	"Detected in some"	16	"Liver Hepatocellular Carcinoma (TCGA): 29.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Kidney - Proximal tubular cells, Kidney - Proximal tubular cells, Testis - Late spermatids"	"Not detected"	"Not detected"												"Secreted to blood"	Transport	NA	NA		6100000000		"Cluster 83: Liver - Metabolism"	"Cluster 39: Astrocytes - Mixed function"	"Cluster 72: Neuronal - Signal transduction"	"Cluster 36: Late spermatids - Unknown function"							"unprognostic (7.32e-2)"				"unprognostic (2.94e-2)"	"unprognostic (5.73e-2)"					"unprognostic (4.41e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.20e-2)"												"unprognostic (3.24e-2)"		"unprognostic (2.77e-1)"		
SOST	"DAND6, VBCH"	ENSG00000167941	Sclerostin	Q9BQB4	17	43753738-43758791	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted secreted proteins"	"Wnt signaling pathway"	Heparin-binding	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"kidney: 13.0"	"Group enriched"	"Detected in some"	5	"B-cells: 1.6;Cholangiocytes: 1.9;Collecting duct cells: 5.8;Pancreatic endocrine cells: 1.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"Bladder Urothelial Carcinoma (TCGA): 7.8;Lung Squamous Cell Carcinoma (TCGA): 17.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Bladder cancer: 12.3;Rhabdoid: 19.6"		"Group enriched"	"Detected in some"	11	"basal ganglia: 1.7;cerebellum: 1.0"	"Not detected"	"Not detected"								"Secreted to extracellular matrix"	Other	NA	NA		350000		"Cluster 52: Kidney - Transmembrane transport"		"Cluster 7: Liver cancer - Metabolism"	"Cluster 73: B-cells - B-cell function"	17				"unprognostic (1.65e-1)"								"unprognostic (2.39e-1)"									"unprognostic (4.78e-2)"	"unprognostic (3.97e-1)"												
TEK	"CD202b, TIE-2, TIE2, VMCM, VMCM1"	ENSG00000120156	"TEK receptor tyrosine kinase"	Q02763	9	27109141-27230174	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	Angiogenesis	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Glaucoma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 44.7"	"Group enriched"	"Detected in some"	6	"Adipocytes: 67.0;Endothelial cells: 74.2;Lymphatic endothelial cells: 34.9;Microglial cells: 36.7;Oligodendrocyte precursor cells: 129.2"	"Group enriched"	"Detected in all"	8	"endothelial cell: 417.7;oligodendrocyte precursor cell: 143.8"	"Cancer enhanced"	"Detected in all"		"Kidney Renal Clear Cell Carcinoma (TCGA): 13.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"Rhabdoid: 17.5;testis cancer: 16.9"	"Adipose subcutaneous - Endothelial cells, Adipose visceral - Endothelial cells, Adrenal gland - Endothelial cells, Breast - Endothelial cells, Colon - Endothelial cells, Heart muscle - Endothelial cells, Kidney - Endothelial cells, Liver - Sinusoid Endothelial cells, Lung - Endothelial cells, Minor Salivary Gland - Endothelial cells, Pituitary gland - Endothelial cells, Prostate - Endothelial cells, Skeletal muscle - Endothelial cells, Stomach - Endothelial cells, Testis - Endothelial cells, Thyroid gland - Endothelial cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010359, HPA073265"	Approved		Supported	"Plasma membrane,Centrosome,Basal body"	"Secreted to blood"	Receptor	NA	NA	7750000	8000000		"Cluster 7: Adipose tissue - Mixed function"	"Cluster 47: Endothelial cells - Vasculature"	"Cluster 48: Adipocytes & Endothelial cells - Angiogenesis"	"Cluster 41: Adipocytes & Endothelial cells - Mixed function"	14	"Plasma membrane"	"Centrosome, Basal body"	"CAB010359: AB_2203226, HPA073265: AB_2686592"	"unprognostic (2.08e-1)"	"unprognostic (3.02e-1)"	"unprognostic (7.64e-3)"	"unprognostic (4.21e-2)"	"unprognostic (3.16e-2)"	"unprognostic (5.78e-2)"	"unprognostic (2.56e-1)"	"unprognostic (8.83e-3)"	"unprognostic (4.71e-3)"	"unprognostic (3.04e-1)"	"validated prognostic favorable (3.45e-13)"	"validated prognostic favorable (5.48e-5)"	"unprognostic (4.39e-3)"	"validated prognostic favorable (1.01e-4)"	"validated prognostic favorable (8.49e-4)"	"unprognostic (2.27e-2)"	"unprognostic (3.43e-2)"	"unprognostic (6.68e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.82e-1)"		"unprognostic (7.71e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.48e-1)"	"unprognostic (6.37e-2)"	"unprognostic (1.74e-2)"	"unprognostic (3.60e-3)"	"unprognostic (3.71e-2)"	"unprognostic (5.25e-2)"	"unprognostic (6.63e-2)"
TFPI	"EPI, LACI, TFI, TFPI1"	ENSG00000003436	"Tissue factor pathway inhibitor"	P10646	2	187464230-187565760	"Candidate cardiovascular disease genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Protease inhibitor, Serine protease inhibitor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 263.9;placenta: 184.8"	"Group enriched"	"Detected in many"	4	"Extravillous trophoblasts: 2784.0;Lymphatic endothelial cells: 1775.9;Syncytiotrophoblasts: 976.8"	"Group enriched"	"Detected in many"	4	"fibroblast: 151.6;pericyte: 575.2;vascular associated smooth muscle cell: 159.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Adrenal gland - Endothelial cells, Breast - Fibroblasts"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA005575, CAB020842"	Supported				"Secreted to blood"	"Blood coagulation"	NA	NA	58100000	170000000	"Cluster 2: Dendritic cells - Unknown function"	"Cluster 11: Liver - Plasma proteins"	"Cluster 23: Choroid plexus - Mixed function"	"Cluster 48: Adipocytes & Endothelial cells - Angiogenesis"	"Cluster 4: Extravillous trophoblasts - Unknown function"	1			"CAB020842: , HPA005575: AB_1080290"	"unprognostic (1.88e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.60e-3)"	"unprognostic (4.89e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.44e-1)"	"unprognostic (6.68e-2)"	"unprognostic (8.07e-2)"	"unprognostic (3.54e-3)"	"unprognostic (2.37e-1)"	"unprognostic (2.25e-1)"	"unprognostic (8.07e-2)"	"unprognostic (2.15e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.89e-3)"	"unprognostic (2.86e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.40e-1)"	"unprognostic (5.08e-3)"	"unprognostic (6.37e-2)"	"unprognostic (6.57e-2)"	"unprognostic (2.12e-2)"	"unprognostic (3.11e-2)"	"unprognostic (7.48e-3)"	"unprognostic (1.32e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.38e-1)"
TFRC	"CD71, p90, TFR1"	ENSG00000072274	"Transferrin receptor"	P02786	3	196012511-196082153	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Endocytosis, Host-virus interaction"	"Host cell receptor for virus entry, Receptor, Transducer"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 451.2;monocytes: 612.3;Syncytiotrophoblasts: 467.6"	"Cell type enriched"	"Detected in all"	6	"endothelial cell: 425.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 9.2"	"Low lineage specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Adrenal gland - Adrenal cortex cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000153, HPA028598"	Enhanced		Supported	Endosomes,Lysosomes	"Secreted to blood"	Receptor	NA	NA	1310000000	73000000	"Cluster 13: Non-specific - Mitochondria"	"Cluster 56: Non-specific - Unknown function"	"Cluster 52: Neurons & Synapses - Synaptic function"	"Cluster 51: Myeloma - Immunoglobulins"	"Cluster 58: Macrophages - Innate immune response"	138	"Endosomes, Lysosomes"		"CAB000153: AB_2533029, HPA028598: AB_10601599"	"unprognostic (1.60e-2)"	"unprognostic (3.39e-2)"	"unprognostic (5.13e-2)"	"potential prognostic unfavorable (1.85e-4)"	"unprognostic (2.38e-1)"	"unprognostic (1.11e-1)"	"unprognostic (8.70e-2)"	"potential prognostic unfavorable (1.03e-4)"	"unprognostic (5.60e-2)"	"potential prognostic unfavorable (5.77e-4)"	"unprognostic (3.95e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.88e-2)"	"validated prognostic unfavorable (9.59e-6)"	"validated prognostic unfavorable (4.51e-6)"	"unprognostic (2.55e-2)"	"unprognostic (8.36e-3)"	"unprognostic (1.66e-2)"	"potential prognostic favorable (9.13e-4)"	"unprognostic (1.15e-2)"	"unprognostic (9.70e-3)"	"unprognostic (9.81e-3)"	"unprognostic (6.19e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.80e-2)"	"unprognostic (9.43e-3)"	"unprognostic (3.05e-2)"	"unprognostic (5.45e-2)"	"unprognostic (2.02e-3)"	"unprognostic (7.72e-2)"
TGFBR2	"MFS2, TBR-ii, TBRII"	ENSG00000163513	"Transforming growth factor beta receptor 2"	P37173	3	30606601-30694142	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Apoptosis, Differentiation, Growth regulation"	"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Aortic aneurysm, Cancer-related genes, Craniosynostosis, Disease variant, FDA approved drug targets, Hereditary nonpolyposis colorectal cancer"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 389.3;Endothelial cells: 383.4;Fibroblasts: 209.7;Lymphatic endothelial cells: 308.2"	"Group enriched"	"Detected in many"	9	"central nervous system macrophage: 646.8;choroid plexus epithelial cell: 610.3;endothelial cell: 572.4;fibroblast: 371.1;leukocyte: 407.5;pericyte: 296.7;vascular associated smooth muscle cell: 163.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Colon - Endothelial cells, Heart muscle - Macrophages, Kidney - Endothelial cells, Pituitary gland - Endothelial cells, Stomach - Endothelial cells, Testis - Endothelial cells, Thyroid gland - Endothelial cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB073537, HPA074821"			Supported	"Plasma membrane"	"Secreted to blood"	Receptor	NA	NA		520000	"Cluster 20: Non-specific - DNA binding"	"Cluster 7: Adipose tissue - Mixed function"	"Cluster 42: Choroid plexus - Mitochondria"	"Cluster 44: Connective tissue cells - ECM organization"	"Cluster 41: Adipocytes & Endothelial cells - Mixed function"	94	"Plasma membrane"		"CAB073537: , HPA074821: "	"unprognostic (1.13e-1)"	"unprognostic (4.37e-1)"	"unprognostic (4.60e-2)"	"unprognostic (4.96e-3)"	"unprognostic (6.38e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.92e-3)"	"validated prognostic favorable (2.35e-7)"	"validated prognostic favorable (3.61e-4)"	"unprognostic (2.97e-1)"	"unprognostic (2.96e-1)"	"unprognostic (3.33e-2)"	"unprognostic (8.78e-2)"	"unprognostic (2.21e-1)"	"unprognostic (4.04e-2)"	"unprognostic (5.62e-2)"	"unprognostic (5.82e-3)"	"unprognostic (1.32e-3)"	"unprognostic (3.90e-2)"	"unprognostic (6.15e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.75e-3)"	"unprognostic (2.56e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.94e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.88e-1)"
TNF	"DIF, TNF-alpha, TNFA, TNFSF2"	ENSG00000232810	"Tumor necrosis factor"	P01375	6	31575565-31578336	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		Cytokine	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 20.9;lymphoid tissue: 6.3"	"Cell type enhanced"	"Detected in many"		"B-cells: 100.4;Hofbauer cells: 84.3;Langerhans cells: 59.4;Macrophages: 158.2;monocytes: 97.8;Secretory cells: 58.0;T-cells: 93.4"	"Group enriched"	"Detected in some"	144	"central nervous system macrophage: 11.6;leukocyte: 17.3"	"Cancer enriched"	"Detected in single"	4	"Ovary Serous Cystadenocarcinoma (TCGA): 2.1"	"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 73.4"	"Group enriched"	"Detected in all"	6	"granulocytes: 22.7;monocytes: 73.4;T-cells: 41.4"	"Group enriched"	"Detected in many"	5	"Leukemia: 13.7;lymphoma: 34.9"	"Thyroid gland - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			CAB078469	Supported				"Secreted to blood"	Cytokine	NA	NA	10100		"Cluster 37: Monocytes & Neutrophils - Innate immune response"	"Cluster 81: Lymphoid tissue & Bone marrow - Innate immune response"	"Cluster 23: Choroid plexus - Mixed function"	"Cluster 55: Lymphoma - Immune response"	"Cluster 80: Non-specific - Transcription"	72			"CAB078469: AB_908070"			"unprognostic (4.29e-2)"					"unprognostic (3.12e-2)"							"unprognostic (2.61e-1)"					"unprognostic (1.68e-1)"	"unprognostic (2.63e-2)"		"unprognostic (1.56e-3)"								
TNFRSF1A	"CD120a, TNF-R, TNF-R-I, TNF-R55, TNFAR, TNFR1, TNFR60"	ENSG00000067182	"TNF receptor superfamily member 1A"	P19438	12	6328757-6342114	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Apoptosis, Host-virus interaction"	Receptor	"Amyloidosis, Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"central nervous system macrophage: 98.7;leukocyte: 78.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 454.7"	"Group enriched"	"Detected in many"	4	"dendritic cells: 116.0;granulocytes: 454.7;monocytes: 152.3"	"Low cancer specificity"	"Detected in all"			"Lung - Endothelial cells, Pituitary gland - Endothelial cells, Spleen - Fibroblast_1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004102, CAB010309"	Approved				"Secreted to blood"	Receptor	NA	NA	17700	650000	"Cluster 38: Monocytes & Neutrophils - Degranulation"	"Cluster 41: Smooth muscle tissue - ECM organization"	"Cluster 39: Astrocytes - Mixed function"	"Cluster 7: Liver cancer - Metabolism"	"Cluster 41: Adipocytes & Endothelial cells - Mixed function"	54			"CAB010309: AB_2206639, HPA004102: AB_1846232"	"unprognostic (1.10e-1)"	"unprognostic (7.91e-2)"	"unprognostic (2.45e-1)"	"unprognostic (7.41e-3)"	"unprognostic (2.64e-2)"	"unprognostic (5.28e-2)"	"unprognostic (4.83e-3)"	"potential prognostic unfavorable (1.94e-4)"	"unprognostic (2.80e-3)"	"unprognostic (1.03e-3)"	"unprognostic (5.66e-3)"	"unprognostic (3.12e-1)"	"unprognostic (5.44e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.09e-1)"	"potential prognostic unfavorable (1.81e-4)"	"unprognostic (1.10e-2)"	"unprognostic (5.05e-2)"	"potential prognostic unfavorable (7.43e-4)"	"unprognostic (1.10e-2)"	"unprognostic (4.00e-1)"	"unprognostic (1.85e-2)"	"potential prognostic unfavorable (5.97e-4)"	"unprognostic (3.29e-2)"	"unprognostic (1.96e-1)"	"unprognostic (4.87e-3)"	"unprognostic (3.77e-1)"	"unprognostic (4.75e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.45e-2)"	"unprognostic (4.70e-2)"
TNFSF11	"CD254, ODF, OPGL, RANKL, TRANCE"	ENSG00000120659	"TNF superfamily member 11"	O14788	13	42562736-42608013	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	Differentiation	"Cytokine, Developmental protein, Receptor"	"Cancer-related genes, Disease variant, FDA approved drug targets, Osteopetrosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"liver: 4.0;lymphoid tissue: 12.0"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 10.1;Ductal cells: 5.6;Early spermatids: 8.4;Late spermatids: 14.2;NK-cells: 3.9;Pancreatic endocrine cells: 3.4"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Pancreatic Adenocarcinoma (TCGA): 5.2"	"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in some"	8	"NK-cell: 9.9"	"Lineage enriched"	"Detected in many"	8	"NK-cells: 9.9"	"Cancer enhanced"	"Detected in some"		"Rhabdoid: 1.5;thyroid cancer: 1.7"	"Testis - Late spermatids"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB009193, HPA045142"	Enhanced				"Secreted to blood"	Cytokine	NA	NA	17200		"Cluster 15: NK-cells - Unknown function"	"Cluster 36: Lymphoid tissue - Cytokine signaling"	"Cluster 44: Non-specific - Mixed function"	"Cluster 55: Lymphoma - Immune response"	"Cluster 17: Breast glandular cells - Lactation"	4			"CAB009193: , HPA045142: AB_2679231"	"unprognostic (4.49e-2)"	"potential prognostic favorable (2.24e-4)"	"unprognostic (1.22e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.71e-2)"	"unprognostic (3.25e-2)"			"unprognostic (1.53e-1)"						"unprognostic (5.15e-2)"	"unprognostic (4.62e-3)"	"unprognostic (6.84e-2)"	"unprognostic (8.06e-2)"	"unprognostic (3.41e-2)"			"unprognostic (6.47e-3)"	"unprognostic (6.85e-2)"		"unprognostic (9.64e-2)"	"unprognostic (1.93e-1)"		"unprognostic (8.95e-2)"			
TNFSF13B	"BAFF, BLYS, CD257, TALL-1, TALL1, THANK, TNFSF20"	ENSG00000102524	"TNF superfamily member 13b"	Q9Y275	13	108251240-108308484	"Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	Immunity	Cytokine	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 19.8;lymphoid tissue: 25.2"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 167.6;Kupffer cells: 106.6;Langerhans cells: 300.8;Macrophages: 143.4;monocytes: 542.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 509.3"	"Group enriched"	"Detected in all"	11	"dendritic cells: 207.0;granulocytes: 509.3;monocytes: 352.4"	"Cancer enriched"	"Detected in some"	10	"Leukemia: 21.6"		"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB009188, HPA030526"	Enhanced		Supported	"Vesicles,Plasma membrane,Focal adhesion sites"	"Secreted to blood"	Cytokine	NA	NA	393000	640000	"Cluster 38: Monocytes & Neutrophils - Degranulation"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 8: Immune cells - Immune response"	"Cluster 14: Myeloid leukemia - Innate immune response"	"Cluster 29: Monocytes - Innate immune response"	26	"Plasma membrane"	"Vesicles, Focal adhesion sites"	"CAB009188: , HPA030526: "	"unprognostic (5.03e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.11e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.72e-2)"	"potential prognostic unfavorable (5.23e-4)"	"unprognostic (1.28e-1)"	"unprognostic (3.10e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.68e-2)"	"unprognostic (9.78e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.10e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.85e-2)"	"unprognostic (2.99e-2)"	"unprognostic (3.60e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.08e-1)"	"unprognostic (5.58e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.08e-2)"	"unprognostic (3.62e-1)"	"unprognostic (1.56e-2)"
TSLP		ENSG00000145777	"Thymic stromal lymphopoietin"	Q969D9	5	111070062-111078026	"FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"		Cytokine	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 11.2;urinary bladder: 11.5"	"Group enriched"	"Detected in many"	4	"Basal respiratory cells: 102.0;Basal squamous epithelial cells: 211.4"	"Cell type enhanced"	"Detected in some"		"bergmann glia: 2.3;fibroblast: 3.2;pericyte: 4.1;vascular associated smooth muscle cell: 2.8"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"thalamus: 2.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"				"Not detected"	"Not detected"							HPA056350			Uncertain	"Golgi apparatus,Vesicles"	"Secreted to blood"	Cytokine	NA	NA	38400			"Cluster 83: Liver - Metabolism"	"Cluster 39: Astrocytes - Mixed function"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 12: Squamous epithelial cells - Keratinization"		"Golgi apparatus, Vesicles"		"HPA056350: "	"unprognostic (2.00e-1)"		"unprognostic (3.84e-1)"	"unprognostic (2.14e-1)"				"unprognostic (6.83e-3)"	"unprognostic (1.34e-1)"				"unprognostic (4.59e-3)"		"potential prognostic favorable (1.34e-4)"			"unprognostic (9.35e-3)"	"unprognostic (1.67e-1)"				"unprognostic (8.36e-2)"	"unprognostic (5.25e-2)"						"unprognostic (9.30e-2)"	
TTR	"CTS, CTS1, HsT2651, PALB"	ENSG00000118271	Transthyretin	P02766	18	31557009-31598833	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Transport	"Hormone, Thyroid hormone"	"Amyloidosis, Cancer-related genes, Disease variant, FDA approved drug targets, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	34	"choroid plexus: 692067.5"	"Cell type enriched"	"Detected in many"	7	"Hepatocytes: 26585.9"	"Cell type enriched"	"Detected in many"	8	"choroid plexus epithelial cell: 40087.7"	"Group enriched"	"Detected in many"	21	"Liver Hepatocellular Carcinoma (TCGA): 5122.1;Pancreatic Adenocarcinoma (TCGA): 4235.1"	"Region enriched"	"Detected in all"	82	"choroid plexus: 302089.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	7	"Gastric cancer: 130.8;liver cancer: 177.5"	"Liver - Hepatocytes, Pancreas - Alpha cells, Pituitary gland - Thyrotropes, Testis - Early spermatids"	"Group enriched"	"Detected in all"	5	"basal ganglia: 1538.8;hippocampal formation: 4894.4;pons and medulla: 5760.6;thalamus: 3403.0"	"Region enhanced"	"Detected in all"		"medulla oblongata: 1291.2"	"CAB002517, HPA002550, CAB062567, CAB073406"	Supported		Approved	"Golgi apparatus"	"Secreted to blood"	Hormone	NA	NA	345000000000	80000000000		"Cluster 60: Choroid plexus - Transmembrane transport"	"Cluster 36: Choroid plexus - Mixed function"	"Cluster 18: Liver cancer - Metabolism"	"Cluster 43: Hepatocytes - Metabolism"	82	"Golgi apparatus"		"CAB002517: AB_563965, CAB062567: AB_2665620, CAB073406: , HPA002550: AB_1080419"	"unprognostic (1.74e-2)"	"unprognostic (2.14e-3)"	"unprognostic (2.36e-1)"	"unprognostic (7.56e-2)"	"unprognostic (9.13e-3)"	"unprognostic (3.33e-1)"	"unprognostic (2.88e-2)"			"unprognostic (1.76e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.81e-2)"	"unprognostic (9.90e-2)"	"unprognostic (9.78e-3)"	"unprognostic (1.09e-3)"	"unprognostic (8.07e-2)"	"unprognostic (3.57e-2)"		"unprognostic (1.64e-1)"			"unprognostic (8.01e-3)"	"unprognostic (5.15e-2)"	"unprognostic (6.35e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.02e-3)"	"unprognostic (8.28e-2)"	"unprognostic (3.94e-2)"	"unprognostic (1.05e-1)"	"unprognostic (5.14e-2)"	
VEGFA	"VEGF, VEGF-A, VPF"	ENSG00000112715	"Vascular endothelial growth factor A"	P15692	6	43770184-43786487	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	"Angiogenesis, Differentiation"	"Developmental protein, Growth factor, Heparin-binding, Mitogen"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 241.3;granulocytes: 274.5;Langerhans cells: 272.3"	"Cell type enhanced"	"Detected in all"		"astrocyte: 127.8;oligodendrocyte precursor cell: 116.3"	"Cancer enhanced"	"Detected in all"		"Kidney Renal Clear Cell Carcinoma (TCGA): 667.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in all"			"Adrenal gland - Adrenal cortex cells, Kidney - Podocytes"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005429, CAB039240, HPA069116, CAB069907"	Supported				"Secreted to blood"	"Growth factor"	NA	NA	562000	20000		"Cluster 19: Non-specific - Basic cellular processes"	"Cluster 42: Choroid plexus - Mitochondria"	"Cluster 15: Kidney cancer - Membrane components"	"Cluster 29: Monocytes - Innate immune response"	24			"CAB005429: AB_2212984, CAB039240: , CAB069907: AB_10001947, HPA069116: AB_2686089"	"unprognostic (2.38e-1)"	"unprognostic (1.70e-2)"	"unprognostic (7.20e-2)"	"potential prognostic unfavorable (8.18e-4)"	"unprognostic (2.97e-3)"	"unprognostic (2.69e-1)"	"unprognostic (6.95e-3)"	"potential prognostic unfavorable (1.56e-4)"	"unprognostic (1.22e-1)"	"unprognostic (4.35e-2)"	"potential prognostic favorable (2.20e-4)"	"unprognostic (3.93e-3)"	"potential prognostic unfavorable (4.09e-5)"	"potential prognostic unfavorable (1.16e-4)"	"unprognostic (3.40e-3)"	"unprognostic (1.24e-2)"	"potential prognostic unfavorable (7.04e-4)"	"unprognostic (1.25e-1)"	"unprognostic (8.42e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.58e-3)"	"unprognostic (8.45e-3)"	"unprognostic (5.90e-3)"	"unprognostic (1.28e-1)"	"unprognostic (9.42e-2)"	"unprognostic (3.35e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.35e-1)"	"unprognostic (4.26e-2)"
VEGFB	"VEGFL, VRF"	ENSG00000173511	"Vascular endothelial growth factor B"	P49765	11	64234584-64239264	"Cancer-related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor, Heparin-binding, Mitogen"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 191.8;dendritic cells: 201.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	10	"plasmacytoid DC: 30.5"	"Lineage enriched"	"Detected in many"	10	"dendritic cells: 30.5"	"Low cancer specificity"	"Detected in all"			"Adipose subcutaneous - Adipocytes (Subcutaneous), Adipose visceral - Adipocytes (Visceral), Breast - Adipocytes (Breast), Thyroid gland - Fibroblasts"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to blood"	"Growth factor"	NA	NA	186000		"Cluster 44: Plasmacytoid DCs - Plasma membrane proteins"	"Cluster 30: Heart muscle - Heart development"	"Cluster 19: Astrocytes - Mixed function"	"Cluster 24: Non-specific - Unknown function"	"Cluster 33: Non-specific - DNA binding"	3				"unprognostic (2.58e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.28e-2)"	"unprognostic (9.85e-2)"	"unprognostic (2.82e-3)"	"unprognostic (3.18e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.32e-2)"	"unprognostic (1.58e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.99e-2)"	"unprognostic (4.45e-3)"	"unprognostic (2.92e-1)"	"unprognostic (1.56e-1)"	"unprognostic (9.06e-3)"	"unprognostic (2.42e-1)"	"unprognostic (9.74e-2)"	"unprognostic (2.04e-1)"	"unprognostic (4.11e-3)"	"unprognostic (2.66e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.84e-3)"	"unprognostic (6.44e-2)"	"unprognostic (6.10e-3)"	"unprognostic (1.28e-1)"
VWF	F8VWF	ENSG00000110799	"Von Willebrand factor"	P04275	12	5948877-6124770	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Cell adhesion, Hemostasis"		"Cancer-related genes, Disease variant, FDA approved drug targets, von Willebrand disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"Adipocytes: 917.4;Endothelial cells: 827.6"	"Cell type enriched"	"Detected in many"	13	"endothelial cell: 1181.2"	"Cancer enriched"	"Detected in all"	4	"Kidney Renal Clear Cell Carcinoma (TCGA): 196.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Adipose subcutaneous - Endothelial cells, Adipose visceral - Endothelial cells, Breast - Endothelial cells, Colon - Endothelial cells, Minor Salivary Gland - Endothelial cells, Prostate - Endothelial cells, Skeletal muscle - Endothelial cells, Stomach - Endothelial cells, Testis - Endothelial cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001694, HPA001815, HPA002082, CAB072874, CAB072875"	Supported				"Secreted to blood"	"Blood coagulation"	NA	NA	28300000000	5000000000		"Cluster 7: Adipose tissue - Mixed function"	"Cluster 47: Endothelial cells - Vasculature"	"Cluster 48: Adipocytes & Endothelial cells - Angiogenesis"	"Cluster 41: Adipocytes & Endothelial cells - Mixed function"	12			"CAB001694: , CAB072874: AB_2665726, CAB072875: AB_2665727, HPA001815: AB_611880, HPA002082: AB_1080575"	"unprognostic (2.57e-1)"	"unprognostic (3.86e-1)"	"unprognostic (1.44e-3)"	"unprognostic (2.94e-1)"	"unprognostic (6.69e-2)"	"unprognostic (7.81e-3)"	"unprognostic (1.24e-1)"	"unprognostic (5.14e-2)"	"unprognostic (2.63e-2)"	"unprognostic (4.13e-2)"	"potential prognostic favorable (5.48e-9)"	"unprognostic (1.34e-3)"	"unprognostic (2.44e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.97e-2)"	"unprognostic (4.36e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.13e-2)"	"unprognostic (6.69e-2)"	"unprognostic (7.28e-2)"	"unprognostic (3.62e-2)"	"unprognostic (2.23e-1)"	"unprognostic (7.57e-2)"	"unprognostic (1.86e-1)"	"unprognostic (5.86e-2)"	"unprognostic (2.59e-1)"	"unprognostic (7.36e-2)"	"potential prognostic unfavorable (1.93e-4)"	"unprognostic (1.09e-1)"	"unprognostic (9.44e-2)"	"unprognostic (1.42e-3)"
